MIME-Version: 1.0
Content-Type: multipart/related; boundary="----=_NextPart_01D74BE8.F0EBCC80"

This document is a Single File Web Page, also known as a Web Archive file.  If you are seeing this message, your browser or editor doesn't support Web Archive files.  Please download a browser that supports Web Archive.

------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1252"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:dt=3D"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
2">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 15">
<meta name=3DOriginator content=3D"Microsoft Word 15">
<link rel=3DFile-List href=3D"Zynteglo_clean_files/filelist.xml">
<link rel=3DEdit-Time-Data href=3D"Zynteglo_clean_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title>Zynteglo, INN-betibeglogene autotemcel</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Subject>EPAR</o:Subject>
  <o:Author>CHMP</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>P Reshma Sagar</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>0</o:TotalTime>
  <o:LastPrinted>2019-10-21T17:01:00Z</o:LastPrinted>
  <o:Created>2021-05-18T07:53:00Z</o:Created>
  <o:LastSaved>2021-05-18T07:53:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>12782</o:Words>
  <o:Characters>72864</o:Characters>
  <o:Company>European Medicines Agency</o:Company>
  <o:Lines>607</o:Lines>
  <o:Paragraphs>170</o:Paragraphs>
  <o:CharactersWithSpaces>85476</o:CharactersWithSpaces>
  <o:Version>16.00</o:Version>
 </o:DocumentProperties>
 <o:CustomDocumentProperties>
  <o:ad0100bce5784abd97063598554744e6 dt:dt=3D"string"></o:ad0100bce5784abd=
97063598554744e6>
  <o:AuthorIds_UIVersion_49152 dt:dt=3D"string">306</o:AuthorIds_UIVersion_=
49152>
  <o:AuthorIds_UIVersion_512 dt:dt=3D"string">13</o:AuthorIds_UIVersion_512>
  <o:ContentTypeId dt:dt=3D"string">0x010100726F91DD1AE57B44B1BCEB7F1056F5D=
0</o:ContentTypeId>
  <o:dcfaeba014cb48c78725c2554a8266a0 dt:dt=3D"string"></o:dcfaeba014cb48c7=
8725c2554a8266a0>
  <o:display_urn_x003a_schemas-microsoft-com_x003a_office_x003a_office_x002=
3_SharedWithUsers
   dt:dt=3D"string">Anne-Virginie Eggimann;Jessie Hanrahan;Fran Smith;Barb =
Morollo;Mohammed Asmal;Weiliang Shi</o:display_urn_x003a_schemas-microsoft-=
com_x003a_office_x003a_office_x0023_SharedWithUsers>
  <o:DM_Author dt:dt=3D"string"></o:DM_Author>
  <o:DM_Authors dt:dt=3D"string"></o:DM_Authors>
  <o:DM_Category dt:dt=3D"string">Product Information</o:DM_Category>
  <o:DM_Creation_Date dt:dt=3D"string">23/04/2019 15:37:31</o:DM_Creation_D=
ate>
  <o:DM_Creator_Name dt:dt=3D"string">Belonina Irina</o:DM_Creator_Name>
  <o:DM_DocRefId dt:dt=3D"string">EMA/232506/2019</o:DM_DocRefId>
  <o:DM_emea_bcc dt:dt=3D"string"></o:DM_emea_bcc>
  <o:DM_emea_cc dt:dt=3D"string"></o:DM_emea_cc>
  <o:DM_emea_doc_category dt:dt=3D"string">General</o:DM_emea_doc_category>
  <o:DM_emea_doc_lang dt:dt=3D"string"></o:DM_emea_doc_lang>
  <o:DM_emea_doc_number dt:dt=3D"string">423415</o:DM_emea_doc_number>
  <o:DM_emea_doc_ref_id dt:dt=3D"string">EMA/232506/2019</o:DM_emea_doc_ref=
_id>
  <o:DM_emea_from dt:dt=3D"string"></o:DM_emea_from>
  <o:DM_emea_internal_label dt:dt=3D"string">EMA</o:DM_emea_internal_label>
  <o:DM_emea_legal_date dt:dt=3D"string">nulldate</o:DM_emea_legal_date>
  <o:DM_emea_meeting_action dt:dt=3D"string"></o:DM_emea_meeting_action>
  <o:DM_emea_meeting_flags dt:dt=3D"string"></o:DM_emea_meeting_flags>
  <o:DM_emea_meeting_hyperlink dt:dt=3D"string"></o:DM_emea_meeting_hyperli=
nk>
  <o:DM_emea_meeting_ref dt:dt=3D"string"></o:DM_emea_meeting_ref>
  <o:DM_emea_meeting_status dt:dt=3D"string"></o:DM_emea_meeting_status>
  <o:DM_emea_meeting_title dt:dt=3D"string"></o:DM_emea_meeting_title>
  <o:DM_emea_message_subject dt:dt=3D"string"></o:DM_emea_message_subject>
  <o:DM_emea_received_date dt:dt=3D"string">nulldate</o:DM_emea_received_da=
te>
  <o:DM_emea_resp_body dt:dt=3D"string"></o:DM_emea_resp_body>
  <o:DM_emea_revision_label dt:dt=3D"string"></o:DM_emea_revision_label>
  <o:DM_emea_sent_date dt:dt=3D"string">nulldate</o:DM_emea_sent_date>
  <o:DM_emea_to dt:dt=3D"string"></o:DM_emea_to>
  <o:DM_emea_year dt:dt=3D"string">2010</o:DM_emea_year>
  <o:DM_Keywords dt:dt=3D"string"></o:DM_Keywords>
  <o:DM_Language dt:dt=3D"string"></o:DM_Language>
  <o:DM_Modifer_Name dt:dt=3D"string">Belonina Irina</o:DM_Modifer_Name>
  <o:DM_Modified_Date dt:dt=3D"string">23/04/2019 15:37:31</o:DM_Modified_D=
ate>
  <o:DM_Modifier_Name dt:dt=3D"string">Belonina Irina</o:DM_Modifier_Name>
  <o:DM_Modify_Date dt:dt=3D"string">23/04/2019 15:37:31</o:DM_Modify_Date>
  <o:DM_Name dt:dt=3D"string">Zynteglo EN PI - Rev. 1</o:DM_Name>
  <o:DM_Owner dt:dt=3D"string">Espinasse Claire</o:DM_Owner>
  <o:DM_Path dt:dt=3D"string">/01. Evaluation of Medicines/H-C/Y-Z/Zynteglo=
 - 003691/03 Evaluation/The Revised CAT Opinion (17.04.2019)</o:DM_Path>
  <o:DM_Status dt:dt=3D"string"></o:DM_Status>
  <o:DM_Subject dt:dt=3D"string"></o:DM_Subject>
  <o:DM_Title dt:dt=3D"string"></o:DM_Title>
  <o:DM_Type dt:dt=3D"string">emea_document</o:DM_Type>
  <o:DM_Version dt:dt=3D"string">1.4,CURRENT</o:DM_Version>
  <o:j62a98e6fcb94578a89bc49268a70fed dt:dt=3D"string"></o:j62a98e6fcb94578=
a89bc49268a70fed>
  <o:MAAModule1Submodule dt:dt=3D"string">15;#1.3 Product Information|286d9=
b8a-281c-4700-9caa-e247beed18ce</o:MAAModule1Submodule>
  <o:MAAModule2Submodules dt:dt=3D"string"></o:MAAModule2Submodules>
  <o:MAAModule3Submodule dt:dt=3D"string"></o:MAAModule3Submodule>
  <o:MAAModule4Submodule dt:dt=3D"string"></o:MAAModule4Submodule>
  <o:MAAModule5Submodule dt:dt=3D"string"></o:MAAModule5Submodule>
  <o:ob62cd5a2ac84a1e8ad9f5882f5c3614 dt:dt=3D"string">1.3 Product Informat=
ion|286d9b8a-281c-4700-9caa-e247beed18ce</o:ob62cd5a2ac84a1e8ad9f5882f5c361=
4>
  <o:p471899d131c4cdba96cabf572bb67df dt:dt=3D"string"></o:p471899d131c4cdb=
a96cabf572bb67df>
  <o:Status dt:dt=3D"string">In Draft</o:Status>
  <o:Table_x0020_and_x0020_figure_x0020_numbering_x0020_style dt:dt=3D"stri=
ng">Document</o:Table_x0020_and_x0020_figure_x0020_numbering_x0020_style>
  <o:TaxCatchAll dt:dt=3D"string">412;#1.3 Product Information|286d9b8a-281=
c-4700-9caa-e247beed18ce</o:TaxCatchAll>
  <o:Module_x0020_1_x0020_Submodule dt:dt=3D"string"></o:Module_x0020_1_x00=
20_Submodule>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Enabled dt:dt=3D"strin=
g">true</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Enabled>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_SetDate dt:dt=3D"strin=
g">2021-03-04T13:28:44Z</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_=
SetDate>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Method dt:dt=3D"string=
">Standard</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Method>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Name dt:dt=3D"string">=
0eea11ca-d417-4147-80ed-01a58412c458</o:MSIP_Label_0eea11ca-d417-4147-80ed-=
01a58412c458_Name>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_SiteId dt:dt=3D"string=
">bc9dc15c-61bc-4f03-b60b-e5b6d8922839</o:MSIP_Label_0eea11ca-d417-4147-80e=
d-01a58412c458_SiteId>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_ActionId dt:dt=3D"stri=
ng">490b9069-7bed-40ea-aa95-c3f0e2dfa077</o:MSIP_Label_0eea11ca-d417-4147-8=
0ed-01a58412c458_ActionId>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_ContentBits dt:dt=3D"s=
tring">2</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_ContentBits>
 </o:CustomDocumentProperties>
 <o:OfficeDocumentSettings>
  <o:RelyOnVML/>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=3DdataStoreItem href=3D"Zynteglo_clean_files/item0001.xml"
target=3D"Zynteglo_clean_files/props002.xml">
<link rel=3DdataStoreItem href=3D"Zynteglo_clean_files/item0003.xml"
target=3D"Zynteglo_clean_files/props004.xml">
<link rel=3DdataStoreItem href=3D"Zynteglo_clean_files/item0005.xml"
target=3D"Zynteglo_clean_files/props006.xml">
<link rel=3DdataStoreItem href=3D"Zynteglo_clean_files/item0007.xml"
target=3D"Zynteglo_clean_files/props008.xml">
<link rel=3DdataStoreItem href=3D"Zynteglo_clean_files/item0009.xml"
target=3D"Zynteglo_clean_files/props010.xml">
<link rel=3DthemeData href=3D"Zynteglo_clean_files/themedata.thmx">
<link rel=3DcolorSchemeMapping href=3D"Zynteglo_clean_files/colorschememapp=
ing.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:HideSpellingErrors/>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:DisplayHorizontalDrawingGridEvery>0</w:DisplayHorizontalDrawingGridEve=
ry>
  <w:DisplayVerticalDrawingGridEvery>0</w:DisplayVerticalDrawingGridEvery>
  <w:UseMarginsForDrawingGridOrigin/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>ZH-TW</w:LidThemeAsian>
  <w:LidThemeComplexScript>AR-SA</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
   <w:UseFELayout/>
  </w:Compatibility>
  <w:DocumentVariables>
   <w:EN.InstantFormat>&lt;ENInstantFormat&gt;&lt;Enabled&gt;1&lt;/Enabled&=
gt;&lt;ScanUnformatted&gt;1&lt;/ScanUnformatted&gt;&lt;ScanChanges&gt;1&lt;=
/ScanChanges&gt;&lt;Suspended&gt;1&lt;/Suspended&gt;&lt;/ENInstantFormat&gt=
;</w:EN.InstantFormat>
   <w:QXCheckInvalidStyle>1</w:QXCheckInvalidStyle>
   <w:QXCitationStyleId>apa</w:QXCitationStyleId>
   <w:QXCitationStyleName>American Psychological Association 6th Edition</w=
:QXCitationStyleName>
   <w:QXCookie>62346321</w:QXCookie>
   <w:QXCRLMode>0</w:QXCRLMode>
   <w:QXFormattingMode>1</w:QXFormattingMode>
   <w:Registered>-1</w:Registered>
   <w:Version>0</w:Version>
  </w:DocumentVariables>
  <m:mathPr>
   <m:mathFont m:val=3D"Cambria Math"/>
   <m:brkBin m:val=3D"before"/>
   <m:brkBinSub m:val=3D"&#45;-"/>
   <m:smallFrac m:val=3D"off"/>
   <m:dispDef/>
   <m:lMargin m:val=3D"0"/>
   <m:rMargin m:val=3D"0"/>
   <m:defJc m:val=3D"centerGroup"/>
   <m:wrapIndent m:val=3D"1440"/>
   <m:intLim m:val=3D"subSup"/>
   <m:naryLim m:val=3D"undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" DefUnhideWhenUsed=3D"false"
  DefSemiHidden=3D"false" DefQFormat=3D"false" LatentStyleCount=3D"376">
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"Normal"/>
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"heading 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 9"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 9"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toc 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toc 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toc 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toc 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toc 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toc 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toc 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toc 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toc 9"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal Indent"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"footnote text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"annotation text"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"header"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"footer"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index heading"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"caption"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"table of figures"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"envelope address"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"envelope return"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"footnote reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"annotation reference"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"line number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"page number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"endnote reference"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"endnote text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"table of authorities"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toa heading"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 5"/>
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"Title"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Closing"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Signature"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Default Paragraph Font"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 2"/>
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"Subtitle"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Salutation"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Date"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text First Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text First Indent 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Note Heading"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Block Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Hyperlink"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"FollowedHyperlink"/>
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"Strong"/>
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"Emphasis"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Document Map"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Plain Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"E-mail Signature"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Top of Form"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Bottom of Form"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Normal (Web)"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Acronym"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Address"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Cite"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Code"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Definition"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Keyboard"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Preformatted"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Sample"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Typewriter"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Variable"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal Table"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"annotation subject"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"No List"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Contemporary"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Elegant"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Professional"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Subtle 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Subtle 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Balloon Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"Table Grid"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Theme"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   Name=3D"Placeholder Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" QFormat=3D"true" Name=3D"=
No Spacing"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true" Name=
=3D"Revision"/>
  <w:LsdException Locked=3D"false" Priority=3D"34" QFormat=3D"true"
   Name=3D"List Paragraph"/>
  <w:LsdException Locked=3D"false" Priority=3D"29" QFormat=3D"true" Name=3D=
"Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"30" QFormat=3D"true"
   Name=3D"Intense Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"19" QFormat=3D"true"
   Name=3D"Subtle Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"21" QFormat=3D"true"
   Name=3D"Intense Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"31" QFormat=3D"true"
   Name=3D"Subtle Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"32" QFormat=3D"true"
   Name=3D"Intense Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"33" QFormat=3D"true" Name=3D=
"Book Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"37" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Bibliography"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"TOC Heading"/>
  <w:LsdException Locked=3D"false" Priority=3D"41" Name=3D"Plain Table 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"42" Name=3D"Plain Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"43" Name=3D"Plain Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"44" Name=3D"Plain Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"45" Name=3D"Plain Table 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"40" Name=3D"Grid Table Light=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"46" Name=3D"Grid Table 1 Lig=
ht"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k"/>
  <w:LsdException Locked=3D"false" Priority=3D"51" Name=3D"Grid Table 6 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"52" Name=3D"Grid Table 7 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"46" Name=3D"List Table 1 Lig=
ht"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k"/>
  <w:LsdException Locked=3D"false" Priority=3D"51" Name=3D"List Table 6 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"52" Name=3D"List Table 7 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Mention"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Smart Hyperlink"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Hashtag"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Unresolved Mention"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Smart Link"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-alt:\5B8B\4F53;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 680460288 22 0 262145 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073732485 9 0 511 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610610945 1073750107 16 0 415 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520081665 -1073717157 41 0 66047 0;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073683329 9 0 511 0;}
@font-face
	{font-family:Consolas;
	panose-1:2 11 6 9 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536869121 64767 1 0 415 0;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 680460288 22 0 262145 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
h1
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 1 Char";
	mso-style-next:Normal;
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	tab-stops:list .25in;
	font-size:14.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	text-transform:uppercase;
	mso-font-kerning:16.0pt;
	font-weight:bold;}
h2
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 2 Char";
	mso-style-next:Normal;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list .25in;
	font-size:14.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	font-weight:bold;}
h3
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 3 Char";
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	tab-stops:list .25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
h4
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 4 Char";
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	tab-stops:list .25in;
	font-size:11.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	font-weight:bold;}
h5
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 5 Char";
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	tab-stops:list .25in;
	font-size:11.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	font-weight:bold;}
h6
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 6 Char";
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	tab-stops:list .25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 7 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-outline-level:7;
	tab-stops:list .25in;
	font-size:11.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 8 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-outline-level:8;
	tab-stops:list .25in;
	font-size:11.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 9 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-outline-level:9;
	tab-stops:list .25in;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoIndex1, li.MsoIndex1, div.MsoIndex1
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	text-indent:-11.0pt;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoIndex2, li.MsoIndex2, div.MsoIndex2
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:22.0pt;
	text-indent:-11.0pt;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoIndex3, li.MsoIndex3, div.MsoIndex3
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:33.0pt;
	text-indent:-11.0pt;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoIndex4, li.MsoIndex4, div.MsoIndex4
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:44.0pt;
	text-indent:-11.0pt;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoIndex5, li.MsoIndex5, div.MsoIndex5
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:55.0pt;
	text-indent:-11.0pt;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoIndex6, li.MsoIndex6, div.MsoIndex6
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:66.0pt;
	text-indent:-11.0pt;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoIndex7, li.MsoIndex7, div.MsoIndex7
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:77.0pt;
	text-indent:-11.0pt;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoIndex8, li.MsoIndex8, div.MsoIndex8
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:88.0pt;
	text-indent:-11.0pt;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoIndex9, li.MsoIndex9, div.MsoIndex9
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:99.0pt;
	text-indent:-11.0pt;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoToc1, li.MsoToc1, div.MsoToc1
	{mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-next:"C-Body Text";
	margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:normal;
	mso-pagination:widow-orphan;
	tab-stops:.8in right dotted 6.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;
	color:blue;
	text-transform:uppercase;}
p.MsoToc2, li.MsoToc2, div.MsoToc2
	{mso-style-unhide:no;
	mso-style-parent:"TOC 1";
	mso-style-next:"C-Body Text";
	margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:normal;
	mso-pagination:widow-orphan;
	tab-stops:.8in right dotted 6.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;
	color:blue;}
p.MsoToc3, li.MsoToc3, div.MsoToc3
	{mso-style-unhide:no;
	mso-style-parent:"TOC 1";
	mso-style-next:"C-Body Text";
	margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:normal;
	mso-pagination:widow-orphan;
	tab-stops:.8in right dotted 6.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;
	color:blue;}
p.MsoToc4, li.MsoToc4, div.MsoToc4
	{mso-style-unhide:no;
	mso-style-parent:"TOC 1";
	mso-style-next:"C-Body Text";
	margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:normal;
	mso-pagination:widow-orphan;
	tab-stops:.8in right dotted 6.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;
	color:blue;}
p.MsoToc5, li.MsoToc5, div.MsoToc5
	{mso-style-unhide:no;
	mso-style-parent:"TOC 1";
	mso-style-next:"C-Body Text";
	margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:normal;
	mso-pagination:widow-orphan;
	tab-stops:.8in right dotted 6.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;
	color:blue;}
p.MsoToc6, li.MsoToc6, div.MsoToc6
	{mso-style-unhide:no;
	mso-style-parent:"TOC 1";
	mso-style-next:"C-Body Text";
	margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:normal;
	mso-pagination:widow-orphan;
	tab-stops:.8in right dotted 6.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;
	color:blue;}
p.MsoToc7, li.MsoToc7, div.MsoToc7
	{mso-style-unhide:no;
	mso-style-parent:"TOC 1";
	mso-style-next:"C-Body Text";
	margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:normal;
	mso-pagination:widow-orphan;
	tab-stops:.8in right dotted 6.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;
	color:blue;}
p.MsoToc8, li.MsoToc8, div.MsoToc8
	{mso-style-unhide:no;
	mso-style-parent:"TOC 1";
	mso-style-next:"C-Body Text";
	margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:normal;
	mso-pagination:widow-orphan;
	tab-stops:.8in right dotted 6.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;
	color:blue;}
p.MsoToc9, li.MsoToc9, div.MsoToc9
	{mso-style-unhide:no;
	mso-style-parent:"TOC 1";
	mso-style-next:"C-Body Text";
	margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:normal;
	mso-pagination:widow-orphan;
	tab-stops:.8in right dotted 6.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;
	color:blue;}
p.MsoNormalIndent, li.MsoNormalIndent, div.MsoNormalIndent
	{mso-style-noshow:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-priority:99;
	mso-style-link:"Footnote Text Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-name:"Comment Text\,Comment Text Char Char\,Comment Text Char C=
har Char Char\,Comment Text Char Char1 Char\,Comment Text Char1 Char Char\,=
Comment Text Char2 Char";
	mso-style-unhide:no;
	mso-style-link:"Comment Text Char\,Comment Text Char Char Char\,Comment Te=
xt Char Char Char Char Char\,Comment Text Char Char1 Char Char\,Comment Tex=
t Char1 Char Char Char\,Comment Text Char2 Char Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-priority:99;
	mso-style-link:"Header Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	tab-stops:center 3.25in right 6.5in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-priority:99;
	mso-style-link:"Footer Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	tab-stops:center 3.25in right 6.5in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoIndexHeading, li.MsoIndexHeading, div.MsoIndexHeading
	{mso-style-noshow:yes;
	mso-style-next:"Index 1";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:PMingLiU;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	font-weight:bold;}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-name:"Caption\,B Caption\,Bayer Caption\,Caption2\,IB Caption\,=
Medical Caption\,Table Caption";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	mso-style-link:"Caption Char\,B Caption Char\,Bayer Caption Char\,Caption2=
 Char\,IB Caption Char\,Medical Caption Char\,Table Caption Char";
	mso-style-next:"C-Body Text";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.0in;
	text-indent:-1.0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoTof, li.MsoTof, div.MsoTof
	{mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-next:"C-Body Text";
	margin-top:6.0pt;
	margin-right:.55in;
	margin-bottom:0in;
	margin-left:.8in;
	text-indent:-.8in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.8in right dotted 6.5in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;
	color:blue;}
p.MsoEnvelopeAddress, li.MsoEnvelopeAddress, div.MsoEnvelopeAddress
	{mso-style-noshow:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	mso-element:frame;
	mso-element-frame-width:5.5in;
	mso-element-frame-height:99.0pt;
	mso-element-frame-hspace:9.0pt;
	mso-element-wrap:auto;
	mso-element-anchor-horizontal:page;
	mso-element-left:center;
	mso-element-top:bottom;
	mso-height-rule:exactly;
	font-size:12.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:PMingLiU;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;}
p.MsoEnvelopeReturn, li.MsoEnvelopeReturn, div.MsoEnvelopeReturn
	{mso-style-noshow:yes;
	margin:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:PMingLiU;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	mso-style-priority:99;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoEndnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
p.MsoEndnoteText, li.MsoEndnoteText, div.MsoEndnoteText
	{mso-style-noshow:yes;
	mso-style-link:"Endnote Text Char";
	margin:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoToa, li.MsoToa, div.MsoToa
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	text-indent:-11.0pt;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoMacroText, li.MsoMacroText, div.MsoMacroText
	{mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-link:"Macro Text Char";
	margin:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	tab-stops:24.0pt 48.0pt 1.0in 96.0pt 120.0pt 2.0in 168.0pt 192.0pt 3.0in;
	font-size:10.0pt;
	font-family:Consolas;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoToaHeading, li.MsoToaHeading, div.MsoToaHeading
	{mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	font-weight:bold;}
p.MsoList, li.MsoList, div.MsoList
	{mso-style-noshow:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListCxSpFirst, li.MsoListCxSpFirst, div.MsoListCxSpFirst
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListCxSpMiddle, li.MsoListCxSpMiddle, div.MsoListCxSpMiddle
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListCxSpLast, li.MsoListCxSpLast, div.MsoListCxSpLast
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBullet, li.MsoListBullet, div.MsoListBullet
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l9 level1 lfo35;
	tab-stops:list .25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBulletCxSpFirst, li.MsoListBulletCxSpFirst, div.MsoListBulletCxSpF=
irst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l9 level1 lfo35;
	tab-stops:list .25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBulletCxSpMiddle, li.MsoListBulletCxSpMiddle, div.MsoListBulletCxS=
pMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l9 level1 lfo35;
	tab-stops:list .25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBulletCxSpLast, li.MsoListBulletCxSpLast, div.MsoListBulletCxSpLast
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l9 level1 lfo35;
	tab-stops:list .25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumber, li.MsoListNumber, div.MsoListNumber
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l8 level1 lfo40;
	tab-stops:list .25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumberCxSpFirst, li.MsoListNumberCxSpFirst, div.MsoListNumberCxSpF=
irst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l8 level1 lfo40;
	tab-stops:list .25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumberCxSpMiddle, li.MsoListNumberCxSpMiddle, div.MsoListNumberCxS=
pMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l8 level1 lfo40;
	tab-stops:list .25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumberCxSpLast, li.MsoListNumberCxSpLast, div.MsoListNumberCxSpLast
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l8 level1 lfo40;
	tab-stops:list .25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoList2, li.MsoList2, div.MsoList2
	{mso-style-noshow:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoList2CxSpFirst, li.MsoList2CxSpFirst, div.MsoList2CxSpFirst
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoList2CxSpMiddle, li.MsoList2CxSpMiddle, div.MsoList2CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoList2CxSpLast, li.MsoList2CxSpLast, div.MsoList2CxSpLast
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoList3, li.MsoList3, div.MsoList3
	{mso-style-noshow:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.75in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoList3CxSpFirst, li.MsoList3CxSpFirst, div.MsoList3CxSpFirst
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoList3CxSpMiddle, li.MsoList3CxSpMiddle, div.MsoList3CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoList3CxSpLast, li.MsoList3CxSpLast, div.MsoList3CxSpLast
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.75in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoList4, li.MsoList4, div.MsoList4
	{mso-style-noshow:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.0in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoList4CxSpFirst, li.MsoList4CxSpFirst, div.MsoList4CxSpFirst
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoList4CxSpMiddle, li.MsoList4CxSpMiddle, div.MsoList4CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoList4CxSpLast, li.MsoList4CxSpLast, div.MsoList4CxSpLast
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.0in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoList5, li.MsoList5, div.MsoList5
	{mso-style-noshow:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoList5CxSpFirst, li.MsoList5CxSpFirst, div.MsoList5CxSpFirst
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoList5CxSpMiddle, li.MsoList5CxSpMiddle, div.MsoList5CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoList5CxSpLast, li.MsoList5CxSpLast, div.MsoList5CxSpLast
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBullet2, li.MsoListBullet2, div.MsoListBullet2
	{mso-style-noshow:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l7 level1 lfo36;
	tab-stops:list .5in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBullet2CxSpFirst, li.MsoListBullet2CxSpFirst, div.MsoListBullet2Cx=
SpFirst
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l7 level1 lfo36;
	tab-stops:list .5in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBullet2CxSpMiddle, li.MsoListBullet2CxSpMiddle, div.MsoListBullet2=
CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l7 level1 lfo36;
	tab-stops:list .5in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBullet2CxSpLast, li.MsoListBullet2CxSpLast, div.MsoListBullet2CxSp=
Last
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l7 level1 lfo36;
	tab-stops:list .5in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBullet3, li.MsoListBullet3, div.MsoListBullet3
	{mso-style-noshow:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.75in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l6 level1 lfo37;
	tab-stops:list .75in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBullet3CxSpFirst, li.MsoListBullet3CxSpFirst, div.MsoListBullet3Cx=
SpFirst
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l6 level1 lfo37;
	tab-stops:list .75in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBullet3CxSpMiddle, li.MsoListBullet3CxSpMiddle, div.MsoListBullet3=
CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l6 level1 lfo37;
	tab-stops:list .75in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBullet3CxSpLast, li.MsoListBullet3CxSpLast, div.MsoListBullet3CxSp=
Last
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.75in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l6 level1 lfo37;
	tab-stops:list .75in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBullet4, li.MsoListBullet4, div.MsoListBullet4
	{mso-style-noshow:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.0in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l5 level1 lfo38;
	tab-stops:list 1.0in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBullet4CxSpFirst, li.MsoListBullet4CxSpFirst, div.MsoListBullet4Cx=
SpFirst
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l5 level1 lfo38;
	tab-stops:list 1.0in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBullet4CxSpMiddle, li.MsoListBullet4CxSpMiddle, div.MsoListBullet4=
CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l5 level1 lfo38;
	tab-stops:list 1.0in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBullet4CxSpLast, li.MsoListBullet4CxSpLast, div.MsoListBullet4CxSp=
Last
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.0in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l5 level1 lfo38;
	tab-stops:list 1.0in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBullet5, li.MsoListBullet5, div.MsoListBullet5
	{mso-style-noshow:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l4 level1 lfo39;
	tab-stops:list 1.25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBullet5CxSpFirst, li.MsoListBullet5CxSpFirst, div.MsoListBullet5Cx=
SpFirst
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l4 level1 lfo39;
	tab-stops:list 1.25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBullet5CxSpMiddle, li.MsoListBullet5CxSpMiddle, div.MsoListBullet5=
CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l4 level1 lfo39;
	tab-stops:list 1.25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListBullet5CxSpLast, li.MsoListBullet5CxSpLast, div.MsoListBullet5CxSp=
Last
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l4 level1 lfo39;
	tab-stops:list 1.25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumber2, li.MsoListNumber2, div.MsoListNumber2
	{mso-style-noshow:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l3 level1 lfo41;
	tab-stops:list .5in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumber2CxSpFirst, li.MsoListNumber2CxSpFirst, div.MsoListNumber2Cx=
SpFirst
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l3 level1 lfo41;
	tab-stops:list .5in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumber2CxSpMiddle, li.MsoListNumber2CxSpMiddle, div.MsoListNumber2=
CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l3 level1 lfo41;
	tab-stops:list .5in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumber2CxSpLast, li.MsoListNumber2CxSpLast, div.MsoListNumber2CxSp=
Last
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l3 level1 lfo41;
	tab-stops:list .5in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumber3, li.MsoListNumber3, div.MsoListNumber3
	{mso-style-noshow:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.75in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l2 level1 lfo42;
	tab-stops:list .75in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumber3CxSpFirst, li.MsoListNumber3CxSpFirst, div.MsoListNumber3Cx=
SpFirst
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l2 level1 lfo42;
	tab-stops:list .75in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumber3CxSpMiddle, li.MsoListNumber3CxSpMiddle, div.MsoListNumber3=
CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l2 level1 lfo42;
	tab-stops:list .75in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumber3CxSpLast, li.MsoListNumber3CxSpLast, div.MsoListNumber3CxSp=
Last
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.75in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l2 level1 lfo42;
	tab-stops:list .75in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumber4, li.MsoListNumber4, div.MsoListNumber4
	{mso-style-noshow:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.0in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l1 level1 lfo43;
	tab-stops:list 1.0in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumber4CxSpFirst, li.MsoListNumber4CxSpFirst, div.MsoListNumber4Cx=
SpFirst
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l1 level1 lfo43;
	tab-stops:list 1.0in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumber4CxSpMiddle, li.MsoListNumber4CxSpMiddle, div.MsoListNumber4=
CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l1 level1 lfo43;
	tab-stops:list 1.0in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumber4CxSpLast, li.MsoListNumber4CxSpLast, div.MsoListNumber4CxSp=
Last
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.0in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l1 level1 lfo43;
	tab-stops:list 1.0in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumber5, li.MsoListNumber5, div.MsoListNumber5
	{mso-style-noshow:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l0 level1 lfo44;
	tab-stops:list 1.25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumber5CxSpFirst, li.MsoListNumber5CxSpFirst, div.MsoListNumber5Cx=
SpFirst
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l0 level1 lfo44;
	tab-stops:list 1.25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumber5CxSpMiddle, li.MsoListNumber5CxSpMiddle, div.MsoListNumber5=
CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l0 level1 lfo44;
	tab-stops:list 1.25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListNumber5CxSpLast, li.MsoListNumber5CxSpLast, div.MsoListNumber5CxSp=
Last
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:1.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l0 level1 lfo44;
	tab-stops:list 1.25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Title Char";
	mso-style-next:Normal;
	margin:0in;
	mso-add-space:auto;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:28.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:PMingLiU;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;}
p.MsoTitleCxSpFirst, li.MsoTitleCxSpFirst, div.MsoTitleCxSpFirst
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Title Char";
	mso-style-next:Normal;
	mso-style-type:export-only;
	margin:0in;
	mso-add-space:auto;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:28.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:PMingLiU;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;}
p.MsoTitleCxSpMiddle, li.MsoTitleCxSpMiddle, div.MsoTitleCxSpMiddle
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Title Char";
	mso-style-next:Normal;
	mso-style-type:export-only;
	margin:0in;
	mso-add-space:auto;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:28.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:PMingLiU;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;}
p.MsoTitleCxSpLast, li.MsoTitleCxSpLast, div.MsoTitleCxSpLast
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Title Char";
	mso-style-next:Normal;
	mso-style-type:export-only;
	margin:0in;
	mso-add-space:auto;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:28.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:PMingLiU;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;}
p.MsoClosing, li.MsoClosing, div.MsoClosing
	{mso-style-noshow:yes;
	mso-style-link:"Closing Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:3.0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoSignature, li.MsoSignature, div.MsoSignature
	{mso-style-noshow:yes;
	mso-style-link:"Signature Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:3.0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-style-unhide:no;
	mso-style-link:"Body Text Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	color:green;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{mso-style-unhide:no;
	mso-style-link:"Body Text Indent Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinue, li.MsoListContinue, div.MsoListContinue
	{mso-style-noshow:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinueCxSpFirst, li.MsoListContinueCxSpFirst, div.MsoListContinu=
eCxSpFirst
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinueCxSpMiddle, li.MsoListContinueCxSpMiddle, div.MsoListConti=
nueCxSpMiddle
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinueCxSpLast, li.MsoListContinueCxSpLast, div.MsoListContinueC=
xSpLast
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinue2, li.MsoListContinue2, div.MsoListContinue2
	{mso-style-noshow:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.5in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinue2CxSpFirst, li.MsoListContinue2CxSpFirst, div.MsoListConti=
nue2CxSpFirst
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinue2CxSpMiddle, li.MsoListContinue2CxSpMiddle, div.MsoListCon=
tinue2CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinue2CxSpLast, li.MsoListContinue2CxSpLast, div.MsoListContinu=
e2CxSpLast
	{mso-style-noshow:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.5in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinue3, li.MsoListContinue3, div.MsoListContinue3
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.75in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinue3CxSpFirst, li.MsoListContinue3CxSpFirst, div.MsoListConti=
nue3CxSpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinue3CxSpMiddle, li.MsoListContinue3CxSpMiddle, div.MsoListCon=
tinue3CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinue3CxSpLast, li.MsoListContinue3CxSpLast, div.MsoListContinu=
e3CxSpLast
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.75in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinue4, li.MsoListContinue4, div.MsoListContinue4
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.0in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinue4CxSpFirst, li.MsoListContinue4CxSpFirst, div.MsoListConti=
nue4CxSpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinue4CxSpMiddle, li.MsoListContinue4CxSpMiddle, div.MsoListCon=
tinue4CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinue4CxSpLast, li.MsoListContinue4CxSpLast, div.MsoListContinu=
e4CxSpLast
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.0in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinue5, li.MsoListContinue5, div.MsoListContinue5
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.25in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinue5CxSpFirst, li.MsoListContinue5CxSpFirst, div.MsoListConti=
nue5CxSpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinue5CxSpMiddle, li.MsoListContinue5CxSpMiddle, div.MsoListCon=
tinue5CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListContinue5CxSpLast, li.MsoListContinue5CxSpLast, div.MsoListContinu=
e5CxSpLast
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.25in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoMessageHeader, li.MsoMessageHeader, div.MsoMessageHeader
	{mso-style-unhide:no;
	mso-style-link:"Message Header Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	mso-pagination:widow-orphan;
	background:#CCCCCC;
	mso-shading:windowtext;
	mso-pattern:gray-20 auto;
	border:none;
	mso-border-alt:solid windowtext .75pt;
	padding:0in;
	mso-padding-alt:1.0pt 1.0pt 1.0pt 1.0pt;
	font-size:12.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:PMingLiU;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;}
p.MsoSubtitle, li.MsoSubtitle, div.MsoSubtitle
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Subtitle Char";
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:PMingLiU;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	color:#5A5A5A;
	mso-themecolor:text1;
	mso-themetint:165;
	letter-spacing:.75pt;}
p.MsoSalutation, li.MsoSalutation, div.MsoSalutation
	{mso-style-noshow:yes;
	mso-style-link:"Salutation Char";
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoDate, li.MsoDate, div.MsoDate
	{mso-style-noshow:yes;
	mso-style-link:"Date Char";
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoBodyTextFirstIndent, li.MsoBodyTextFirstIndent, div.MsoBodyTextFirstIn=
dent
	{mso-style-noshow:yes;
	mso-style-parent:"Body Text";
	mso-style-link:"Body Text First Indent Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	text-indent:.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoBodyTextFirstIndent2, li.MsoBodyTextFirstIndent2, div.MsoBodyTextFirst=
Indent2
	{mso-style-unhide:no;
	mso-style-parent:"Body Text Indent";
	mso-style-link:"Body Text First Indent 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	text-indent:10.5pt;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoNoteHeading, li.MsoNoteHeading, div.MsoNoteHeading
	{mso-style-noshow:yes;
	mso-style-link:"Note Heading Char";
	mso-style-next:Normal;
	margin:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{mso-style-noshow:yes;
	mso-style-link:"Body Text 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{mso-style-noshow:yes;
	mso-style-link:"Body Text 3 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{mso-style-noshow:yes;
	mso-style-link:"Body Text Indent 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	line-height:200%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{mso-style-noshow:yes;
	mso-style-link:"Body Text Indent 3 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoBlockText, li.MsoBlockText, div.MsoBlockText
	{mso-style-noshow:yes;
	margin-top:0in;
	margin-right:.8in;
	margin-bottom:8.0pt;
	margin-left:.8in;
	line-height:107%;
	mso-pagination:widow-orphan;
	border:none;
	mso-border-alt:solid #4472C4 .25pt;
	mso-border-themecolor:accent1;
	padding:0in;
	mso-padding-alt:10.0pt 10.0pt 10.0pt 10.0pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:PMingLiU;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	color:#4472C4;
	mso-themecolor:accent1;
	font-style:italic;}
a:link, span.MsoHyperlink
	{mso-style-unhide:no;
	mso-style-parent:"";
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	color:#954F72;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	mso-style-link:"Document Map Char";
	margin:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:"Segoe UI",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
	{mso-style-noshow:yes;
	mso-style-link:"Plain Text Char";
	margin:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:10.5pt;
	font-family:Consolas;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoAutoSig, li.MsoAutoSig, div.MsoAutoSig
	{mso-style-noshow:yes;
	mso-style-link:"E-mail Signature Char";
	margin:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p
	{mso-style-priority:99;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
address
	{mso-style-noshow:yes;
	mso-style-link:"HTML Address Char";
	margin:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	font-style:italic;}
kbd
	{mso-style-unhide:no;
	mso-style-parent:"";
	font-family:"Courier New";
	mso-ascii-font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
pre
	{mso-style-noshow:yes;
	mso-style-link:"HTML Preformatted Char";
	margin:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:10.0pt;
	font-family:Consolas;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-unhide:no;
	mso-style-parent:"Comment Text\,Comment Text Char Char\,Comment Text Char =
Char Char Char\,Comment Text Char Char1 Char\,Comment Text Char1 Char Char\=
,Comment Text Char2 Char";
	mso-style-link:"Comment Subject Char";
	mso-style-next:"Comment Text\,Comment Text Char Char\,Comment Text Char Ch=
ar Char Char\,Comment Text Char Char1 Char\,Comment Text Char1 Char Char\,C=
omment Text Char2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;}
span.MsoPlaceholderText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	color:gray;}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
	{mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoRMPane, li.MsoRMPane, div.MsoRMPane
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParag=
raphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListPar=
agraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagra=
phCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoQuote, li.MsoQuote, div.MsoQuote
	{mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Quote Char";
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:.6in;
	margin-bottom:8.0pt;
	margin-left:.6in;
	text-align:center;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	color:#404040;
	mso-themecolor:text1;
	mso-themetint:191;
	font-style:italic;}
p.MsoIntenseQuote, li.MsoIntenseQuote, div.MsoIntenseQuote
	{mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Intense Quote Char";
	mso-style-next:Normal;
	margin-top:.25in;
	margin-right:.6in;
	margin-bottom:.25in;
	margin-left:.6in;
	text-align:center;
	line-height:107%;
	mso-pagination:widow-orphan;
	border:none;
	mso-border-top-alt:solid #4472C4 .5pt;
	mso-border-top-themecolor:accent1;
	mso-border-bottom-alt:solid #4472C4 .5pt;
	mso-border-bottom-themecolor:accent1;
	padding:0in;
	mso-padding-alt:10.0pt 0in 10.0pt 0in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	color:#4472C4;
	mso-themecolor:accent1;
	font-style:italic;}
p.MsoBibliography, li.MsoBibliography, div.MsoBibliography
	{mso-style-noshow:yes;
	mso-style-priority:37;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.MsoTocHeading, li.MsoTocHeading, div.MsoTocHeading
	{mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-qformat:yes;
	mso-style-parent:"Heading 1";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:PMingLiU;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#2F5496;
	mso-themecolor:accent1;
	mso-themeshade:191;}
p.MemoHeaderStyle, li.MemoHeaderStyle, div.MemoHeaderStyle
	{mso-style-name:MemoHeaderStyle;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:70.9pt;
	text-align:justify;
	text-justify:inter-ideograph;
	mso-line-height-alt:6.0pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	font-variant:small-caps;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.EMEAEnBodyText, li.EMEAEnBodyText, div.EMEAEnBodyText
	{mso-style-name:"EMEA En Body Text";
	mso-style-unhide:no;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:justify;
	text-justify:inter-ideograph;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.BodytextAgency, li.BodytextAgency, div.BodytextAgency
	{mso-style-name:"Body text \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Body text \(Agency\) Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-fareast-language:EN-GB;}
span.BodytextAgencyChar
	{mso-style-name:"Body text \(Agency\) Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body text \(Agency\)";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-fareast-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
p.DraftingNotesAgency, li.DraftingNotesAgency, div.DraftingNotesAgency
	{mso-style-name:"Drafting Notes \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Drafting Notes \(Agency\) Char";
	mso-style-next:"Body text \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	color:#339966;
	mso-fareast-language:EN-GB;
	font-style:italic;
	mso-bidi-font-style:normal;}
span.DraftingNotesAgencyChar
	{mso-style-name:"Drafting Notes \(Agency\) Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Drafting Notes \(Agency\)";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Courier New";
	mso-ascii-font-family:"Courier New";
	mso-fareast-font-family:Verdana;
	mso-hansi-font-family:"Courier New";
	color:#339966;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.NormalAgency, li.NormalAgency, div.NormalAgency
	{mso-style-name:"Normal \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	mso-style-link:"Normal \(Agency\) Char";
	margin:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
p.TableheadingrowsAgency, li.TableheadingrowsAgency, div.TableheadingrowsAg=
ency
	{mso-style-name:"Table heading rows \(Agency\)";
	mso-style-unhide:no;
	mso-style-parent:"Body text \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Verdana;
	mso-fareast-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.TabletextrowsAgency, li.TabletextrowsAgency, div.TabletextrowsAgency
	{mso-style-name:"Table text rows \(Agency\)";
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:Verdana;}
span.NormalAgencyChar
	{mso-style-name:"Normal \(Agency\) Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Normal \(Agency\)";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-fareast-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char\,Comment Text Char Char Char\,Comment T=
ext Char Char Char Char Char\,Comment Text Char Char1 Char Char\,Comment Te=
xt Char1 Char Char Char\,Comment Text Char2 Char Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Comment Text\,Comment Text Char Char\,Comment Text Char Ch=
ar Char Char\,Comment Text Char Char1 Char\,Comment Text Char1 Char Char\,C=
omment Text Char2 Char";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Comment Subject";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;
	font-weight:bold;}
p.documenttextoutlinenumbered, li.documenttextoutlinenumbered, div.document=
textoutlinenumbered
	{mso-style-name:"document text outline numbered";
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:107%;
	mso-pagination:widow-orphan;
	mso-list:l36 level1 lfo1;
	tab-stops:list .25in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
p.Default, li.Default, div.Default
	{mso-style-name:Default;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	color:black;}
p.C-BodyText, li.C-BodyText, div.C-BodyText
	{mso-style-name:"C-Body Text";
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-link:"C-Body Text Char";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
span.C-BodyTextChar
	{mso-style-name:"C-Body Text Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"C-Body Text";
	mso-ansi-font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
span.Mention1
	{mso-style-name:Mention1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	color:#2B579A;
	background:#E6E6E6;}
p.C-Bullet, li.C-Bullet, div.C-Bullet
	{mso-style-name:C-Bullet;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	mso-list:l38 level1 lfo2;
	tab-stops:list .75in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
p.C-BulletIndented, li.C-BulletIndented, div.C-BulletIndented
	{mso-style-name:"C-Bullet Indented";
	mso-style-unhide:no;
	mso-style-parent:"";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.0in;
	text-indent:-.25in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	mso-list:l38 level2 lfo2;
	tab-stops:list 1.0in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;}
p.tablefootnote, li.tablefootnote, div.tablefootnote
	{mso-style-name:"table footnote";
	mso-style-unhide:no;
	mso-style-parent:"";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:normal;
	mso-pagination:widow-orphan;
	tab-stops:.25in;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
span.CaptionChar
	{mso-style-name:"Caption Char\,B Caption Char\,Bayer Caption Char\,Caption=
2 Char\,IB Caption Char\,Medical Caption Char\,Table Caption Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Caption\,B Caption\,Bayer Caption\,Caption2\,IB Caption\,M=
edical Caption\,Table Caption";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.C-Hyperlink
	{mso-style-name:C-Hyperlink;
	mso-style-unhide:no;
	mso-style-parent:"";
	color:blue;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 1";
	mso-ansi-font-size:14.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;
	text-transform:uppercase;
	mso-font-kerning:16.0pt;
	font-weight:bold;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 2";
	mso-ansi-font-size:14.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;
	font-weight:bold;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 3";
	mso-ansi-font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
span.Heading4Char
	{mso-style-name:"Heading 4 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 4";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.Heading5Char
	{mso-style-name:"Heading 5 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 5";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;
	font-weight:bold;}
span.Heading6Char
	{mso-style-name:"Heading 6 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 6";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.Heading7Char
	{mso-style-name:"Heading 7 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 7";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
span.Heading8Char
	{mso-style-name:"Heading 8 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 8";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
span.Heading9Char
	{mso-style-name:"Heading 9 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 9";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Arial",sans-serif;
	mso-ascii-font-family:Arial;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Arial;
	mso-bidi-font-family:Arial;}
p.C-Heading1, li.C-Heading1, div.C-Heading1
	{mso-style-name:"C-Heading 1";
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-link:"C-Heading 1 Char";
	mso-style-next:"C-Body Text";
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	page-break-before:always;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	mso-list:l28 level1 lfo3;
	tab-stops:list .75in;
	font-size:14.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	text-transform:uppercase;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-Heading2, li.C-Heading2, div.C-Heading2
	{mso-style-name:"C-Heading 2";
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-next:"C-Body Text";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	mso-list:l28 level2 lfo3;
	tab-stops:list .75in;
	font-size:14.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-Heading3, li.C-Heading3, div.C-Heading3
	{mso-style-name:"C-Heading 3";
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-next:"C-Body Text";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	mso-list:l28 level3 lfo3;
	tab-stops:list .75in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-Heading4, li.C-Heading4, div.C-Heading4
	{mso-style-name:"C-Heading 4";
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-next:"C-Body Text";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	mso-list:l28 level4 lfo3;
	tab-stops:list .75in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-Heading5, li.C-Heading5, div.C-Heading5
	{mso-style-name:"C-Heading 5";
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-next:"C-Body Text";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	mso-list:l28 level5 lfo3;
	tab-stops:list .75in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-Heading6, li.C-Heading6, div.C-Heading6
	{mso-style-name:"C-Heading 6";
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-next:"C-Body Text";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.85in;
	text-indent:-.85in;
	line-height:normal;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	mso-list:l28 level6 lfo3;
	tab-stops:list .85in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-BodyTextIndent, li.C-BodyTextIndent, div.C-BodyTextIndent
	{mso-style-name:"C-Body Text Indent";
	mso-style-unhide:no;
	mso-style-parent:"";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.25in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
p.C-TableHeader, li.C-TableHeader, div.C-TableHeader
	{mso-style-name:"C-Table Header";
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-next:"C-Table Text";
	margin-top:1.0pt;
	margin-right:0in;
	margin-bottom:1.0pt;
	margin-left:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-TableText, li.C-TableText, div.C-TableText
	{mso-style-name:"C-Table Text";
	mso-style-unhide:no;
	mso-style-parent:"";
	margin-top:1.0pt;
	margin-right:0in;
	margin-bottom:1.0pt;
	margin-left:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
p.C-TableFootnote, li.C-TableFootnote, div.C-TableFootnote
	{mso-style-name:"C-Table Footnote";
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-next:"C-Body Text";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.1in;
	text-indent:-.1in;
	line-height:normal;
	mso-pagination:widow-orphan;
	tab-stops:.1in;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;}
p.C-TOCTitle, li.C-TOCTitle, div.C-TOCTitle
	{mso-style-name:"C-TOC Title";
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-next:"C-Body Text";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:normal;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	font-size:14.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	text-transform:uppercase;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-CaptionContinued, li.C-CaptionContinued, div.C-CaptionContinued
	{mso-style-name:"C-Caption Continued";
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-next:"C-Body Text";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.0in;
	text-indent:-1.0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-NumberedList, li.C-NumberedList, div.C-NumberedList
	{mso-style-name:"C-Numbered List";
	mso-style-unhide:no;
	mso-style-parent:"";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.5in;
	text-indent:-.25in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	mso-list:l31 level1 lfo6;
	tab-stops:list .5in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
p.C-InstructionText, li.C-InstructionText, div.C-InstructionText
	{mso-style-name:"C-Instruction Text";
	mso-style-unhide:no;
	mso-style-parent:"";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	color:red;
	display:none;
	mso-hide:all;}
p.C-Title, li.C-Title, div.C-Title
	{mso-style-name:C-Title;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-next:"C-Body Text";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:18.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	text-transform:uppercase;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-Header, li.C-Header, div.C-Header
	{mso-style-name:C-Header;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
p.C-Footer, li.C-Footer, div.C-Footer
	{mso-style-name:C-Footer;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0in;
	text-align:right;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
p.C-Heading1non-numbered, li.C-Heading1non-numbered, div.C-Heading1non-numb=
ered
	{mso-style-name:"C-Heading 1 \(non-numbered\)";
	mso-style-unhide:no;
	mso-style-parent:"C-Heading 1";
	mso-style-next:"C-Body Text";
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	page-break-before:always;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	tab-stops:.75in;
	font-size:14.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	text-transform:uppercase;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-Heading2non-numbered, li.C-Heading2non-numbered, div.C-Heading2non-numb=
ered
	{mso-style-name:"C-Heading 2 \(non-numbered\)";
	mso-style-unhide:no;
	mso-style-parent:"C-Heading 2";
	mso-style-next:"C-Body Text";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:.75in;
	font-size:14.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-Heading3non-numbered, li.C-Heading3non-numbered, div.C-Heading3non-numb=
ered
	{mso-style-name:"C-Heading 3 \(non-numbered\)";
	mso-style-unhide:no;
	mso-style-parent:"C-Heading 3";
	mso-style-next:"C-Body Text";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	tab-stops:.75in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-Heading4non-numbered, li.C-Heading4non-numbered, div.C-Heading4non-numb=
ered
	{mso-style-name:"C-Heading 4 \(non-numbered\)";
	mso-style-unhide:no;
	mso-style-parent:"C-Heading 4";
	mso-style-next:"C-Body Text";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	tab-stops:.75in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-Heading5non-numbered, li.C-Heading5non-numbered, div.C-Heading5non-numb=
ered
	{mso-style-name:"C-Heading 5 \(non-numbered\)";
	mso-style-unhide:no;
	mso-style-parent:"C-Heading 5";
	mso-style-next:"C-Body Text";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	tab-stops:.75in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-Heading6non-numbered, li.C-Heading6non-numbered, div.C-Heading6non-numb=
ered
	{mso-style-name:"C-Heading 6 \(non-numbered\)";
	mso-style-unhide:no;
	mso-style-parent:"C-Heading 6";
	mso-style-next:"C-Body Text";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	tab-stops:.75in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-Heading1nopagebreak, li.C-Heading1nopagebreak, div.C-Heading1nopagebreak
	{mso-style-name:"C-Heading 1 \(no page break\)";
	mso-style-unhide:no;
	mso-style-parent:"C-Heading 1";
	mso-style-next:"C-Body Text";
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	mso-list:l28 level1 lfo3;
	tab-stops:list .75in;
	font-size:14.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	text-transform:uppercase;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-Heading1nopagebreak0, li.C-Heading1nopagebreak0, div.C-Heading1nopagebr=
eak0
	{mso-style-name:"C-Heading 1 \(no page break\,non-numbered\)";
	mso-style-unhide:no;
	mso-style-parent:"C-Heading 1 \(non-numbered\)";
	mso-style-next:"C-Body Text";
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	tab-stops:.75in;
	font-size:14.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	text-transform:uppercase;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-AlphabeticList, li.C-AlphabeticList, div.C-AlphabeticList
	{mso-style-name:"C-Alphabetic List";
	mso-style-unhide:no;
	mso-style-parent:"";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	line-height:normal;
	mso-pagination:widow-orphan;
	mso-list:l31 level2 lfo6;
	tab-stops:list .75in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
p.C-Appendix, li.C-Appendix, div.C-Appendix
	{mso-style-name:C-Appendix;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-next:"C-Body Text";
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:99.35pt;
	text-indent:-99.35pt;
	line-height:normal;
	page-break-before:always;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	mso-list:l43 level1 lfo4;
	tab-stops:list 99.35pt;
	font-size:14.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	text-transform:uppercase;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
span.C-TableCallout
	{mso-style-name:"C-Table Callout";
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	color:windowtext;
	mso-text-animation:none;
	position:relative;
	top:.5pt;
	mso-text-raise:-.5pt;
	letter-spacing:0pt;
	mso-font-width:100%;
	text-decoration:none;
	text-underline:none;
	text-decoration:none;
	text-line-through:none;
	vertical-align:super;}
span.BodyTextIndentChar
	{mso-style-name:"Body Text Indent Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Body Text Indent";
	mso-ansi-font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;}
span.BodyTextFirstIndent2Char
	{mso-style-name:"Body Text First Indent 2 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"Body Text Indent Char";
	mso-style-link:"Body Text First Indent 2";
	mso-ansi-font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;}
p.C-AppendixNumbered, li.C-AppendixNumbered, div.C-AppendixNumbered
	{mso-style-name:"C-Appendix \(Numbered\)";
	mso-style-unhide:no;
	mso-style-parent:C-Appendix;
	mso-style-next:"C-Body Text";
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:99.35pt;
	text-indent:-99.35pt;
	line-height:normal;
	page-break-before:always;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	mso-list:l25 level1 lfo5;
	tab-stops:99.35pt;
	font-size:14.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	text-transform:uppercase;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-Alphabetic, li.C-Alphabetic, div.C-Alphabetic
	{mso-style-name:C-Alphabetic;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"C-Heading 1";
	mso-style-link:"C-Alphabetic Char";
	mso-style-next:"C-Body Text";
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.75in;
	text-indent:-.75in;
	line-height:normal;
	page-break-before:always;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	mso-list:l19 level1 lfo7;
	tab-stops:.75in;
	font-size:14.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	text-transform:uppercase;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.C-Footnote, li.C-Footnote, div.C-Footnote
	{mso-style-name:C-Footnote;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"C-Table Footnote";
	margin:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	tab-stops:.1in;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;}
span.C-Heading1Char
	{mso-style-name:"C-Heading 1 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"C-Heading 1";
	mso-ansi-font-size:14.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	text-transform:uppercase;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
span.C-AlphabeticChar
	{mso-style-name:"C-Alphabetic Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"C-Heading 1 Char";
	mso-style-link:C-Alphabetic;
	mso-ansi-font-size:14.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	text-transform:uppercase;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Header;
	mso-ansi-font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Footer;
	mso-ansi-font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Arial;}
span.normaltextrun
	{mso-style-name:normaltextrun;
	mso-style-unhide:no;}
span.spellingerror
	{mso-style-name:spellingerror;
	mso-style-unhide:no;}
p.DisclaimerAgency, li.DisclaimerAgency, div.DisclaimerAgency
	{mso-style-name:"Disclaimer \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:2.85pt;
	margin-left:0in;
	line-height:7.5pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:6.5pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	color:#6D6F71;
	mso-fareast-language:EN-GB;
	layout-grid-mode:line;}
p.DoccategoryheadingAgency, li.DoccategoryheadingAgency, div.Doccategoryhea=
dingAgency
	{mso-style-name:"Doc category heading \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	mso-style-next:"Body text \(Agency\)";
	margin-top:28.35pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	color:#003399;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.DocsubtitleAgency, li.DocsubtitleAgency, div.DocsubtitleAgency
	{mso-style-name:"Doc subtitle \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:"Body text \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:32.0pt;
	margin-left:0in;
	line-height:18.0pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-fareast-language:EN-GB;}
p.DoctitleAgency, li.DoctitleAgency, div.DoctitleAgency
	{mso-style-name:"Doc title \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:"Doc subtitle \(Agency\)";
	margin-top:.5in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:18.0pt;
	mso-pagination:widow-orphan;
	font-size:16.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	color:#003399;
	mso-fareast-language:EN-GB;}
span.EndnotereferenceAgency
	{mso-style-name:"Endnote reference \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"";
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	vertical-align:super;}
p.EndnotetextAgency, li.EndnotetextAgency, div.EndnotetextAgency
	{mso-style-name:"Endnote text \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:7.5pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-fareast-language:EN-GB;}
p.FigureAgency, li.FigureAgency, div.FigureAgency
	{mso-style-name:"Figure \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-next:"Body text \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	text-align:center;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:Verdana;}
p.FigureheadingAgency, li.FigureheadingAgency, div.FigureheadingAgency
	{mso-style-name:"Figure heading \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-next:"Figure \(Agency\)";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.3in;
	text-indent:-.3in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-list:l20 level1 lfo15;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:Verdana;}
p.FooterAgency, li.FooterAgency, div.FooterAgency
	{mso-style-name:"Footer \(Agency\)";
	mso-style-unhide:no;
	mso-style-link:"Footer \(Agency\) Char Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:7.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	color:#6D6F71;
	mso-fareast-language:EN-GB;}
span.FooterAgencyCharChar
	{mso-style-name:"Footer \(Agency\) Char Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Footer \(Agency\)";
	mso-ansi-font-size:7.0pt;
	mso-bidi-font-size:7.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-fareast-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	color:#6D6F71;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
p.FooterblueAgency, li.FooterblueAgency, div.FooterblueAgency
	{mso-style-name:"Footer blue \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-link:"Footer blue \(Agency\) Char Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:6.5pt;
	mso-bidi-font-size:7.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	color:#003399;
	mso-fareast-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
span.FooterblueAgencyCharChar
	{mso-style-name:"Footer blue \(Agency\) Char Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Footer blue \(Agency\)";
	mso-ansi-font-size:6.5pt;
	mso-bidi-font-size:7.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-fareast-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	color:#003399;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
span.FootnotereferenceAgency
	{mso-style-name:"Footnote reference \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"";
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	color:windowtext;
	vertical-align:super;}
p.FootnotetextAgency, li.FootnotetextAgency, div.FootnotetextAgency
	{mso-style-name:"Footnote text \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:7.5pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-fareast-language:EN-GB;}
p.HeaderAgency, li.HeaderAgency, div.HeaderAgency
	{mso-style-name:"Header \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"Footer \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:7.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	color:#6D6F71;
	mso-fareast-language:EN-GB;}
p.Heading1Agency, li.Heading1Agency, div.Heading1Agency
	{mso-style-name:"Heading 1 \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	mso-list:l34 level1 lfo16;
	font-size:13.5pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
p.Heading2Agency, li.Heading2Agency, div.Heading2Agency
	{mso-style-name:"Heading 2 \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	mso-list:l34 level2 lfo16;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.Heading3Agency, li.Heading3Agency, div.Heading3Agency
	{mso-style-name:"Heading 3 \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	mso-list:l34 level3 lfo16;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
p.Heading4Agency, li.Heading4Agency, div.Heading4Agency
	{mso-style-name:"Heading 4 \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"Heading 3 \(Agency\)";
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	mso-list:l34 level4 lfo16;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.Heading5Agency, li.Heading5Agency, div.Heading5Agency
	{mso-style-name:"Heading 5 \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"Heading 4 \(Agency\)";
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	mso-list:l34 level5 lfo16;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
p.Heading6Agency, li.Heading6Agency, div.Heading6Agency
	{mso-style-name:"Heading 6 \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"Heading 5 \(Agency\)";
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	mso-list:l34 level6 lfo16;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
p.Heading7Agency, li.Heading7Agency, div.Heading7Agency
	{mso-style-name:"Heading 7 \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"Heading 6 \(Agency\)";
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	mso-list:l34 level7 lfo16;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
p.Heading8Agency, li.Heading8Agency, div.Heading8Agency
	{mso-style-name:"Heading 8 \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"Heading 7 \(Agency\)";
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	mso-list:l34 level8 lfo16;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
p.Heading9Agency, li.Heading9Agency, div.Heading9Agency
	{mso-style-name:"Heading 9 \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"Heading 8 \(Agency\)";
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	mso-list:l34 level9 lfo16;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
p.No-numheading1Agency, li.No-numheading1Agency, div.No-numheading1Agency
	{mso-style-name:"No-num heading 1 \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:13.5pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
p.HeadingcentredAgency, li.HeadingcentredAgency, div.HeadingcentredAgency
	{mso-style-name:"Heading centred \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"No-num heading 1 \(Agency\)";
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	text-align:center;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:13.5pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
p.No-numheading2Agency, li.No-numheading2Agency, div.No-numheading2Agency
	{mso-style-name:"No-num heading 2 \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.No-numheading3Agency, li.No-numheading3Agency, div.No-numheading3Agency
	{mso-style-name:"No-num heading 3 \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"Heading 3 \(Agency\)";
	mso-style-link:"No-num heading 3 \(Agency\) Char";
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
p.No-numheading4Agency, li.No-numheading4Agency, div.No-numheading4Agency
	{mso-style-name:"No-num heading 4 \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"Heading 4 \(Agency\)";
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.No-numheading5Agency, li.No-numheading5Agency, div.No-numheading5Agency
	{mso-style-name:"No-num heading 5 \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"Heading 5 \(Agency\)";
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
p.No-numheading6Agency, li.No-numheading6Agency, div.No-numheading6Agency
	{mso-style-name:"No-num heading 6 \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"No-num heading 5 \(Agency\)";
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
p.No-numheading7Agency, li.No-numheading7Agency, div.No-numheading7Agency
	{mso-style-name:"No-num heading 7 \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"No-num heading 6 \(Agency\)";
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
p.No-numheading8Agency, li.No-numheading8Agency, div.No-numheading8Agency
	{mso-style-name:"No-num heading 8 \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"No-num heading 7 \(Agency\)";
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
p.No-numheading9Agency, li.No-numheading9Agency, div.No-numheading9Agency
	{mso-style-name:"No-num heading 9 \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"No-num heading 8 \(Agency\)";
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
p.No-TOCheadingAgency, li.No-TOCheadingAgency, div.No-TOCheadingAgency
	{mso-style-name:"No-TOC heading \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	font-size:13.5pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.PagenumberAgency, li.PagenumberAgency, div.PagenumberAgency
	{mso-style-name:"Page number \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-link:"Page number \(Agency\) Char Char";
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	text-align:right;
	line-height:107%;
	mso-pagination:widow-orphan;
	tab-stops:right 489.05pt;
	font-size:7.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	color:#6D6F71;
	mso-fareast-language:EN-GB;}
span.PagenumberAgencyCharChar
	{mso-style-name:"Page number \(Agency\) Char Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Page number \(Agency\)";
	mso-ansi-font-size:7.0pt;
	mso-bidi-font-size:7.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-fareast-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	color:#6D6F71;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
p.RefAgency, li.RefAgency, div.RefAgency
	{mso-style-name:"Ref\. \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:8.5pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:EN-GB;}
p.SpecialcommentAgency, li.SpecialcommentAgency, div.SpecialcommentAgency
	{mso-style-name:"Special comment \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	mso-style-next:"Body text \(Agency\)";
	margin:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:8.5pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:red;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
p.TablefirstrowAgency, li.TablefirstrowAgency, div.TablefirstrowAgency
	{mso-style-name:"Table first row \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"Body text \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Verdana;
	mso-fareast-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.TableheadingAgency, li.TableheadingAgency, div.TableheadingAgency
	{mso-style-name:"Table heading \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-next:"Body text \(Agency\)";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-indent:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-list:l18 level1 lfo18;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:Verdana;}
p.TableFigurenoteAgency, li.TableFigurenoteAgency, div.TableFigurenoteAgency
	{mso-style-name:"Table\/Figure note \(Agency\)";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"Body text \(Agency\)";
	mso-style-next:"Body text \(Agency\)";
	margin-top:3.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	line-height:normal;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-fareast-language:EN-GB;}
span.FootnoteTextChar
	{mso-style-name:"Footnote Text Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Footnote Text";
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
span.UnresolvedMention1
	{mso-style-name:"Unresolved Mention1";
	mso-style-noshow:yes;
	mso-style-priority:99;
	color:#605E5C;
	background:#E1DFDD;}
span.No-numheading3AgencyChar
	{mso-style-name:"No-num heading 3 \(Agency\) Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"No-num heading 3 \(Agency\)";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-fareast-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:16.0pt;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
span.EndnoteTextChar
	{mso-style-name:"Endnote Text Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Endnote Text";
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
span.UnresolvedMention2
	{mso-style-name:"Unresolved Mention2";
	mso-style-priority:99;
	color:#605E5C;
	background:#E1DFDD;}
span.Mention2
	{mso-style-name:Mention2;
	mso-style-priority:99;
	color:#2B579A;
	background:#E1DFDD;}
span.BodyText2Char
	{mso-style-name:"Body Text 2 Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Body Text 2";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
span.BodyText3Char
	{mso-style-name:"Body Text 3 Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Body Text 3";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
span.BodyTextChar
	{mso-style-name:"Body Text Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Body Text";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	color:green;
	font-style:italic;
	mso-bidi-font-style:normal;}
span.BodyTextFirstIndentChar
	{mso-style-name:"Body Text First Indent Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"Body Text Char";
	mso-style-link:"Body Text First Indent";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	color:green;
	font-style:normal;}
span.BodyTextIndent2Char
	{mso-style-name:"Body Text Indent 2 Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Body Text Indent 2";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
span.BodyTextIndent3Char
	{mso-style-name:"Body Text Indent 3 Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Body Text Indent 3";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
span.ClosingChar
	{mso-style-name:"Closing Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Closing;
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
span.DateChar
	{mso-style-name:"Date Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Date;
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
span.DocumentMapChar
	{mso-style-name:"Document Map Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Document Map";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Segoe UI",sans-serif;
	mso-ascii-font-family:"Segoe UI";
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:"Segoe UI";
	mso-bidi-font-family:"Segoe UI";}
span.E-mailSignatureChar
	{mso-style-name:"E-mail Signature Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"E-mail Signature";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
span.HTMLAddressChar
	{mso-style-name:"HTML Address Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"HTML Address";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	font-style:italic;}
span.HTMLPreformattedChar
	{mso-style-name:"HTML Preformatted Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"HTML Preformatted";
	font-family:Consolas;
	mso-ascii-font-family:Consolas;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Consolas;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
span.IntenseQuoteChar
	{mso-style-name:"Intense Quote Char";
	mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Intense Quote";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	color:#4472C4;
	mso-themecolor:accent1;
	font-style:italic;}
span.MacroTextChar
	{mso-style-name:"Macro Text Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Macro Text";
	font-family:Consolas;
	mso-ascii-font-family:Consolas;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Consolas;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
span.MessageHeaderChar
	{mso-style-name:"Message Header Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Message Header";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:PMingLiU;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	background:#CCCCCC;
	mso-shading:windowtext;
	mso-pattern:gray-20 auto;}
span.NoteHeadingChar
	{mso-style-name:"Note Heading Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Note Heading";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
span.PlainTextChar
	{mso-style-name:"Plain Text Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Plain Text";
	mso-ansi-font-size:10.5pt;
	mso-bidi-font-size:10.5pt;
	font-family:Consolas;
	mso-ascii-font-family:Consolas;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Consolas;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
span.QuoteChar
	{mso-style-name:"Quote Char";
	mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Quote;
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	color:#404040;
	mso-themecolor:text1;
	mso-themetint:191;
	font-style:italic;}
span.SalutationChar
	{mso-style-name:"Salutation Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Salutation;
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
span.SignatureChar
	{mso-style-name:"Signature Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Signature;
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
span.SubtitleChar
	{mso-style-name:"Subtitle Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Subtitle;
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:PMingLiU;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	color:#5A5A5A;
	mso-themecolor:text1;
	mso-themetint:165;
	letter-spacing:.75pt;}
span.TitleChar
	{mso-style-name:"Title Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Title;
	mso-ansi-font-size:28.0pt;
	mso-bidi-font-size:28.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:PMingLiU;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-size:10.0pt;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	mso-fareast-font-family:SimSun;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("Zynteglo_clean_files/header.htm") fs;
	mso-footnote-continuation-separator:url("Zynteglo_clean_files/header.htm")=
 fcs;
	mso-footnote-continuation-notice:url("Zynteglo_clean_files/header.htm") fc=
n;
	mso-endnote-separator:url("Zynteglo_clean_files/header.htm") es;
	mso-endnote-continuation-separator:url("Zynteglo_clean_files/header.htm") =
ecs;
	mso-endnote-continuation-notice:url("Zynteglo_clean_files/header.htm") ecn;
	mso-endnote-numbering-style:arabic;}
@page WordSection1
	{size:595.35pt 842.0pt;
	margin:56.9pt 70.55pt 56.9pt 70.55pt;
	mso-header-margin:36.7pt;
	mso-footer-margin:36.7pt;
	mso-title-page:yes;
	mso-footer:url("Zynteglo_clean_files/header.htm") f1;
	mso-first-footer:url("Zynteglo_clean_files/header.htm") ff1;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;
	mso-endnote-numbering-style:arabic;}
 /* List Definitions */
 @list l0
	{mso-list-id:-132;
	mso-list-type:simple;
	mso-list-template-ids:1067082368;}
@list l0:level1
	{mso-level-style-link:"List Number 5";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;}
@list l1
	{mso-list-id:-131;
	mso-list-type:simple;
	mso-list-template-ids:-566618664;}
@list l1:level1
	{mso-level-style-link:"List Number 4";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-.25in;}
@list l2
	{mso-list-id:-130;
	mso-list-type:simple;
	mso-list-template-ids:-1769688932;}
@list l2:level1
	{mso-level-style-link:"List Number 3";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l3
	{mso-list-id:-129;
	mso-list-type:simple;
	mso-list-template-ids:-401204942;}
@list l3:level1
	{mso-level-style-link:"List Number 2";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l4
	{mso-list-id:-128;
	mso-list-type:simple;
	mso-list-template-ids:836126048;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet 5";
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l5
	{mso-list-id:-127;
	mso-list-type:simple;
	mso-list-template-ids:815694400;}
@list l5:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet 4";
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l6
	{mso-list-id:-126;
	mso-list-type:simple;
	mso-list-template-ids:1543411112;}
@list l6:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet 3";
	mso-level-text:\F0B7;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l7
	{mso-list-id:-125;
	mso-list-type:simple;
	mso-list-template-ids:2114628796;}
@list l7:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet 2";
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l8
	{mso-list-id:-120;
	mso-list-type:simple;
	mso-list-template-ids:1663500110;}
@list l8:level1
	{mso-level-style-link:"List Number";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;}
@list l9
	{mso-list-id:-119;
	mso-list-type:simple;
	mso-list-template-ids:-397646890;}
@list l9:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet";
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l10
	{mso-list-id:-2;
	mso-list-type:simple;
	mso-list-template-ids:-1;}
@list l10:level1
	{mso-level-start-at:0;
	mso-level-text:*;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l11
	{mso-list-id:3364565;
	mso-list-type:hybrid;
	mso-list-template-ids:481833144 500713932 2131366616 715700554 -769759260 =
-269550188 -1639255442 720657510 167931532 1456764426;}
@list l11:level1
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l11:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l11:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l11:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l11:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l11:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l11:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l11:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l11:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l12
	{mso-list-id:30694055;
	mso-list-type:hybrid;
	mso-list-template-ids:-1447134842 -1894871400 98231870 1986670830 17287278=
32 999477724 1554913336 1702683256 -1820951324 -993868342;
	mso-list-name:"C-Number List Template";}
@list l12:level1
	{mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:12.0pt;
	color:windowtext;
	mso-hide:none;
	text-transform:none;
	mso-style-textoutline-type:none;
	mso-style-textoutline-outlinestyle-dpiwidth:0pt;
	mso-style-textoutline-outlinestyle-linecap:round;
	mso-style-textoutline-outlinestyle-join:bevel;
	mso-style-textoutline-outlinestyle-pctmiterlimit:0%;
	mso-style-textoutline-outlinestyle-dash:solid;
	mso-style-textoutline-outlinestyle-align:center;
	mso-style-textoutline-outlinestyle-compound:simple;
	mso-effects-shadow-color:black;
	mso-effects-shadow-alpha:100.0%;
	mso-effects-shadow-dpiradius:0pt;
	mso-effects-shadow-dpidistance:0pt;
	mso-effects-shadow-angledirection:0;
	mso-effects-shadow-align:none;
	mso-effects-shadow-pctsx:0%;
	mso-effects-shadow-pctsy:0%;
	mso-effects-shadow-anglekx:0;
	mso-effects-shadow-angleky:0;
	mso-ansi-font-weight:normal;
	mso-ansi-font-style:normal;
	text-decoration:none;
	text-underline:none;
	text-decoration:none;
	text-line-through:none;
	vertical-align:baseline;}
@list l12:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l12:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l12:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l12:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l12:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l12:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l13
	{mso-list-id:42143549;
	mso-list-type:hybrid;
	mso-list-template-ids:-2125668388 1673531774 1337118850 -1702301474 -14558=
1912 -536026536 -561612140 339223132 1810371248 1575930310;}
@list l13:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l13:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l13:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l13:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l13:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l13:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l13:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l13:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l13:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l14
	{mso-list-id:138113562;
	mso-list-type:simple;
	mso-list-template-ids:703758718;
	mso-list-name:TableNoteNumeric;}
@list l14:level1
	{mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l15
	{mso-list-id:138303649;
	mso-list-type:hybrid;
	mso-list-template-ids:-746797286 -184891054 -945911686 1324793268 11707582=
56 40793556 -1579275984 -1677328382 -1189039424 457311218;}
@list l15:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l15:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l15:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l15:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l15:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l15:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l15:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l15:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l15:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l16
	{mso-list-id:140463476;
	mso-list-template-ids:-1607560406;
	mso-list-style-name:"Bullets \(Agency\)";}
@list l16:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:17.85pt;
	mso-level-number-position:left;
	margin-left:17.85pt;
	text-indent:-17.85pt;
	mso-ansi-font-size:9.0pt;
	font-family:Symbol;
	color:#003399;}
@list l16:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-18.15pt;
	font-family:Symbol;
	color:#003399;}
@list l16:level3
	{mso-level-number-format:none;
	mso-level-text:"";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:0in;}
@list l16:level4
	{mso-level-number-format:none;
	mso-level-text:"";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:0in;}
@list l16:level5
	{mso-level-number-format:none;
	mso-level-text:"";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:0in;}
@list l16:level6
	{mso-level-number-format:none;
	mso-level-text:"";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:0in;}
@list l16:level7
	{mso-level-number-format:none;
	mso-level-text:"";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:0in;}
@list l16:level8
	{mso-level-number-format:none;
	mso-level-text:"";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:0in;}
@list l16:level9
	{mso-level-number-format:none;
	mso-level-text:"";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:0in;}
@list l17
	{mso-list-id:163859649;
	mso-list-type:hybrid;
	mso-list-template-ids:2146616686 -1658830476 1446676192 -1181564472 -10081=
90802 1901498862 -6361278 1066930454 -323189976 -83049970;}
@list l17:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l17:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l17:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l17:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l17:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l17:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l17:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l17:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l17:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l18
	{mso-list-id:168983496;
	mso-list-template-ids:-1502951802;}
@list l18:level1
	{mso-level-style-link:"Table heading \(Agency\)";
	mso-level-suffix:space;
	mso-level-text:"Table %1\. ";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-ansi-font-weight:bold;
	mso-ansi-font-style:normal;}
@list l18:level2
	{mso-level-text:"%1Section \.%2";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l18:level3
	{mso-level-number-format:alpha-lower;
	mso-level-text:"\(%3\)";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.3in;}
@list l18:level4
	{mso-level-number-format:roman-lower;
	mso-level-text:"\(%4\)";
	mso-level-tab-stop:.6in;
	mso-level-number-position:right;
	margin-left:.6in;
	text-indent:-.1in;}
@list l18:level5
	{mso-level-text:"%5\)";
	mso-level-tab-stop:.7in;
	mso-level-number-position:left;
	margin-left:.7in;
	text-indent:-.3in;}
@list l18:level6
	{mso-level-number-format:alpha-lower;
	mso-level-text:"%6\)";
	mso-level-tab-stop:.8in;
	mso-level-number-position:left;
	margin-left:.8in;
	text-indent:-.3in;}
@list l18:level7
	{mso-level-number-format:roman-lower;
	mso-level-text:"%7\)";
	mso-level-tab-stop:.9in;
	mso-level-number-position:right;
	margin-left:.9in;
	text-indent:-.2in;}
@list l18:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-.3in;}
@list l18:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:1.1in;
	mso-level-number-position:right;
	margin-left:1.1in;
	text-indent:-.1in;}
@list l19
	{mso-list-id:230505803;
	mso-list-type:hybrid;
	mso-list-template-ids:-1430256466 46193694 -158834678 -733985004 135755272=
6 681239088 -217951668 -1415913294 -1807592464 -2102619404;}
@list l19:level1
	{mso-level-number-format:alpha-upper;
	mso-level-style-link:C-Alphabetic;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l19:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l19:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l19:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l19:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l19:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l19:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l19:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l19:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l20
	{mso-list-id:242879220;
	mso-list-template-ids:349861654;}
@list l20:level1
	{mso-level-style-link:"Figure heading \(Agency\)";
	mso-level-suffix:space;
	mso-level-text:"Figure %1\. ";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.3in;
	text-indent:-.3in;
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	color:windowtext;
	mso-ansi-font-weight:bold;
	mso-ansi-font-style:normal;}
@list l20:level2
	{mso-level-text:"%1\.%2";
	mso-level-tab-stop:.4in;
	mso-level-number-position:left;
	margin-left:.4in;
	text-indent:-.4in;}
@list l20:level3
	{mso-level-text:"%1\.%2\.%3";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l20:level4
	{mso-level-text:"%1\.%2\.%3\.%4";
	mso-level-tab-stop:.6in;
	mso-level-number-position:left;
	margin-left:.6in;
	text-indent:-.6in;}
@list l20:level5
	{mso-level-text:"%1\.%2\.%3\.%4\.%5";
	mso-level-tab-stop:.7in;
	mso-level-number-position:left;
	margin-left:.7in;
	text-indent:-.7in;}
@list l20:level6
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6";
	mso-level-tab-stop:.8in;
	mso-level-number-position:left;
	margin-left:.8in;
	text-indent:-.8in;}
@list l20:level7
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7";
	mso-level-tab-stop:.9in;
	mso-level-number-position:left;
	margin-left:.9in;
	text-indent:-.9in;}
@list l20:level8
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l20:level9
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9";
	mso-level-tab-stop:1.1in;
	mso-level-number-position:left;
	margin-left:1.1in;
	text-indent:-1.1in;}
@list l21
	{mso-list-id:276913456;
	mso-list-type:hybrid;
	mso-list-template-ids:-1936029090 1636990714 -1556605432 -1804985302 -5052=
256 -670016064 188662912 318942148 -324118700 -966198376;}
@list l21:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l21:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l21:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l21:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l21:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l21:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l21:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l21:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l21:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l22
	{mso-list-id:305933605;
	mso-list-type:hybrid;
	mso-list-template-ids:1706747896 1687486344 -1282092744 -495548132 1769739=
110 2130894446 -953383768 -1111196274 1074167404 -2006263214;}
@list l22:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l22:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l22:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l22:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l22:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l22:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l22:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l22:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l22:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l23
	{mso-list-id:337124354;
	mso-list-type:simple;
	mso-list-template-ids:-1259585340;
	mso-list-name:TableNoteAlpha;}
@list l23:level1
	{mso-level-number-format:alpha-lower;
	mso-level-suffix:none;
	mso-level-text:%1;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l24
	{mso-list-id:509880363;
	mso-list-template-ids:1981052474;
	mso-list-style-name:"Number list \(Agency\)";}
@list l24:level1
	{mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	color:windowtext;
	mso-hide:none;
	text-transform:none;
	mso-style-textoutline-type:none;
	mso-style-textoutline-outlinestyle-dpiwidth:0pt;
	mso-style-textoutline-outlinestyle-linecap:round;
	mso-style-textoutline-outlinestyle-join:bevel;
	mso-style-textoutline-outlinestyle-pctmiterlimit:0%;
	mso-style-textoutline-outlinestyle-dash:solid;
	mso-style-textoutline-outlinestyle-align:center;
	mso-style-textoutline-outlinestyle-compound:simple;
	mso-effects-shadow-color:black;
	mso-effects-shadow-alpha:100.0%;
	mso-effects-shadow-dpiradius:0pt;
	mso-effects-shadow-dpidistance:0pt;
	mso-effects-shadow-angledirection:0;
	mso-effects-shadow-align:none;
	mso-effects-shadow-pctsx:0%;
	mso-effects-shadow-pctsy:0%;
	mso-effects-shadow-anglekx:0;
	mso-effects-shadow-angleky:0;
	mso-ansi-font-weight:normal;
	mso-ansi-font-style:normal;
	text-decoration:none;
	text-underline:none;
	text-decoration:none;
	text-line-through:none;
	vertical-align:baseline;}
@list l24:level2
	{mso-level-text:"%1\.%2\.";
	mso-level-tab-stop:48.2pt;
	mso-level-number-position:left;
	margin-left:48.2pt;
	text-indent:-30.2pt;
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	color:windowtext;
	mso-hide:none;
	text-transform:none;
	mso-style-textoutline-type:none;
	mso-style-textoutline-outlinestyle-dpiwidth:0pt;
	mso-style-textoutline-outlinestyle-linecap:round;
	mso-style-textoutline-outlinestyle-join:bevel;
	mso-style-textoutline-outlinestyle-pctmiterlimit:0%;
	mso-style-textoutline-outlinestyle-dash:solid;
	mso-style-textoutline-outlinestyle-align:center;
	mso-style-textoutline-outlinestyle-compound:simple;
	mso-effects-shadow-color:black;
	mso-effects-shadow-alpha:100.0%;
	mso-effects-shadow-dpiradius:0pt;
	mso-effects-shadow-dpidistance:0pt;
	mso-effects-shadow-angledirection:0;
	mso-effects-shadow-align:none;
	mso-effects-shadow-pctsx:0%;
	mso-effects-shadow-pctsy:0%;
	mso-effects-shadow-anglekx:0;
	mso-effects-shadow-angleky:0;
	mso-ansi-font-weight:normal;
	mso-ansi-font-style:normal;
	text-decoration:none;
	text-underline:none;
	text-decoration:none;
	text-line-through:none;
	vertical-align:baseline;}
@list l24:level3
	{mso-level-number-format:none;
	mso-level-text:"";
	mso-level-tab-stop:48.2pt;
	mso-level-number-position:left;
	margin-left:48.2pt;
	text-indent:-30.35pt;}
@list l24:level4
	{mso-level-number-format:none;
	mso-level-text:"";
	mso-level-tab-stop:48.2pt;
	mso-level-number-position:left;
	margin-left:48.2pt;
	text-indent:-30.35pt;}
@list l24:level5
	{mso-level-number-format:none;
	mso-level-text:"";
	mso-level-tab-stop:48.2pt;
	mso-level-number-position:left;
	margin-left:48.2pt;
	text-indent:-30.35pt;}
@list l24:level6
	{mso-level-number-format:none;
	mso-level-text:"";
	mso-level-tab-stop:48.2pt;
	mso-level-number-position:left;
	margin-left:48.2pt;
	text-indent:-30.35pt;}
@list l24:level7
	{mso-level-number-format:none;
	mso-level-text:%7;
	mso-level-tab-stop:48.2pt;
	mso-level-number-position:left;
	margin-left:48.2pt;
	text-indent:-30.35pt;}
@list l24:level8
	{mso-level-number-format:none;
	mso-level-text:"";
	mso-level-tab-stop:48.2pt;
	mso-level-number-position:left;
	margin-left:48.2pt;
	text-indent:-30.35pt;}
@list l24:level9
	{mso-level-number-format:none;
	mso-level-text:"";
	mso-level-tab-stop:48.2pt;
	mso-level-number-position:left;
	margin-left:48.2pt;
	text-indent:-30.35pt;}
@list l25
	{mso-list-id:613905804;
	mso-list-type:hybrid;
	mso-list-template-ids:23767782 -853481772 -761119284 973345336 730893842 -=
521000668 -1811383174 -272464452 439024436 -1953076408;}
@list l25:level1
	{mso-level-style-link:"C-Appendix \(Numbered\)";
	mso-level-text:"Appendix%1\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:67.5pt;
	text-indent:-.25in;}
@list l25:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:121.5pt;
	text-indent:-.25in;}
@list l25:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:157.5pt;
	text-indent:-9.0pt;}
@list l25:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:193.5pt;
	text-indent:-.25in;}
@list l25:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:229.5pt;
	text-indent:-.25in;}
@list l25:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:265.5pt;
	text-indent:-9.0pt;}
@list l25:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:301.5pt;
	text-indent:-.25in;}
@list l25:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:337.5pt;
	text-indent:-.25in;}
@list l25:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:373.5pt;
	text-indent:-9.0pt;}
@list l26
	{mso-list-id:695041690;
	mso-list-type:hybrid;
	mso-list-template-ids:1860629322 67698689 67698691 67698693 67698689 67698=
691 67698693 67698689 67698691 67698693;}
@list l26:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l26:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l26:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l26:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l26:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l26:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l26:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l26:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l26:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l27
	{mso-list-id:1045567885;
	mso-list-type:hybrid;
	mso-list-template-ids:-697767596 115264672 -1088753092 -1411995022 1301194=
594 -1019443858 1330408044 1268526530 -479054994 1383755092;}
@list l27:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l27:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l27:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l27:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l27:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l27:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l27:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l27:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l27:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l28
	{mso-list-id:1064714665;
	mso-list-template-ids:645939432;}
@list l28:level1
	{mso-level-style-link:"C-Heading 1";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l28:level2
	{mso-level-style-link:"C-Heading 2";
	mso-level-text:"%1\.%2\.";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l28:level3
	{mso-level-style-link:"C-Heading 3";
	mso-level-text:"%1\.%2\.%3\.";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l28:level4
	{mso-level-style-link:"C-Heading 4";
	mso-level-text:"%1\.%2\.%3\.%4\.";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l28:level5
	{mso-level-style-link:"C-Heading 5";
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l28:level6
	{mso-level-style-link:"C-Heading 6";
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l28:level7
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l28:level8
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l28:level9
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9\.";
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l29
	{mso-list-id:1136411465;
	mso-list-type:hybrid;
	mso-list-template-ids:-288875814 -1624740736 -451919212 -1666143666 -13192=
7702 875599970 -1904673708 -829510104 -1441122692 2087354514;}
@list l29:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l29:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l29:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l29:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l29:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l29:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l29:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l29:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l29:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l30
	{mso-list-id:1174565418;
	mso-list-type:hybrid;
	mso-list-template-ids:274907752 -1663383934 32172942 1075185436 612791996 =
-1574252714 -1053372160 -1745862114 155901900 928544140;}
@list l30:level1
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l30:level2
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
@list l30:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l30:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l30:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l30:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l30:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l30:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l30:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l31
	{mso-list-id:1237666617;
	mso-list-template-ids:-218731994;}
@list l31:level1
	{mso-level-style-link:"C-Numbered List";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:windowtext;
	mso-hide:none;
	text-transform:none;
	mso-style-textoutline-type:none;
	mso-style-textoutline-outlinestyle-dpiwidth:0pt;
	mso-style-textoutline-outlinestyle-linecap:round;
	mso-style-textoutline-outlinestyle-join:bevel;
	mso-style-textoutline-outlinestyle-pctmiterlimit:0%;
	mso-style-textoutline-outlinestyle-dash:solid;
	mso-style-textoutline-outlinestyle-align:center;
	mso-style-textoutline-outlinestyle-compound:simple;
	mso-effects-shadow-color:black;
	mso-effects-shadow-alpha:100.0%;
	mso-effects-shadow-dpiradius:0pt;
	mso-effects-shadow-dpidistance:0pt;
	mso-effects-shadow-angledirection:0;
	mso-effects-shadow-align:none;
	mso-effects-shadow-pctsx:0%;
	mso-effects-shadow-pctsy:0%;
	mso-effects-shadow-anglekx:0;
	mso-effects-shadow-angleky:0;
	mso-ansi-font-weight:normal;
	mso-ansi-font-style:normal;
	text-decoration:none;
	text-underline:none;
	text-decoration:none;
	text-line-through:none;
	vertical-align:baseline;}
@list l31:level2
	{mso-level-number-format:alpha-lower;
	mso-level-style-link:"C-Alphabetic List";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l31:level3
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l31:level4
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l31:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l31:level6
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l31:level7
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l31:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l31:level9
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l32
	{mso-list-id:1291665676;
	mso-list-type:hybrid;
	mso-list-template-ids:1136309882 -1924618150 -217180126 651954136 74632446=
6 -404599484 -1165229084 -1038876246 653283370 -947512780;}
@list l32:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l32:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l32:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l32:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l32:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l32:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l32:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l32:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l32:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l33
	{mso-list-id:1355810830;
	mso-list-template-ids:-218731994;
	mso-list-style-name:"SP Numbered Tabs";}
@list l33:level1
	{mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:windowtext;
	mso-hide:none;
	text-transform:none;
	mso-style-textoutline-type:none;
	mso-style-textoutline-outlinestyle-dpiwidth:0pt;
	mso-style-textoutline-outlinestyle-linecap:round;
	mso-style-textoutline-outlinestyle-join:bevel;
	mso-style-textoutline-outlinestyle-pctmiterlimit:0%;
	mso-style-textoutline-outlinestyle-dash:solid;
	mso-style-textoutline-outlinestyle-align:center;
	mso-style-textoutline-outlinestyle-compound:simple;
	mso-effects-shadow-color:black;
	mso-effects-shadow-alpha:100.0%;
	mso-effects-shadow-dpiradius:0pt;
	mso-effects-shadow-dpidistance:0pt;
	mso-effects-shadow-angledirection:0;
	mso-effects-shadow-align:none;
	mso-effects-shadow-pctsx:0%;
	mso-effects-shadow-pctsy:0%;
	mso-effects-shadow-anglekx:0;
	mso-effects-shadow-angleky:0;
	mso-ansi-font-weight:normal;
	mso-ansi-font-style:normal;
	text-decoration:none;
	text-underline:none;
	text-decoration:none;
	text-line-through:none;
	vertical-align:baseline;}
@list l33:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l33:level3
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l33:level4
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l33:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l33:level6
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l33:level7
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l33:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l33:level9
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l34
	{mso-list-id:1373771571;
	mso-list-template-ids:-1454614594;}
@list l34:level1
	{mso-level-style-link:"Heading 1 \(Agency\)";
	mso-level-suffix:space;
	mso-level-text:"%1\. ";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l34:level2
	{mso-level-style-link:"Heading 2 \(Agency\)";
	mso-level-suffix:space;
	mso-level-text:"%1\.%2\. ";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l34:level3
	{mso-level-style-link:"Heading 3 \(Agency\)";
	mso-level-suffix:space;
	mso-level-text:"%1\.%2\.%3\. ";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l34:level4
	{mso-level-style-link:"Heading 4 \(Agency\)";
	mso-level-suffix:space;
	mso-level-text:"%1\.%2\.%3\.%4\. ";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l34:level5
	{mso-level-style-link:"Heading 5 \(Agency\)";
	mso-level-suffix:space;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\. ";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l34:level6
	{mso-level-style-link:"Heading 6 \(Agency\)";
	mso-level-suffix:space;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\. ";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l34:level7
	{mso-level-style-link:"Heading 7 \(Agency\)";
	mso-level-suffix:space;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\. ";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l34:level8
	{mso-level-style-link:"Heading 8 \(Agency\)";
	mso-level-suffix:space;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\. ";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l34:level9
	{mso-level-style-link:"Heading 9 \(Agency\)";
	mso-level-suffix:space;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9\. ";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l35
	{mso-list-id:1402823800;
	mso-list-template-ids:-1998786368;
	mso-list-style-name:"SP Bullet Tabs";}
@list l35:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	text-indent:0in;
	mso-ansi-font-size:12.0pt;
	font-family:Symbol;}
@list l35:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:0in;
	font-family:Symbol;}
@list l35:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:0in;
	font-family:Symbol;}
@list l35:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:0in;
	font-family:Symbol;}
@list l35:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:0in;
	font-family:Symbol;}
@list l35:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:0in;
	font-family:Symbol;}
@list l35:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:0in;
	font-family:Symbol;}
@list l35:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:0in;
	font-family:Symbol;}
@list l35:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:0in;
	font-family:Symbol;}
@list l36
	{mso-list-id:1505853109;
	mso-list-template-ids:1384307974;}
@list l36:level1
	{mso-level-style-link:"document text outline numbered";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;}
@list l36:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.25in;}
@list l36:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l36:level4
	{mso-level-text:"\(%4\)";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-.25in;}
@list l36:level5
	{mso-level-number-format:alpha-lower;
	mso-level-text:"\(%5\)";
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;}
@list l36:level6
	{mso-level-number-format:roman-lower;
	mso-level-text:"\(%6\)";
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	margin-left:1.5in;
	text-indent:-.25in;}
@list l36:level7
	{mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;}
@list l36:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	margin-left:2.0in;
	text-indent:-.25in;}
@list l36:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;}
@list l37
	{mso-list-id:1693919587;
	mso-list-type:hybrid;
	mso-list-template-ids:-930324038 1981974146 -866359488 1484288516 18269373=
08 -2021601996 -247033980 1312453432 -1788951486 -1774444160;}
@list l37:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;}
@list l37:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l37:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l37:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l37:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l37:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l37:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l37:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l37:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l38
	{mso-list-id:1773697023;
	mso-list-template-ids:-1102944678;}
@list l38:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:C-Bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	mso-ansi-font-size:12.0pt;
	font-family:Symbol;}
@list l38:level2
	{mso-level-number-format:bullet;
	mso-level-style-link:"C-Bullet Indented";
	mso-level-text:\F02D;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l38:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:0in;
	font-family:Symbol;}
@list l38:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:0in;
	font-family:Symbol;}
@list l38:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:0in;
	font-family:Symbol;}
@list l38:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:0in;
	font-family:Symbol;}
@list l38:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:0in;
	font-family:Symbol;}
@list l38:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:0in;
	font-family:Symbol;}
@list l38:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:0in;
	font-family:Symbol;}
@list l39
	{mso-list-id:1776900692;
	mso-list-type:hybrid;
	mso-list-template-ids:-1816228102 -31411804 2059976082 623441804 178825433=
6 -202240284 2134825392 -648888848 1038006980 2074090822;}
@list l39:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:19.85pt;
	mso-level-number-position:left;
	margin-left:19.85pt;
	text-indent:-19.85pt;
	font-family:Symbol;}
@list l39:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l39:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l39:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l39:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l39:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l39:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l39:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l39:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l40
	{mso-list-id:1819885105;
	mso-list-type:hybrid;
	mso-list-template-ids:938893156 67698689 67698691 67698693 67698689 676986=
91 67698693 67698689 67698691 67698693;}
@list l40:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l40:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l40:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l40:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l40:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l40:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l40:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l40:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l40:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l41
	{mso-list-id:1860001483;
	mso-list-type:hybrid;
	mso-list-template-ids:-1052507278 -981978686 616343568 147246886 160739763=
0 16518340 -151064802 -627389472 -277025480 300056512;}
@list l41:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l41:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l41:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l41:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l41:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l41:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l41:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l41:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l41:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l42
	{mso-list-id:1871919056;
	mso-list-type:hybrid;
	mso-list-template-ids:-1228372506 -1010117684 -1307443028 836957198 213214=
8424 1503699306 -411148838 -428414610 -1472575730 1431473138;}
@list l42:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l42:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l42:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l42:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l42:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l42:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l42:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l42:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l42:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l43
	{mso-list-id:1896887715;
	mso-list-template-ids:1373522026;}
@list l43:level1
	{mso-level-number-format:alpha-upper;
	mso-level-style-link:C-Appendix;
	mso-level-text:"Appendix%1\.";
	mso-level-tab-stop:99.35pt;
	mso-level-number-position:left;
	margin-left:99.35pt;
	text-indent:-99.35pt;}
@list l43:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l43:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l43:level4
	{mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l43:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l43:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l43:level7
	{mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l43:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l43:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l44
	{mso-list-id:1897156113;
	mso-list-type:hybrid;
	mso-list-template-ids:1925620960 -1414755880 -2096455726 -1542410868 17515=
45778 1386912648 719248440 -822021398 -1612026158 -339210172;}
@list l44:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l44:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l44:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l44:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l44:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l44:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l44:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l44:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l44:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l10:level1 lfo10
	{mso-level-start-at:1;
	mso-level-number-format:bullet;
	mso-level-numbering:continue;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:.25in;
	text-indent:-.25in;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
table.MsoTableGrid
	{mso-style-name:"Table Grid\,Table Grid No Line";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-priority:39;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-border-insideh:.5pt solid windowtext;
	mso-border-insidev:.5pt solid windowtext;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
table.MsoTableTheme
	{mso-style-name:"Table Theme";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-border-insideh:.5pt solid windowtext;
	mso-border-insidev:.5pt solid windowtext;
	mso-para-margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
table.TablegridAgencyblack
	{mso-style-name:"Table grid \(Agency\) black";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"Table grid \(Agency\)";
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-border-insideh:.75pt solid windowtext;
	mso-border-insidev:.75pt solid windowtext;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-ansi-language:EN-GB;}
table.TablegridAgencyblackFirstRow
	{mso-style-name:"Table grid \(Agency\) black";
	mso-table-condition:first-row;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"Table grid \(Agency\)";
	mso-tstyle-border-top:.5pt solid windowtext;
	mso-tstyle-border-left:.5pt solid windowtext;
	mso-tstyle-border-bottom:.5pt solid windowtext;
	mso-tstyle-border-right:.5pt solid windowtext;
	mso-tstyle-diagonal-down:cell-none;
	mso-tstyle-diagonal-up:cell-none;
	mso-tstyle-border-insideh:.75pt solid windowtext;
	mso-tstyle-border-insidev:.75pt solid windowtext;
	font-size:9.0pt;
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Arial Black",sans-serif;
	mso-ascii-font-family:"Arial Black";
	mso-hansi-font-family:"Arial Black";
	color:windowtext;
	mso-ansi-font-weight:bold;
	mso-ansi-font-style:normal;}
table.C-Table
	{mso-style-name:C-Table;
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .75pt;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-border-insideh:.75pt solid windowtext;
	mso-border-insidev:.75pt solid windowtext;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
table.FootertableAgency
	{mso-style-name:"Footer table \(Agency\)";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-tstyle-padding:0in 0in 0in 0in;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-ansi-language:EN-GB;}
table.FootertableAgencyFirstRow
	{mso-style-name:"Footer table \(Agency\)";
	mso-table-condition:first-row;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-tstyle-border-top:.25pt solid windowtext;
	mso-tstyle-border-left:cell-none;
	mso-tstyle-border-bottom:cell-none;
	mso-tstyle-border-right:cell-none;
	mso-tstyle-diagonal-down:cell-none;
	mso-tstyle-diagonal-up:cell-none;
	mso-tstyle-border-insideh:cell-none;
	mso-tstyle-border-insidev:cell-none;
	font-size:9.0pt;
	mso-ansi-font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	mso-ascii-font-family:"Segoe UI";
	mso-hansi-font-family:"Segoe UI";
	mso-ansi-font-weight:normal;}
table.TablegridAgency
	{mso-style-name:"Table grid \(Agency\)";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	border:solid white 1.0pt;
	mso-border-alt:solid white .5pt;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-border-insideh:.75pt solid white;
	mso-border-insidev:.75pt solid white;
	mso-tstyle-shading:#E1E3F2;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-ansi-language:EN-GB;}
table.TablegridAgencyFirstRow
	{mso-style-name:"Table grid \(Agency\)";
	mso-table-condition:first-row;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-tstyle-shading:#003399;
	mso-tstyle-border-top:cell-none;
	mso-tstyle-border-left:cell-none;
	mso-tstyle-border-bottom:cell-none;
	mso-tstyle-border-right:cell-none;
	mso-tstyle-diagonal-down:cell-none;
	mso-tstyle-diagonal-up:cell-none;
	mso-tstyle-border-insideh:cell-none;
	mso-tstyle-border-insidev:cell-none;
	font-size:9.0pt;
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	mso-ascii-font-family:"Segoe UI";
	mso-hansi-font-family:"Segoe UI";
	mso-ansi-font-weight:bold;
	mso-ansi-font-style:normal;}
table.TablegridAgencyblank
	{mso-style-name:"Table grid \(Agency\) blank";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-ansi-language:EN-GB;}
table.TablegridAgencyblankFirstRow
	{mso-style-name:"Table grid \(Agency\) blank";
	mso-table-condition:first-row;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-tstyle-border-top:cell-none;
	mso-tstyle-border-left:cell-none;
	mso-tstyle-border-bottom:cell-none;
	mso-tstyle-border-right:cell-none;
	mso-tstyle-diagonal-down:cell-none;
	mso-tstyle-diagonal-up:cell-none;
	mso-tstyle-border-insideh:cell-none;
	mso-tstyle-border-insidev:cell-none;
	font-size:9.0pt;
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Tahoma",sans-serif;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	color:windowtext;
	mso-ansi-font-weight:normal;
	mso-ansi-font-style:normal;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"2049"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DEN-US link=3Dblue vlink=3D"#954F72" style=3D'tab-interval:.5in=
;word-wrap:
break-word'>

<div class=3DWordSection1>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align:c=
enter;
line-height:normal;mso-outline-level:1'><b style=3D'mso-bidi-font-weight:no=
rmal'><span
style=3D'font-family:"Times New Roman",serif'>ANNEX I<o:p></o:p></span></b>=
</p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align:c=
enter;
line-height:normal'><span style=3D'font-family:"Times New Roman",serif'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align:c=
enter;
line-height:normal;mso-outline-level:1'><b style=3D'mso-bidi-font-weight:no=
rmal'><span
style=3D'font-family:"Times New Roman",serif'>SUMMARY OF PRODUCT CHARACTERI=
STICS<o:p></o:p></span></b></p>

<span style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;mso-far=
east-font-family:
Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fare=
ast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'mso-special-charact=
er:line-break;
page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span lang=3D=
EN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;mso-fareast-language:ZH-C=
N;
mso-no-proof:yes'><v:shapetype id=3D"_x0000_t75" coordsize=3D"21600,21600" =
o:spt=3D"75"
 o:preferrelative=3D"t" path=3D"m@4@5l@4@11@9@11@9@5xe" filled=3D"f" stroke=
d=3D"f">
 <v:stroke joinstyle=3D"miter"/>
 <v:formulas>
  <v:f eqn=3D"if lineDrawn pixelLineWidth 0"/>
  <v:f eqn=3D"sum @0 1 0"/>
  <v:f eqn=3D"sum 0 0 @1"/>
  <v:f eqn=3D"prod @2 1 2"/>
  <v:f eqn=3D"prod @3 21600 pixelWidth"/>
  <v:f eqn=3D"prod @3 21600 pixelHeight"/>
  <v:f eqn=3D"sum @0 0 1"/>
  <v:f eqn=3D"prod @6 1 2"/>
  <v:f eqn=3D"prod @7 21600 pixelWidth"/>
  <v:f eqn=3D"sum @8 21600 0"/>
  <v:f eqn=3D"prod @7 21600 pixelHeight"/>
  <v:f eqn=3D"sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok=3D"f" gradientshapeok=3D"t" o:connecttype=3D"rect"/>
 <o:lock v:ext=3D"edit" aspectratio=3D"t"/>
</v:shapetype><v:shape id=3D"Picture_x0020_2" o:spid=3D"_x0000_i1027" type=
=3D"#_x0000_t75"
 alt=3D"BT_1000x858px" style=3D'width:15pt;height:15pt;visibility:visible;
 mso-wrap-style:square'>
 <v:imagedata src=3D"Zynteglo_clean_files/image001.png" o:title=3D"BT_1000x=
858px"/>
</v:shape></span><span style=3D'font-size:11.0pt'>This medicinal product is
subject to additional monitoring. This will allow quick identification of n=
ew
safety information. Healthcare professionals are asked to report any suspec=
ted
adverse reactions. See section 4.8 for how to report adverse reactions.<o:p=
></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>1.<span style=3D'mso-tab-count:1'> </span>NA=
ME OF
THE MEDICINAL PRODUCT</span></b><span lang=3DEN-GB style=3D'font-family:"Ti=
mes New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'><o:p></o=
:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span lang=3D=
FR
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:FR'>Z=
ynteglo
1.2&#8209;20&nbsp;&nbsp;10<sup>6</sup>&nbsp;cells/mL dispersion for infusi=
on. <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span lang=3D=
FR
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:FR'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span lang=3D=
FR
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:FR'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DFR
style=3D'font-family:"Times New Roman",serif;mso-bidi-font-family:Arial;
mso-bidi-theme-font:minor-bidi;mso-ansi-language:FR'>2.<span style=3D'mso-t=
ab-count:
1'> </span>QUALITATIVE AND QUANTITATIVE COMPOSITION</span></b><span
lang=3DFR style=3D'font-family:"Times New Roman",serif;mso-bidi-font-family=
:Arial;
mso-bidi-theme-font:minor-bidi;mso-ansi-language:FR'><o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span lang=3D=
FR
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:FR'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFR
style=3D'font-family:"Times New Roman",serif;mso-bidi-font-family:Arial;
mso-bidi-theme-font:minor-bidi;mso-ansi-language:FR'>2.1<span style=3D'mso-=
tab-count:
1'> </span>General description<o:p></o:p></span></b></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span lang=3D=
FR
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:FR'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span lang=3D=
FR
style=3D'font-size:11.0pt;mso-ansi-language:FR'>Zynteglo (betibeglogene
autotemcel) is a</span><span lang=3DFR style=3D'font-size:11.0pt;mso-bidi-f=
ont-size:
10.0pt;mso-ansi-language:FR'> genetically modified autologous CD34<sup>+ </=
sup>cell
enriched population that contains haematopoietic stem cells (HSC) transduced
with lentiviral vector (LVV) encoding the </span><span style=3D'font-size:1=
1.0pt'>&#946;</span><sup><span
lang=3DFR style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-lang=
uage:
FR'>A&#8209;T87Q</span></sup><span lang=3DFR style=3D'font-size:11.0pt;mso-=
bidi-font-size:
10.0pt;mso-ansi-language:FR'>&#8209;globin gene.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span lang=3D=
FR
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:FR'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'>2.2<span
style=3D'mso-tab-count:1'> </span>Qualitative and quantitative composit=
ion</span></b><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB;
mso-bidi-font-weight:bold'><o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>The finished product is composed of one or more
infusion bags which contain a dispersion of <span style=3D'color:black'>1.2=
&#8209;20&nbsp;&nbsp;</span>10<sup>6&nbsp;</sup><span
style=3D'color:black'>cells/mL </span>suspended in cryopreservative solutio=
n<span
style=3D'color:black'>. </span>Each infusion bag contains approximately
20&nbsp;mL of Zynteglo.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>The quantitative information regarding strength,=
 CD34<sup>+</sup>
cells, and dose for the medicinal product is provided in the Lot Information
Sheet. The Lot Information Sheet is included inside the lid of the cryoship=
per
used to transport Zynteglo.<span style=3D'mso-spacerun:yes'> </span><o:p><=
/o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Excipient with known effect<o:p></o:p></span></u=
></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Each dose contains 391&#8209;1564&nbsp;mg sodium=
.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>For the full list of excipients, see section 6.1=
.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>3.<span style=3D'mso-tab-count:1'> </span>PH=
ARMACEUTICAL
FORM</span></b><span lang=3DEN-GB style=3D'font-family:"Times New Roman",se=
rif;
mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Dispersion for infusion.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>A clear to slightly cloudy, colourless to yellow=
 or
pink dispersion.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>4.<span style=3D'mso-tab-count:1'> </span>CL=
INICAL
PARTICULARS<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o:p=
>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'>4.1<span
style=3D'mso-tab-count:1'> </span>Therapeutic indication<o:p></o:p></sp=
an></b></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><a
name=3D"_Hlk500066939"><span style=3D'font-size:11.0pt'>Zynteglo is indicat=
ed for
the treatment of patients 12 years and older with transfusion&#8209;depende=
nt
&#946;&#8209;thalassaemia (TDT) who do not have a &#946;<sup>0</sup>/&#946;=
<sup>0</sup>
genotype, for whom haematopoietic stem cell (HSC) transplantation is
appropriate but a human leukocyte antigen (HLA)&#8209;matched related HSC d=
onor
is not available (see sections 4.4 and 5.1).</span></a><span style=3D'font-=
size:
11.0pt'><o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'>4.2<span
style=3D'mso-tab-count:1'> </span>Posology and method of administration=
<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><a
name=3D"_Hlk497649473"><span style=3D'font-size:11.0pt'>Zynteglo must be
administered in a qualified treatment centre by a physician(s) with experie=
nce
in HSC transplantation and in the treatment of patients with TDT. </span></=
a><a
name=3D"_Hlk511314218"><span style=3D'mso-bookmark:_Hlk497649473'></span></=
a><span
style=3D'mso-bookmark:_Hlk511314218'><span style=3D'mso-bookmark:_Hlk497649=
473'><span
style=3D'font-size:11.0pt'><o:p></o:p></span></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk511314218'><span style=3D'mso-bookmark:_Hlk497649=
473'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk511314218'><span style=3D'mso-bookmark:_Hlk497649=
473'><span
style=3D'font-size:11.0pt'>Patients are expected to enrol in a registry and=
 will
be followed in the registry in order to better understand the long-term saf=
ety
and efficacy of Zynteglo. </span></span></span><span style=3D'mso-bookmark:=
_Hlk497649473'><span
style=3D'font-size:11.0pt'><o:p></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><u><span style=3D'font-size:11.0pt'><o=
:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><span
style=3D'mso-bookmark:_Hlk497649473'><u><span style=3D'font-size:11.0pt'>Po=
sology<o:p></o:p></span></u></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><span
style=3D'mso-bookmark:_Hlk497649473'><u><span style=3D'font-size:11.0pt'><o=
:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'>The m=
inimum
recommended dose of Zynteglo is 5.0&nbsp;&nbsp;10<sup>6</sup>&nbsp;CD34<su=
p>+</sup>
cells/kg. In clinical studies doses up to 20&nbsp;&nbsp;10<sup>6</sup>&nbs=
p;CD34<sup>+</sup>
cells/kg have been administered. The minimum recommended dose is the same f=
or
adults and adolescents 12 years of age and older.<o:p></o:p></span></span><=
/p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'>Zynte=
glo is
intended for autologous use (see section 4.4) and should only be administer=
ed
once.<o:p></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><i style=3D'mso-bidi-font-style:normal=
'><span
style=3D'font-family:"Times New Roman",serif'>Mobilisation and apheresis</s=
pan></i></span><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'>Patie=
nts are
required to undergo HSC mobilisation followed by apheresis to obtain CD34<s=
up>+</sup>
stem cells which will be used for medicinal product manufacturing (see sect=
ion
5.1 for a description of the mobilisation regimen used in clinical studies)=
. <o:p></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'>The m=
inimum
target number of CD34<sup>+</sup> cells to be collected is 12&nbsp;&nbsp;1=
0<sup>6</sup>&nbsp;CD34<sup>+</sup>&nbsp;cells/kg.
If the minimum dose of Zynteglo of 5.0&nbsp;&nbsp;10<sup>6</sup>&nbsp;CD34=
<sup>+</sup>&nbsp;cells/kg
is not met after initial medicinal product manufacturing, the patient may
undergo one or more additional cycles of mobilisation and apheresis, separa=
ted
by at least 14&nbsp;days, in order to obtain more cells for additional
manufacture.<o:p></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'>A bac=
k-up
collection of CD34<sup>+</sup> stem cells of &#8805;1.5&nbsp;&nbsp;10<sup>=
6</sup>&nbsp;CD34<sup>+</sup>&nbsp;cells/kg
(if collected by apheresis) or &gt;1.0&nbsp;&nbsp;10<sup>8</sup>&nbsp;TNC/=
kg
(if collected by bone marrow harvest) is required. These cells must be
collected from the patient and be cryopreserved prior to myeloablative
conditioning and infusion with Zynteglo. The back&#8209;up collection may be
needed for rescue treatment if there is: 1) compromise of Zynteglo after
initiation of myeloablative conditioning and before Zynteglo infusion, 2)
primary engraftment failure, or 3) loss of engraftment after infusion with
Zynteglo (see section 4.4). <o:p></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><i style=3D'mso-bidi-font-style:normal=
'><span
style=3D'font-family:"Times New Roman",serif'>Pre-treatment conditioning </=
span></i></span><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'>The t=
reating
physician should confirm that HSC transplantation is appropriate for the
patient before myeloablative conditioning is initiated (see section 4.4). <=
o:p></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt;color:=
black'>Full
myeloablative conditioning must be administered before infusion of Zynteglo
(see section 5.1 for a description of the myeloablative regimen used in
clinical studies). </span></span><span style=3D'mso-bookmark:_Hlk497649473'=
><span
style=3D'font-size:11.0pt'>It is recommended that patients maintain haemogl=
obin
(Hb) &#8805;11&nbsp;g/dL for at least 30&nbsp;days prior to mobilisation and
during myeloablative conditioning. Iron chelation should be stopped at least
7&nbsp;days prior to myeloablative conditioning. Prophylaxis for hepatic ve=
no&#8209;occlusive
disease (VOD) is recommended. Prophylaxis for seizures should be considered
(see section 5.1 for a description of the prophylaxis regimen used in clini=
cal
studies).<o:p></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'>Myelo=
ablative
conditioning should not begin until the complete set of infusion bag(s)
constituting the dose of Zynteglo has been received and stored at the
administration site, and the availability of the back-up collection is
confirmed. <s><o:p></o:p></s></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><i style=3D'mso-bidi-font-style:normal=
'><span
style=3D'font-family:"Times New Roman",serif'>Zynteglo administration</span=
></i></span><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'>See M=
ethod of
Administration below and section 6.6 for details on Zynteglo administration=
 and
handling.<o:p></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk497649473'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk497649473'></span>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><i
style=3D'mso-bidi-font-style:normal'><span style=3D'font-family:"Times New =
Roman",serif'>After
Zynteglo administration<o:p></o:p></span></i></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Any blood products required within the first
3&nbsp;months after Zynteglo infusion should be irradiated. <o:p></o:p></sp=
an></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Restarting iron chelation after Zynteglo infusio=
n may
be necessary and should be based on clinical practice (see sections 4.5 and
5.1). Phlebotomy can be used in lieu of iron chelation, when appropriate.<o=
:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><u><span
style=3D'font-size:11.0pt;mso-bidi-font-style:italic'>Special populations<o=
:p></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><i
style=3D'mso-bidi-font-style:normal'><u><span style=3D'font-size:11.0pt'><o=
:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></i></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><i
style=3D'mso-bidi-font-style:normal'><span style=3D'font-size:11.0pt'>Elder=
ly<o:p></o:p></span></i></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Zynteglo has not been studied in patients
&gt;65&nbsp;years of age. HSC transplantation must be appropriate for a pat=
ient
with TDT to be treated with Zynteglo (see section 4.4). No dose adjustment =
is
required.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span style=3D'font-size:11.0pt'>Renal impairment<o:p></o:p></span>=
</i></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Zynteglo has not been studied in patients with r=
enal
impairment. Patients should be assessed for renal impairment defined as
creatinine clearance &#8804;70&nbsp;mL/min/1.73&nbsp;m<sup>2</sup> to ensure
HSC transplantation is appropriate. No dose adjustment is required.<o:p></o=
:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span style=3D'font-size:11.0pt'>Hepatic impairment<o:p></o:p></spa=
n></i></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Zynteglo has not been studied in patients with h=
epatic
impairment. Patients should be assessed for hepatic impairment to ensure HSC
transplantation is appropriate (see section 4.4.). No dose adjustment is
required.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span style=3D'font-size:11.0pt'>Paediatric population<o:p></o:p></=
span></i></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>The safety and efficacy of Zynteglo in children
&lt;12&nbsp;years of age have not yet been established. <o:p></o:p></span><=
/p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span style=3D'font-size:11.0pt'>Patients seropositive for human
immunodeficiency virus (HIV) or human T&#8209;lymphotropic virus (HTLV)<o:p=
></o:p></span></i></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Zynteglo has not been studied in patients with H=
IV&#8209;1,
HIV&#8209;2, HTLV&#8209;1, or HTLV&#8209;2. A negative serology test for HI=
V is
necessary to ensure acceptance of apheresis material for Zynteglo
manufacturing. Apheresis material from patients with a positive test for HIV
will not be accepted for Zynteglo manufacturing. <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Method of administration <o:p></o:p></span></u><=
/p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><i style=3D'm=
so-bidi-font-style:
normal'><u><span style=3D'font-size:11.0pt'><o:p><span style=3D'text-decora=
tion:
 none'>&nbsp;</span></o:p></span></u></i></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Zynteglo is for intravenous use only (see sectio=
n 6.6
for full details on the administration process).<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>After completion of the 4&#8209;day course of
myeloablative conditioning, there must be a minimum of 48&nbsp;hours of was=
hout
before Zynteglo infusion. <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Before infusion, it must be confirmed that the
patients identity matches the unique patient information on the Zynteglo
infusion bag(s). The total number of infusion bags to be administered should
also be confirmed with the Lot Information Sheet (see section 4.4).<o:p></o=
:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Zynteglo infusion should be completed as soon as
possible and no more than 4&nbsp;hours after thawing. Each infusion bag sho=
uld
be administered in less than 30&nbsp;minutes. In the event that more than o=
ne
infusion bag is provided, all infusion bags must be administered. The entire
volume of each infusion bag should be infused. <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Standard procedures for patient management after=
 HSC
transplantation should be followed after Zynteglo infusion.<o:p></o:p></spa=
n></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'>4.3<span
style=3D'mso-tab-count:1'> </span>Contraindications<o:p></o:p></span></=
b></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Hypersensitivity to the active substance or to a=
ny of
the excipients listed in section 6.1.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Pregnancy and breast-feeding (see section 4.6).<=
o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Previous treatment with HSC gene therapy.<o:p></=
o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Contraindications to the mobilisation agents and=
 the
myeloablative conditioning agent must be considered.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;page-break-after:avoid;tab-stops:28.35pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>4.4<span style=3D'mso-tab-count:1'> </span>Spe=
cial
warnings and precautions for use<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><u><span
style=3D'font-family:"Times New Roman",serif'>Traceability<o:p></o:p></span=
></u></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><u><span
style=3D'font-family:"Times New Roman",serif'><o:p><span style=3D'text-deco=
ration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>The traceability requirements of cell-based adva=
nced
therapy medicinal products must apply. To ensure traceability the name of t=
he
product, the batch number and the name of the treated patient should be kept
for a period of 30 years.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>General<o:p></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Warnings and precautions of the mobilisation age=
nts
and the myeloablative conditioning agent must be considered.<o:p></o:p></sp=
an></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Patients treated with Zynteglo should not donate
blood, organs, tissues or cells for transplantation at any time in the futu=
re.
This information is provided in the Patient Alert Card which must be given =
to
the patient after treatment. <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Zynteglo is intended solely for autologous use a=
nd
must not be administered to other patients. Confirm that the patients iden=
tity
matches the unique patient identification information on the Zynteglo infus=
ion
bag(s) and metal cassette(s). Do not infuse Zynteglo if the information on =
the
patient specific label on the infusion bag(s) or metal cassette(s) do not m=
atch
the intended patient.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Risks associated with TDT and iron overload<o:p>=
</o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'>Patients with TDT experience =
iron
overload due to chronic red blood cell (RBC) transfusions that can lead to =
end
organ damage. HSC transplantation with myeloablative conditioning is not
appropriate for patients with TDT who have evidence of severely elevated ir=
on
in the heart i.e., patients with cardiac T2* &lt;10&nbsp;msec by magnetic
resonance imaging (MRI). MRI of the liver should be performed on all patien=
ts
prior to myeloablative conditioning. It is recommended that patients with M=
RI
results demonstrating liver iron content &#8805;15&nbsp;mg/g undergo liver
biopsy for further evaluation. If the liver biopsy demonstrates bridging
fibrosis, cirrhosis, or active hepatitis, HSC transplantation with
myeloablative conditioning is not appropriate.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Risk of insertional oncogenesis<o:p></o:p></span=
></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>No cases of leukaemia or lymphoma have been repo=
rted
in clinical studies with Zynteglo in patients with TDT. There are no report=
s of
LVV&#8209;mediated insertional mutagenesis resulting in oncogenesis.
Nevertheless, there is a theoretical risk of leukaemia or lymphoma after
treatment with Zynteglo. <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Patients should be monitored annually for leukae=
mia or
lymphoma (including with a complete blood count) for 15&nbsp;years post
treatment with Zynteglo. If leukaemia or lymphoma is detected in any patient
who received Zynteglo, blood samples should be collected for integration si=
te
analysis.<span style=3D'mso-spacerun:yes'> </span><o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Serological testing<o:p></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>All patients should be tested for HIV-1/2 prior =
to
mobilisation and apheresis to ensure acceptance of the apheresis material f=
or
Zynteglo manufacturing (see section 4.2). <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Interference with serology testing<o:p></o:p></s=
pan></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>It is important to note that patients who have
received Zynteglo are likely to test positive by polymerase chain reaction
(PCR) assays for HIV due to LVV provirus insertion, resulting in a false
positive test for HIV. Therefore, patients who have received Zynteglo should
not be screened for HIV infection using a PCR-based assay. <o:p></o:p></spa=
n></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><u><span
style=3D'font-size:11.0pt'>Engraftment failure as measured by neutrophil
engraftment<o:p></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Treatment with Zynteglo involves the infusion and
engraftment of CD34<sup>+</sup> HSCs that have been genetically modified <i
style=3D'mso-bidi-font-style:normal'>ex vivo</i> with a LVV. In clinical tr=
ials,
no patients failed to engraft bone marrow, as measured by neutrophil
engraftment (N=3D45). <span style=3D'color:black'>Neutrophil engraftment oc=
curred
on median&nbsp;(min,&nbsp;max) Day&nbsp;21.0 (13, 38) after medicinal produ=
ct
infusion. </span>Failure of neutrophil engraftment is a short-term but
potentially severe risk, defined as failure to achieve 3&nbsp;consecutive
absolute neutrophil counts (ANC) &#8805;500&nbsp;cells/L obtained on diffe=
rent
days by Day&nbsp;43 after infusion of Zynteglo. Patients who experience neu=
trophil
engraftment failure should receive rescue treatment with the back-up collec=
tion
(see section 4.2).<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Delayed platelet engraftment<o:p></o:p></span></=
u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Platelet engraftment is defined as 3&nbsp;consec=
utive
platelet values &#8805;20&nbsp;&nbsp;10<sup>9</sup>/L obtained on different
days after Zynteglo infusion, with no platelet transfusions administered for
7&nbsp;days immediately preceding and during the evaluation period.<b><i
style=3D'mso-bidi-font-style:normal'> </i></b>Patients with TDT treated with
Zynteglo who achieved platelet engraftment had a median (min, max) platelet
engraftment on Day&nbsp;42.0 (19, 191) in clinical trials (N=3D45). No
correlation was observed between incidence of bleeding and delayed platelet
engraftment. Patients should be made aware of the risk of bleeding until
platelet recovery has been achieved. Patients should be monitored for
thrombocytopenia and bleeding according to standard guidelines. Platelet co=
unts
should be monitored according to medical judgment until platelet engraftment
and platelet recovery are achieved. Blood cell count determination and other
appropriate testing should be promptly considered whenever clinical symptoms
suggestive of bleeding arise. <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Anti-retroviral and hydroxyurea use<o:p></o:p></=
span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Patients should not take anti&#8209;retroviral
medications or hydroxyurea from at least one month prior to mobilisation un=
til
at least 7&nbsp;days after Zynteglo infusion (see section 4.5). <a
name=3D"_Hlk3111940">If a patient requires anti&#8209;retrovirals for HIV
prophylaxis, Zynteglo treatment, including mobilisation and apheresis of CD=
34</a></span><span
style=3D'mso-bookmark:_Hlk3111940'><sup>+</sup></span><span style=3D'mso-bo=
okmark:
_Hlk3111940'><span style=3D'font-size:11.0pt'> cells through Zynteglo infus=
ion,
should be delayed until an HIV infection could be adequately ruled out
according to local guidance for HIV testing.<o:p></o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk3111940'></span>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Sodium content<o:p></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>This medicinal product contains 391&#8209;1564&n=
bsp;mg
sodium per dose equivalent to 20 to 78% of the WHO recommended maximum daily
intake of 2&nbsp;g sodium for an adult. <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'>4.5<span
style=3D'mso-tab-count:1'> </span>Interaction with other medicinal prod=
ucts
and other forms of interaction<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Patients should not take anti&#8209;retroviral
medicinal products or hydroxyurea from at least one month prior to mobilisa=
tion
until at least 7&nbsp;days after Zynteglo infusion (see section 4.4).<o:p><=
/o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Drug-drug interactions between iron chelators an=
d the
myeloablative conditioning agent must be considered. Iron chelators should =
be
discontinued 7&nbsp;days prior to initiation of conditioning. The Summary of
Product Characteristics (SmPC) for the iron chelator and the myeloablative
conditioning agent must be consulted for the recommendations regarding
co-administration with CYP3A substrates.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Some iron chelators are myelosuppressive. After
Zynteglo infusion, avoid use of these iron chelators for 6&nbsp;months. If =
iron
chelation is needed, consider administration of non-myelosuppressive iron
chelators (see sections 4.2 and 5.1).<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>No formal drug interaction studies have been
performed. Zynteglo is not expected to interact with the hepatic cytochrome=
 P&#8209;450
family of enzymes or drug transporters.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>There is no clinical experience with the use of
erythropoiesis-stimulating agents in patients treated with Zynteglo.<o:p></=
o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>The safety of immunisation with live viral vacci=
nes
during or following Zynteglo treatment has not been studied. <o:p></o:p></s=
pan></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;page-break-after:avoid;tab-stops:28.35pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>4.6<span style=3D'mso-tab-count:1'> </span>Fer=
tility,
pregnancy and lactation<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;page-break-after:avoid;tab-stops:28.35pt'><span style=3D'font-family:"=
Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><u><span
style=3D'font-size:11.0pt'>Women of childbearing potential/Contraception in=
 males
and females<o:p></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt;color:black'>There are insufficient exposure data=
 to
provide a precise recommendation on duration of </span><span style=3D'font-=
size:
11.0pt'>contraception following treatment with Zynteglo. Women of childbear=
ing
potential and men capable of fathering a child must use a reliable method of
contraception (intra-uterine device or combination of hormonal and barrier
contraception) from start of mobilisation through at least 6&nbsp;months af=
ter
administration of Zynteglo. Consult the SmPC of the myeloablative condition=
ing
agent for information on the need for effective contraception in patients w=
ho
undergo conditioning. <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Pregnancy<o:p></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>A negative serum pregnancy test must be confirmed
prior to the start of mobilisation and re-confirmed prior to conditioning
procedures and before medicinal product administration.<o:p></o:p></span></=
p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>No clinical data on exposed pregnancies are avai=
lable.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Reproductive and developmental toxicity studies =
with
Zynteglo were not performed. Zynteglo must not be used during pregnancy bec=
ause
of myeloablative conditioning (see section 4.3). It is unknown whether Zynt=
eglo
transduced cells have the potential to be transferred in utero to a foetus.=
<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>There is no opportunity for germline transmissio=
n of
the &#946;<sup>A&#8209;T87Q</sup>&#8209;globin gene after treatment with
Zynteglo, therefore the likelihood that an offspring would have general som=
atic
expression of the &#946;<sup>A&#8209;T87Q</sup>&#8209;globin gene is consid=
ered
negligible.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Breast-feeding<o:p></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>It is unknown whether Zynteglo is excreted in hu=
man
milk. The effect of administration of Zynteglo to mothers on their breast-f=
ed
children has not been studied.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Zynteglo must not be administered to women who a=
re
breast-feeding.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Fertility<o:p></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>There are no data on the effects of Zynteglo on =
human
fertility. Effects on male and female fertility have not been evaluated in
animal studies. <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Data are available on the risk of infertility wi=
th
myeloablative conditioning. <span style=3D'color:black'>It is therefore adv=
ised
to cryopreserve semen or ova before treatment if possible.<o:p></o:p></span=
></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'>4.7<span
style=3D'mso-tab-count:1'> </span>Effects on ability to drive and use
machines<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Zynteglo has no influence on the ability to driv=
e or
use machines.<br style=3D'mso-special-character:line-break'>
<![if !supportLineBreakNewLine]><br style=3D'mso-special-character:line-bre=
ak'>
<![endif]><o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>The effect of the mobilisation agents and the
myeloablative conditioning agent on the ability to drive or use machines mu=
st
be considered.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'>4.8<span
style=3D'mso-tab-count:1'> </span>Undesirable effects<o:p></o:p></span>=
</b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Summary of the safety profile<o:p></o:p></span><=
/u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>The safety of Zynteglo was evaluated in
45&nbsp;patients with TDT. The only serious adverse reaction attributed to
Zynteglo was thrombocytopenia (2.2%). <span style=3D'color:black'>Given the=
 small
patient population and size of cohorts, adverse reactions in the table belo=
w do
not provide a complete perspective on the nature and frequency of these eve=
nts.
<o:p></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><u><span
style=3D'font-size:11.0pt'>Tabulated list of adverse reactions<br
style=3D'mso-special-character:line-break'>
<![if !supportLineBreakNewLine]><br style=3D'mso-special-character:line-bre=
ak'>
<![endif]><o:p></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Adverse reactions are listed by MedDRA body syst=
em
organ class and by frequency convention. Frequencies are defined as: very
common <span style=3D'color:#323232'>(&#8805;1/10), and c</span>ommon
(&#8805;1/100 to &lt;1/10). Within each frequency grouping, adverse reactio=
ns
are presented in the order of decreasing seriousness.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Tables 1, 2, and 3 are lists of adverse reactions
attributed to mobilisation/apheresis, myeloablative conditioning, and Zynte=
glo,
respectively, experienced by patients with TDT in clinical trials with Zynt=
eglo.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:1.0in;text-indent:-1.0in;line-height:normal;page-break-after:av=
oid;
mso-layout-grid-align:none;text-autospace:none'><b style=3D'mso-bidi-font-w=
eight:
normal'><span style=3D'font-family:"Times New Roman",serif'>Table 1<span
style=3D'mso-tab-count:1'> </span>Adverse reactions attributed=
 to
mobilisation/apheresis<o:p></o:p></span></b></p>

<table class=3DMsoTableGrid border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;border:none;mso-border-alt:solid windowt=
ext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D201 valign=3Dtop style=3D'width:150.95pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><a
  name=3D"_Hlk4086514"><b style=3D'mso-bidi-font-weight:normal'><span
  style=3D'font-family:"Times New Roman",serif'>System Organ Class (SOC)<o:=
p></o:p></span></b></a></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border:solid windowte=
xt 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><b style=3D'mso-bidi-font-weight:norma=
l'><span
  style=3D'font-family:"Times New Roman",serif'>Very Common (&#8805;10%)<o:=
p></o:p></span></b></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border:solid windowte=
xt 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><b style=3D'mso-bidi-font-weight:norma=
l'><span
  style=3D'font-family:"Times New Roman",serif'>Common (&#8805;1% - &lt;10%=
)<o:p></o:p></span></b></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:1;height:8.5pt'>
  <td width=3D201 valign=3Dtop style=3D'width:150.95pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:8.5pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Blood and lymphatic system disorders</span></span><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:8=
.5pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Thrombocytopenia</span></span><span style=3D'mso-bookmark:_H=
lk4086514'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:8=
.5pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Splenomegaly, Leukocytosis</span></span><span style=3D'mso-b=
ookmark:
  _Hlk4086514'><span style=3D'font-family:"Times New Roman",serif'><o:p></o=
:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:2'>
  <td width=3D201 valign=3Dtop style=3D'width:150.95pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Metabolism and nutrition disorders</span></span><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Hypocalcaemia</span></span><span style=3D'mso-bookmark:_Hlk4=
086514'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Hypokalaemia, Hypomagnesaemia</span></span><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:3'>
  <td width=3D201 valign=3Dtop style=3D'width:150.95pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Psychiatric disorders</span></span><span style=3D'mso-bookma=
rk:
  _Hlk4086514'><span style=3D'font-family:"Times New Roman",serif'><o:p></o=
:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'><span
  style=3D'mso-bookmark:_Hlk4086514'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Agitation</span></span><span style=3D'mso-bookmark:_Hlk40865=
14'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:4'>
  <td width=3D201 valign=3Dtop style=3D'width:150.95pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Nervous system disorders</span></span><span style=3D'mso-boo=
kmark:
  _Hlk4086514'><span style=3D'font-family:"Times New Roman",serif'><o:p></o=
:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Headache, Peripheral sensory neuropathy</span></span><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Dizziness, Head discomfort, Paraesthesia</span></span><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:5'>
  <td width=3D201 valign=3Dtop style=3D'width:150.95pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Cardiac disorders</span></span><span style=3D'mso-bookmark:_=
Hlk4086514'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'><span
  style=3D'mso-bookmark:_Hlk4086514'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Cardiac flutter</span></span><span style=3D'mso-bookmark:_Hl=
k4086514'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:6'>
  <td width=3D201 valign=3Dtop style=3D'width:150.95pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Vascular disorders</span></span><span style=3D'mso-bookmark:=
_Hlk4086514'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'><span
  style=3D'mso-bookmark:_Hlk4086514'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Hypotension</span></span><span style=3D'mso-bookmark:_Hlk408=
6514'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:7'>
  <td width=3D201 valign=3Dtop style=3D'width:150.95pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Respiratory, thoracic and mediastinal disorders<o:p></o:p></=
span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'><span
  style=3D'mso-bookmark:_Hlk4086514'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Hypoxia, Epistaxis</span></span><span style=3D'mso-bookmark:=
_Hlk4086514'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:8'>
  <td width=3D201 valign=3Dtop style=3D'width:150.95pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Gastrointestinal disorders<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Nausea</span></span><span style=3D'mso-bookmark:_Hlk4086514'=
><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Vomiting, Lip swelling, Abdominal pain, Abdominal pain upper,
  Paraesthesia oral </span></span><span style=3D'mso-bookmark:_Hlk4086514'>=
<span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:9'>
  <td width=3D201 valign=3Dtop style=3D'width:150.95pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Skin and subcutaneous tissue disorders<o:p></o:p></span></sp=
an></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'><span
  style=3D'mso-bookmark:_Hlk4086514'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Rash, Hyperhidrosis</span></span><span style=3D'mso-bookmark=
:_Hlk4086514'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:10;height:22.9pt'>
  <td width=3D201 valign=3Dtop style=3D'width:150.95pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:22.9pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Musculoskeletal and connective tissue disorders<o:p></o:p></=
span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:2=
2.9pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Bone pain</span></span><span style=3D'mso-bookmark:_Hlk40865=
14'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:2=
2.9pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Back pain, Musculoskeletal discomfort</span></span><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:11'>
  <td width=3D201 valign=3Dtop style=3D'width:150.95pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>General disorders and administration site conditions<o:p></o=
:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'><span
  style=3D'mso-bookmark:_Hlk4086514'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Pyrexia, Influenza like illness, Chest discomfort, Chest pai=
n,
  Injection site reaction, Catheter site haemorrhage, Catheter site bruise,
  Injection site bruising, Fatigue, Non-cardiac chest pain, Catheter site p=
ain,
  Injection site pain, Puncture site pain, Pain</span></span><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:12'>
  <td width=3D201 valign=3Dtop style=3D'width:150.95pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Investigations<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'><span
  style=3D'mso-bookmark:_Hlk4086514'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Blood magnesium decreased</span></span><span style=3D'mso-bo=
okmark:
  _Hlk4086514'><span style=3D'font-family:"Times New Roman",serif'><o:p></o=
:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:13;mso-yfti-lastrow:yes'>
  <td width=3D201 valign=3Dtop style=3D'width:150.95pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Injury, poisoning and procedural complications<o:p></o:p></s=
pan></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'><span
  style=3D'mso-bookmark:_Hlk4086514'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Citrate toxicity, Contusion, Procedural pain</span></span><s=
pan
  style=3D'mso-bookmark:_Hlk4086514'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086514'></span>
 </tr>
</table>

<span style=3D'mso-bookmark:_Hlk4086514'></span>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:1.0in;text-indent:-1.0in;line-height:normal;mso-layout-grid-ali=
gn:
none;text-autospace:none'><span style=3D'font-family:"Times New Roman",seri=
f'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:1.0in;text-indent:-1.0in;line-height:normal;page-break-before:a=
lways;
page-break-after:avoid;mso-layout-grid-align:none;text-autospace:none'><a
name=3D"_Hlk4086533"><b style=3D'mso-bidi-font-weight:normal'><span
style=3D'font-family:"Times New Roman",serif'>Table 2<span style=3D'mso-tab=
-count:
1'> </span>Adverse reactions attributed to myeloablative
conditioning<o:p></o:p></span></b></a></p>

<table class=3DMsoTableGrid border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;border:none;mso-border-alt:solid windowt=
ext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <thead>
  <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;height:10.3pt'>
   <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid window=
text 1.0pt;
   mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:
   10.3pt'>
   <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
   style=3D'mso-bookmark:_Hlk4086533'><b style=3D'mso-bidi-font-weight:norm=
al'><span
   style=3D'font-family:"Times New Roman",serif'>SOC<o:p></o:p></span></b><=
/span></p>
   </td>
   <span style=3D'mso-bookmark:_Hlk4086533'></span>
   <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid window=
text 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:10.3pt'>
   <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
   style=3D'mso-bookmark:_Hlk4086533'><b style=3D'mso-bidi-font-weight:norm=
al'><span
   style=3D'font-family:"Times New Roman",serif'>Very Common (&#8805;10%)<o=
:p></o:p></span></b></span></p>
   </td>
   <span style=3D'mso-bookmark:_Hlk4086533'></span>
   <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid window=
text 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:10.3pt'>
   <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
   style=3D'mso-bookmark:_Hlk4086533'><b style=3D'mso-bidi-font-weight:norm=
al'><span
   style=3D'font-family:"Times New Roman",serif'>Common (&#8805;1% - &lt;10=
%)<o:p></o:p></span></b></span></p>
   </td>
   <span style=3D'mso-bookmark:_Hlk4086533'></span>
  </tr>
 </thead>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Infections and infestations<o:p></o:p></span></span></p>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'><span
  style=3D'mso-bookmark:_Hlk4086533'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Neutropenic sepsis, Systemic infection, Staphylococcal
  infection, Pneumonia, Lower respiratory tract infection, Urinary tract
  infection, Mucosal infection, Cellulitis, Vaginal infection, Rash pustula=
r,
  Folliculitis, Gingivitis, Vulvovaginal candidiasis</span></span><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:2;height:8.5pt'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:8.5pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-b=
reak-after:
  avoid'><span style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-famil=
y:"Times New Roman",serif;
  color:black'>Blood and lymphatic system disorders</span></span><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:8=
.5pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-b=
reak-after:
  avoid'><span style=3D'mso-bookmark:_Hlk4086533'><span lang=3DIT style=3D'=
font-family:
  "Times New Roman",serif;color:black;mso-ansi-language:IT'>Febrile
  neutropenia, Neutropenia, Thrombocytopenia, Leukopenia, Anaemia</span></s=
pan><span
  style=3D'mso-bookmark:_Hlk4086533'><span lang=3DIT style=3D'font-family:"=
Times New Roman",serif;
  mso-ansi-language:IT'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:8=
.5pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-b=
reak-after:
  avoid'><span style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-famil=
y:"Times New Roman",serif;
  color:black'>Lymphopenia, Leukocytosis, Monocyte count decreased,
  Neutrophilia, Mean cell haemoglobin concentration increased</span></span>=
<span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:3;height:8.5pt'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:8.5pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-b=
reak-after:
  avoid'><span style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-famil=
y:"Times New Roman",serif;
  color:black'>Endocrine disorders<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:8=
.5pt'><span
  style=3D'mso-bookmark:_Hlk4086533'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-b=
reak-after:
  avoid'><span style=3D'mso-bookmark:_Hlk4086533'><span lang=3DIT style=3D'=
font-family:
  "Times New Roman",serif;color:black;mso-ansi-language:IT'><o:p>&nbsp;</o:=
p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:8=
.5pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-b=
reak-after:
  avoid'><span style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-famil=
y:"Times New Roman",serif;
  color:black'>Primary hypogonadism<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:4'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Metabolism and nutrition disorders</span></span><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Decreased appetite</span></span><span style=3D'mso-bookmark:=
_Hlk4086533'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Hypocalcaemia, Hypokalaemia, Metabolic acidosis, Fluid overl=
oad,
  Fluid retention, Hypomagnesaemia, Hyponatraemia, Hypophosphataemia,
  Hyperphosphataemia</span></span><span style=3D'mso-bookmark:_Hlk4086533'>=
<span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:5'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Psychiatric disorders</span></span><span style=3D'mso-bookma=
rk:
  _Hlk4086533'><span style=3D'font-family:"Times New Roman",serif'><o:p></o=
:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Insomnia</span></span><span style=3D'mso-bookmark:_Hlk408653=
3'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Anxiety</span></span><span style=3D'mso-bookmark:_Hlk4086533=
'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:6'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Nervous system disorders</span></span><span style=3D'mso-boo=
kmark:
  _Hlk4086533'><span style=3D'font-family:"Times New Roman",serif'><o:p></o=
:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Headache</span></span><span style=3D'mso-bookmark:_Hlk408653=
3'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Dizziness, Lethargy, Dysgeusia, Ageusia, Memory impairment</=
span></span><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:7'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Eye disorders</span></span><span style=3D'mso-bookmark:_Hlk4=
086533'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'><span
  style=3D'mso-bookmark:_Hlk4086533'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Conjunctival haemorrhage</span></span><span style=3D'mso-boo=
kmark:
  _Hlk4086533'><span style=3D'font-family:"Times New Roman",serif'><o:p></o=
:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:8'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Ear and labyrinth disorders</span></span><span style=3D'mso-=
bookmark:
  _Hlk4086533'><span style=3D'font-family:"Times New Roman",serif'><o:p></o=
:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'><span
  style=3D'mso-bookmark:_Hlk4086533'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Vertigo</span></span><span style=3D'mso-bookmark:_Hlk4086533=
'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:9'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Cardiac disorders</span></span><span style=3D'mso-bookmark:_=
Hlk4086533'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'><span
  style=3D'mso-bookmark:_Hlk4086533'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Cardiac failure congestive, Atrial fibrillation </span></spa=
n><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:10'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Vascular disorders</span></span><span style=3D'mso-bookmark:=
_Hlk4086533'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'><span
  style=3D'mso-bookmark:_Hlk4086533'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Hypotension, Haematoma, Hot flush</span></span><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:11'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Respiratory, thoracic and mediastinal disorders<o:p></o:p></=
span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Epistaxis, Pharyngeal inflammation</span></span><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Hypoxia, Pulmonary mass, Dyspnoea, Pleural effusion, Rales,
  Upper-airway cough syndrome, Cough, Laryngeal pain, Hiccups, Oropharyngeal
  pain </span></span><span style=3D'mso-bookmark:_Hlk4086533'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:12'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Gastrointestinal disorders<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Stomatitis, Vomiting, Nausea, Diarrhoea, Gingival bleeding,
  Constipation, Abdominal pain, Anal inflammation </span></span><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Anal haemorrhage, Gastritis, Gastrointestinal inflammation,
  Abdominal distension, Abdominal pain upper, Anal fissure, Dyspepsia,
  Dysphagia, Oesophagitis, Haemorrhoids, Proctalgia, Lip dry</span></span><=
span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:13'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Hepatobiliary disorders<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Veno&#8209;occlusive liver disease, Alanine aminotransferase
  increased, Aspartate aminotransferase increased, Blood bilirubin increase=
d</span></span><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Cholecystitis, Cholelithiasis, Hepatomegaly, Jaundice,
  Transaminases increased, Gamma-glutamyltransferase increased</span></span=
><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:14'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Skin and subcutaneous tissue disorders<o:p></o:p></span></sp=
an></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Alopecia, Pruritus, Skin hyperpigmentation</span></span><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Petechiae, Ecchymosis, Pain of skin, Palpable purpura,
  Pigmentation disorder, Pruritus generalised, Purpura, Sweat gland disorde=
r,
  Urticaria, Dry skin, Rash</span></span><span style=3D'mso-bookmark:_Hlk40=
86533'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:15'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Musculoskeletal and connective tissue disorders<o:p></o:p></=
span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'><span
  style=3D'mso-bookmark:_Hlk4086533'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Bone pain, Myalgia, Pain&nbsp;in&nbsp;extremity, Back pain</=
span></span><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:16'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Renal and urinary disorders<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'><span
  style=3D'mso-bookmark:_Hlk4086533'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Haematuria, Pollakiuria</span></span><span style=3D'mso-book=
mark:
  _Hlk4086533'><span style=3D'font-family:"Times New Roman",serif'><o:p></o=
:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:17'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Reproductive system and breast disorders<o:p></o:p></span></=
span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Vaginal haemorrhage</span></span><span style=3D'mso-bookmark=
:_Hlk4086533'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Ovarian failure, Menstruation irregular, Premature menopause,
  Blood follicle stimulating hormone increased, Blood testosterone decrease=
d</span></span><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:18'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>General disorders and administration site conditions<o:p></o=
:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Pyrexia, Fatigue, Mucosal inflammation</span></span><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Face oedema, Hypothermia, Feeling cold, Pain, Xerosis</span>=
</span><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:19'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-b=
reak-after:
  avoid'><span style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-famil=
y:"Times New Roman",serif;
  color:black'>Investigations<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'><span
  style=3D'mso-bookmark:_Hlk4086533'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-b=
reak-after:
  avoid'><span style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-famil=
y:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-b=
reak-after:
  avoid'><span style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-famil=
y:"Times New Roman",serif;
  color:black'>C&#8209;reactive protein increased, Aspergillus test positiv=
e,
  Blood potassium decreased, Weight decreased, Blood alkaline phosphatase
  decreased, Blood magnesium decreased, Forced expiratory flow decreased,
  Protein total decreased, Blood albumin decreased, Reticulocyte count
  decreased, Reticulocyte percentage decreased</span></span><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:20;mso-yfti-lastrow:yes;height:23.8pt'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:23.8pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Injury, poisoning and procedural complications<o:p></o:p></s=
pan></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:2=
3.8pt'><span
  style=3D'mso-bookmark:_Hlk4086533'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:2=
3.8pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Transfusion reaction, Skin abrasion</span></span><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:1.0in;text-indent:-1.0in;line-height:normal;mso-layout-grid-ali=
gn:
none;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4086533'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:1.0in;text-indent:-1.0in;line-height:normal;page-break-after:av=
oid;
mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-bookmark=
:_Hlk4086533'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'>Table
3<span style=3D'mso-tab-count:1'> </span>Adverse reactions
attributed to Zynteglo<o:p></o:p></span></b></span></p>

<table class=3DMsoTableGrid border=3D1 cellspacing=3D0 cellpadding=3D0 widt=
h=3D602
 style=3D'width:451.75pt;border-collapse:collapse;border:none;mso-border-al=
t:
 solid windowtext .5pt;mso-yfti-tbllook:1184;mso-padding-alt:0in 5.4pt 0in =
5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;height:14.35pt'>
  <td width=3D201 valign=3Dtop style=3D'width:150.55pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><b style=3D'mso-bidi-font-weight:norma=
l'><span
  style=3D'font-family:"Times New Roman",serif'>SOC<o:p></o:p></span></b></=
span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D201 valign=3Dtop style=3D'width:150.6pt;border:solid windowte=
xt 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:14.35pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><b style=3D'mso-bidi-font-weight:norma=
l'><span
  style=3D'font-family:"Times New Roman",serif'>Very Common (&#8805;10%)<o:=
p></o:p></span></b></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D201 valign=3Dtop style=3D'width:150.6pt;border:solid windowte=
xt 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:14.35pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><b style=3D'mso-bidi-font-weight:norma=
l'><span
  style=3D'font-family:"Times New Roman",serif'>Common (&#8805;1% - &lt;10%=
)<o:p></o:p></span></b></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:1;height:9.4pt'>
  <td width=3D201 valign=3Dtop style=3D'width:150.55pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:9.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Blood and lymphatic system disorders</span></span><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D201 valign=3Dtop style=3D'width:150.6pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:9=
.4pt'><span
  style=3D'mso-bookmark:_Hlk4086533'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D201 valign=3Dtop style=3D'width:150.6pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:9=
.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Thrombocytopenia, <o:p></o:p></span></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Leukopenia, Neutropenia</span></span><span style=3D'mso-book=
mark:
  _Hlk4086533'><span style=3D'font-family:"Times New Roman",serif'><o:p></o=
:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:2;height:14.35pt'>
  <td width=3D201 valign=3Dtop style=3D'width:150.55pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.35pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Vascular disorders</span></span><span style=3D'mso-bookmark:=
_Hlk4086533'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D201 valign=3Dtop style=3D'width:150.6pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'><span
  style=3D'mso-bookmark:_Hlk4086533'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D201 valign=3Dtop style=3D'width:150.6pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Hot flush</span></span><span style=3D'mso-bookmark:_Hlk40865=
33'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:3;height:14.05pt'>
  <td width=3D201 valign=3Dtop style=3D'width:150.55pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.05pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Respiratory, thoracic and mediastinal disorders<o:p></o:p></=
span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D201 valign=3Dtop style=3D'width:150.6pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.05pt'><span
  style=3D'mso-bookmark:_Hlk4086533'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D201 valign=3Dtop style=3D'width:150.6pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.05pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Dyspnoea</span></span><span style=3D'mso-bookmark:_Hlk408653=
3'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:4;height:14.35pt'>
  <td width=3D201 valign=3Dtop style=3D'width:150.55pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.35pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Gastrointestinal disorders<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D201 valign=3Dtop style=3D'width:150.6pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Abdominal pain<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D201 valign=3Dtop style=3D'width:150.6pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'><span
  style=3D'mso-bookmark:_Hlk4086533'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:5;height:14.35pt'>
  <td width=3D201 valign=3Dtop style=3D'width:150.55pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.35pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Musculoskeletal and connective tissue disorders<o:p></o:p></=
span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D201 valign=3Dtop style=3D'width:150.6pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'><span
  style=3D'mso-bookmark:_Hlk4086533'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D201 valign=3Dtop style=3D'width:150.6pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Pain in extremity</span></span><span style=3D'mso-bookmark:_=
Hlk4086533'><span
  style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:6;mso-yfti-lastrow:yes;height:28.5pt'>
  <td width=3D201 valign=3Dtop style=3D'width:150.55pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:28.5pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>General disorders and administration site conditions<o:p></o=
:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D201 valign=3Dtop style=3D'width:150.6pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:2=
8.5pt'><span
  style=3D'mso-bookmark:_Hlk4086533'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
  <td width=3D201 valign=3Dtop style=3D'width:150.6pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:2=
8.5pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk4086533'><span style=3D'font-family:"Times New =
Roman",serif;
  color:black'>Non-cardiac chest pain</span></span><span style=3D'mso-bookm=
ark:
  _Hlk4086533'><span style=3D'font-family:"Times New Roman",serif'><o:p></o=
:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4086533'></span>
 </tr>
</table>

<span style=3D'mso-bookmark:_Hlk4086533'></span>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:1.0in;text-indent:-1.0in;line-height:normal;mso-layout-grid-ali=
gn:
none;text-autospace:none'><span style=3D'font-family:"Times New Roman",seri=
f'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Description of selected adverse reactions<o:p></=
o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><a name=3D"_H=
lk4059620"><i
style=3D'mso-bidi-font-style:normal'><span style=3D'font-size:11.0pt'>Bleed=
ing<o:p></o:p></span></i></a></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk4059620'><span style=3D'font-size:11.0pt'><o:p>&n=
bsp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk4059620'><span style=3D'font-size:11.0pt'>Bleedin=
g is a
potential complication of thrombocytopenia subsequent to myeloablative
conditioning and treatment with Zynteglo. The majority of all reported blee=
ding
events were nonserious. A risk of bleeding exists before platelet engraftme=
nt
and may continue after platelet engraftment in patients who have continued
thrombocytopenia.<span style=3D'mso-spacerun:yes'> </span><o:p></o:p></sp=
an></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk4059620'><span style=3D'font-size:11.0pt'><o:p>&n=
bsp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk4059620'><span style=3D'font-size:11.0pt'>Followi=
ng
platelet engraftment, all patients maintained platelet levels of
&#8805;20&nbsp;&nbsp;10<sup>9</sup>/L. Median (min, max) times to unsuppor=
ted
platelet counts of &#8805;50&nbsp;&nbsp;10<sup>9</sup>/L<span
style=3D'mso-spacerun:yes'> </span>and &#8805;100&nbsp;&nbsp;10<sup>9</su=
p>/L
were 51 (20, 268) days (N=3D45) and 63.5 (20, 1231) days (N=3D42), respecti=
vely
(see section 4.4 for guidance on platelet monitoring and management).<o:p><=
/o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk4059620'><span style=3D'font-size:11.0pt'><o:p>&n=
bsp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk4059620'><i style=3D'mso-bidi-font-style:normal'>=
<span
style=3D'font-size:11.0pt'>Hepatic veno-occlusive disease<o:p></o:p></span>=
</i></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk4059620'><span style=3D'font-size:11.0pt'><o:p>&n=
bsp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk4059620'><span style=3D'font-size:11.0pt'>Serious=
 events
of hepatic VOD occurred in 11.1% of patients following myeloablative
conditioning; 80% of these patients did not receive prophylaxis for VOD. All
patients who experienced VOD received treatment with defibrotide and recove=
red.
Patients with TDT may be at an increased risk of VOD following myeloablativ=
e conditioning
compared with other patient populations.<span style=3D'mso-spacerun:yes'>
</span><o:p></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk4059620'><span style=3D'font-size:11.0pt'><o:p>&n=
bsp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><span
style=3D'mso-bookmark:_Hlk4059620'><i style=3D'mso-bidi-font-style:normal'>=
<span
style=3D'font-size:11.0pt'>Infusion related reactions to Zynteglo<o:p></o:p=
></span></i></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><span
style=3D'mso-bookmark:_Hlk4059620'><span style=3D'font-size:11.0pt'><o:p>&n=
bsp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><span
style=3D'mso-bookmark:_Hlk4059620'><span style=3D'font-size:11.0pt'>Pre-med=
ication
for infusion reactions was managed at physician discretion. Infusion related
reactions to Zynteglo were observed in 13.3% of patients and occurred on the
day of Zynteglo infusion. All reactions resolved and the majority were mild.
Events included abdominal pain, dyspnoea, hot flush, and non&#8209;cardiac
chest pain in 11.1%, 2.2%, 2.2%, and 2.2% of patients, respectively.<span
style=3D'mso-spacerun:yes'> </span></span></span><span style=3D'font-size:=
11.0pt'><o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><u><span
style=3D'font-size:11.0pt'>Paediatric population<o:p></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><a name=3D"_H=
lk3021378"></a><a
name=3D"_Hlk2980904"><span style=3D'mso-bookmark:_Hlk3021378'><span
style=3D'font-size:11.0pt'>According to available data, the frequency, type=
, and
severity of adverse reactions in adolescents 12&#8209;17&nbsp;years of age =
are
similar to adults with the exception that VOD and pyrexia occurred more
frequently in adolescents.<o:p></o:p></span></span></a></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk2980904'><span style=3D'mso-bookmark:_Hlk3021378'=
><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></span></span></p>

<span style=3D'mso-bookmark:_Hlk3021378'></span><span style=3D'mso-bookmark=
:_Hlk2980904'></span>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Reporting of suspected adverse reactions<o:p></o=
:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Reporting suspected adverse reactions after
authorisation of the medicinal product is important. It allows continued
monitoring of the benefit/risk balance of the medicinal product. Healthcare
professionals are asked to report any suspected adverse reactions via <span
style=3D'background:lightgrey;mso-highlight:lightgrey'>the national reporti=
ng
system listed in <span class=3DMsoHyperlink>Appendix V</span>.</span><o:p><=
/o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'>4.9<span
style=3D'mso-tab-count:1'> </span>Overdose<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>No data from clinical studies are available rega=
rding
overdose of Zynteglo. <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>5.<span style=3D'mso-tab-count:1'> </span>PH=
ARMACOLOGICAL
PROPERTIES</span></b><span lang=3DEN-GB style=3D'font-family:"Times New Rom=
an",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'><o:p></o=
:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'>5.1<span
style=3D'mso-tab-count:1'> </span>Pharmacodynamic properties</span></b>=
<b><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p></o:p></span></b></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Pharmacotherapeutic group: Other haematological
agents, ATC code: B06AX02<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Mechanism of action<o:p></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Zynteglo adds functional copies of a modified
&#946;-globin gene into the patients HSCs through transduction of autologo=
us
CD34<sup>+</sup> cells with BB305 LVV, thereby addressing the underlying
genetic cause of the disease. After Zynteglo infusion, transduced CD34<sup>=
+</sup>
HSCs engraft in the bone marrow and differentiate to produce RBCs containing
biologically active <span style=3D'color:black'>&#946;<sup>A&#8209;T87Q</su=
p>&#8209;globin
(a modified &#946;&#8209;globin protein) that will combine with &#945;-glob=
in
to produce functional Hb containing </span>&#946;<sup>A&#8209;T87Q</sup>&#8=
209;globin
(Hb<span style=3D'color:black'>A<sup>T87Q</sup>). </span>&#946;<sup>A&#8209=
;T87Q</sup>&#8209;globin
can be quantified relative to other globin species in peripheral blood using
high performance liquid chromatography.<span style=3D'color:black'> </span>=
&#946;<sup>A&#8209;T87Q</sup>&#8209;globin
expression is designed to correct the &#946;/&#945;&#8209;globin imbalance =
in
erythroid cells of patients with TDT and has the potential to increase tota=
l Hb
to normal levels and eliminate dependence on chronic RBC transfusions. <a
name=3D"_Hlk2981031">Following successful engraftment and achievement of
transfusion independence, the effects of the product are expected to be lif=
e&#8209;long.<o:p></o:p></a></span></p>

<span style=3D'mso-bookmark:_Hlk2981031'></span>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Pharmacodynamic effects <o:p></o:p></span></u></=
p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>All patients with TDT with a non&#8209;&#946;<su=
p>0</sup>/&#946;<sup>0</sup>&nbsp;genotype
who received Zynteglo with at least 3&nbsp;months of follow-up produced HbA=
<sup>T87Q</sup>
(N=3D10, HGB&#8209;204; N=3D4, HGB&#8209;205; N=3D15, HGB&#8209;207; N=3D3,=
 HGB&#8209;212).
For patients with at least 6&nbsp;months of follow-up, HbA<sup>T87Q</sup>
generally increased steadily after Zynteglo infusion and stabilised by
approximately Month&nbsp;6. Patients had a Month&nbsp;6 median&nbsp;(min, m=
ax)
HbA<sup>T87Q</sup> of 4.901&nbsp;(1.03,&nbsp;9.59)&nbsp;g/dL in the Phase 1=
/2
studies (N=3D14, HGB&#8209;204 and HGB&#8209;205) and 9.409&nbsp;(3.35,&nbs=
p;10.60)&nbsp;g/dL
in ongoing Phase 3 studies (N=3D16, HGB&#8209;207 and HGB-212).<span
style=3D'mso-spacerun:yes'> </span><o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>HbA<sup>T87Q</sup> remained generally stable thr=
ough
Month&nbsp;24 with a&nbsp;median (min, max) of
6.444&nbsp;(1.10,&nbsp;10.13)&nbsp;g/dL in the completed Phase 1/2 studies =
(N=3D14,
HGB&#8209;204 and HGB&#8209;205) and 8.766&nbsp;(0.89,&nbsp;11.40)&nbsp;g/d=
L in
the ongoing Phase 3 studies (N=3D3, HGB&#8209;207). HbA<sup>T87Q</sup> cont=
inued
to be stable at last follow-up through Month&nbsp;60, demonstrating stable
integration of the &#946;<sup>A&#8209;T87Q</sup>&#8209;globin gene into lon=
g&#8209;term
HSCs and stable expression of the &#946;<sup>A&#8209;T87Q</sup>&#8209;globin
gene in cells of the erythroid lineage. <a name=3DIDX></a><o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;text-aut=
ospace:
none'><i style=3D'mso-bidi-font-style:normal'><span style=3D'font-family:"T=
imes New Roman",serif'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><a
name=3D"_Hlk535595211"><u><span style=3D'font-size:11.0pt'>Clinical efficac=
y <o:p></o:p></span></u></a></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><span
style=3D'mso-bookmark:_Hlk535595211'><i style=3D'mso-bidi-font-style:normal=
'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></i></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk535595211'><span style=3D'font-size:11.0pt'>Effic=
acy was
based on 32&nbsp;adult and adolescent patients with TDT and a non&#8209;&#9=
46;<sup>0</sup>/&#946;<sup>0</sup>
genotype treated with Zynteglo (N=3D10, HGB&#8209;204; N=3D4, HGB&#8209;205=
; N=3D15,
HGB&#8209;207; N=3D3, HGB&#8209;212) (see Table 4). <a name=3D"_Hlk2977601"=
>A few
patients have been included in the clinical studies with genotypes
characterised by low endogenous &#946;&#8209;globin production phenotypical=
ly
similar to patients with a &#946;<sup>0</sup>/&#946;<sup>0</sup> genotype, =
such
as patients homozygous for IVS&#8209;I&#8209;110 or IVS&#8209;I&#8209;5. <o=
:p></o:p></a></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk535595211'><span style=3D'mso-bookmark:_Hlk297760=
1'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></span></span></p>

<span style=3D'mso-bookmark:_Hlk2977601'></span>

<p class=3DC-BodyText style=3D'margin-top:0in;margin-right:0in;margin-botto=
m:0in;
margin-left:1.0in;text-indent:-1.0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk535595211'><b style=3D'mso-bidi-font-weight:norma=
l'><span
style=3D'font-size:11.0pt'>Table 4<span style=3D'mso-tab-count:1'>=
 </span>Baseline
characteristics for non&#8209;&#946;<sup>0</sup>/&#946;<sup>0</sup> patients
with TDT &#8805;12 years of age treated with Zynteglo (Studies HGB&#8209;20=
4,
HGB&#8209;205, HGB&#8209;207, HGB&#8209;212, LTF&#8209;303)<span
style=3D'mso-tab-count:1'> </span><o:p></o:p></span></b></span></p>

<p class=3DC-BodyText style=3D'margin-top:0in;margin-right:0in;margin-botto=
m:0in;
margin-left:1.0in;text-indent:-1.0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk535595211'><b style=3D'mso-bidi-font-weight:norma=
l'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></span></p>

<table class=3DMsoTableGrid border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;border:none;mso-border-alt:solid windowt=
ext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;height:48.6pt'>
  <td width=3D83 valign=3Dtop style=3D'width:62.5pt;border:solid windowtext=
 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:4=
8.6pt'>
  <p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk535595211'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
  style=3D'font-size:11.0pt'>Study</span></b></span><span style=3D'mso-book=
mark:
  _Hlk535595211'><span style=3D'font-size:11.0pt'><o:p></o:p></span></span>=
</p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D102 valign=3Dtop style=3D'width:76.65pt;border:solid windowte=
xt 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:48.6pt'>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:EN-GB'>Total number of patients <o:p></o:p></span></b><=
/span></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;mso-bidi-f=
ont-weight:
  bold'>(young adults/ adolescents)<o:p></o:p></span></span></p>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbs=
p;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D90 valign=3Dtop style=3D'width:67.6pt;border:solid windowtext=
 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:48.6pt'>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><b
  style=3D'mso-bidi-font-weight:normal'><span style=3D'font-size:11.0pt'>Ag=
e<o:p></o:p></span></b></span></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>(years)<o:p></o:p></span></span></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>median (min, max)<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D162 valign=3Dtop style=3D'width:121.85pt;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:48.6pt'>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><b
  style=3D'mso-bidi-font-weight:normal'><span style=3D'font-size:11.0pt'>Pr=
e-enrolment
  transfusion volumes<o:p></o:p></span></b></span></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>(mL/kg/year)<o:p></o:p></span></span></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>median (min, max)<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D167 valign=3Dtop style=3D'width:125.15pt;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:48.6pt'>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><b
  style=3D'mso-bidi-font-weight:normal'><span style=3D'font-size:11.0pt'>Pr=
e-enrolment
  transfusion frequency<o:p></o:p></span></b></span></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt;mso-bidi-font-weight:bold'>(number/year)<o:p></=
o:p></span></span></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>median (min, max)<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:1;height:11.9pt'>
  <td width=3D83 valign=3Dtop style=3D'width:62.5pt;border:solid windowtext=
 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:11.9pt'>
  <p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk535595211'><span style=3D'font-size:11.0pt'>HGB=
&#8209;205<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D102 valign=3Dtop style=3D'width:76.65pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
1.9pt'>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>4<o:p></o:p></span></span></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>(2)<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D90 valign=3Dtop style=3D'width:67.6pt;border-top:none;border-=
left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
1.9pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-family:"Times New Roman",serif'>young adults/ adolescents*<=
o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D162 valign=3Dtop style=3D'width:121.85pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
1.9pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-family:"Times New Roman",serif'>181.85<o:p></o:p></span></s=
pan></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-family:"Times New Roman",serif'>(138.8, 197.3)<o:p></o:p></=
span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D167 valign=3Dtop style=3D'width:125.15pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
1.9pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-family:"Times New Roman",serif'>12.50<o:p></o:p></span></sp=
an></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-family:"Times New Roman",serif'>(10.5, 13.0) <o:p></o:p></s=
pan></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:2;height:11.9pt'>
  <td width=3D83 valign=3Dtop style=3D'width:62.5pt;border:solid windowtext=
 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:11.9pt'>
  <p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk535595211'><span style=3D'font-size:11.0pt'>HGB=
&#8209;204<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D102 valign=3Dtop style=3D'width:76.65pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
1.9pt'>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>10<o:p></o:p></span></span></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>(2)<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D90 valign=3Dtop style=3D'width:67.6pt;border-top:none;border-=
left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
1.9pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-family:"Times New Roman",serif'>19.5<o:p></o:p></span></spa=
n></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>(16, 34)<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D162 valign=3Dtop style=3D'width:121.85pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
1.9pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-family:"Times New Roman",serif'>151.28<o:p></o:p></span></s=
pan></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>(140.0, 234.5)<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D167 valign=3Dtop style=3D'width:125.15pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
1.9pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-family:"Times New Roman",serif'>13.75<o:p></o:p></span></sp=
an></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>(10.0, 16.5)<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:3;height:11.9pt'>
  <td width=3D83 valign=3Dtop style=3D'width:62.5pt;border:solid windowtext=
 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:11.9pt'>
  <p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk535595211'><span style=3D'font-size:11.0pt'>HGB=
&#8209;207<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D102 valign=3Dtop style=3D'width:76.65pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
1.9pt'>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>15<o:p></o:p></span></span></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>(6)<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D90 valign=3Dtop style=3D'width:67.6pt;border-top:none;border-=
left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
1.9pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-family:"Times New Roman",serif'>20.0<o:p></o:p></span></spa=
n></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>(12, 34)<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D162 valign=3Dtop style=3D'width:121.85pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
1.9pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-family:"Times New Roman",serif'>192.92<o:p></o:p></span></s=
pan></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>(152.3, 251.3)<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D167 valign=3Dtop style=3D'width:125.15pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
1.9pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-family:"Times New Roman",serif'>17.50<o:p></o:p></span></sp=
an></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>(11.5, 37.0)<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:4;mso-yfti-lastrow:yes;height:12.3pt'>
  <td width=3D83 valign=3Dtop style=3D'width:62.5pt;border:solid windowtext=
 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:12.3pt'>
  <p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk535595211'><span style=3D'font-size:11.0pt'>HGB=
&#8209;212<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D102 valign=3Dtop style=3D'width:76.65pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
2.3pt'>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>3<o:p></o:p></span></span></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>(1)<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D90 valign=3Dtop style=3D'width:67.6pt;border-top:none;border-=
left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
2.3pt'>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span lang=
=3DPT
  style=3D'mso-ansi-language:PT;mso-bidi-font-weight:bold'>adults/ adolesce=
nts*</span></span><span
  style=3D'mso-bookmark:_Hlk535595211'><span style=3D'font-size:11.0pt'><o:=
p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D162 valign=3Dtop style=3D'width:121.85pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
2.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-family:"Times New Roman",serif'>175.51<o:p></o:p></span></s=
pan></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>(170.7, 209.6)<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
  <td width=3D167 valign=3Dtop style=3D'width:125.15pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
2.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-family:"Times New Roman",serif'>21.50<o:p></o:p></span></sp=
an></p>
  <p class=3DC-BodyText align=3Dcenter style=3D'margin:0in;text-align:cente=
r;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk535595211'><span
  style=3D'font-size:11.0pt'>(17.5, 39.5)<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk535595211'></span>
 </tr>
</table>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk535595211'><span style=3D'font-size:11.0pt'>*Age =
range is
not provided to protect patient identity.<o:p></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk535595211'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk535595211'><i style=3D'mso-bidi-font-style:normal=
'><span
style=3D'font-size:11.0pt'>Transfusion&#8209;dependent &#946;&#8209;thalass=
aemia
(TDT)</span></i></span><span style=3D'mso-bookmark:_Hlk535595211'><span
style=3D'font-size:11.0pt'><o:p></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk535595211'><a name=3D"_Hlk2977740"><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></a></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk535595211'><span style=3D'mso-bookmark:_Hlk297774=
0'><span
style=3D'font-size:11.0pt'>Patients were considered to be transfusion&#8209=
;dependent
if they had a history of transfusions of at least 100&nbsp;mL/kg/year of RB=
Cs
or with &#8805;8&nbsp;transfusions of RBCs per year in the 2&nbsp;years
preceding enrolment. In the clinical studies, patients received a median (m=
in,
max) RBC transfusion volume of 175.74&nbsp;(138.8,&nbsp;251.3)&nbsp;mL/kg/y=
ear
and a median (min, max) number of 14.75&nbsp;(10.0,&nbsp;39.5)&nbsp;RBC
transfusions per year. </span></span></span><span style=3D'mso-bookmark:_Hl=
k535595211'><span
style=3D'font-size:11.0pt'><o:p></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk535595211'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk535595211'><span style=3D'font-size:11.0pt'>Adole=
scents
were excluded from Phase&nbsp;3 studies if they had a known and available H=
LA&#8209;matched
related HSC donor. The median (min, max) age in the studies was 19.0&nbsp;(=
12,&nbsp;34)
years, 56.3% were females, 59.4% were Asian, and 40.6% White/Caucasian. All
patients had a Karnofsky/Lansky performance score &#8805;80 and the majority
(18/32, 56.3%) had a performance score of 100 at baseline. Cardiac T2* at
baseline was &gt;20 msec. The median (min, max) serum ferritin at baseline =
was
3778.7&nbsp;(784,&nbsp;22517) pmol/L and median (min, max) liver iron
concentration was 6.75&nbsp;(1.0,&nbsp;41.0)&nbsp;mg/g (N=3D10, HGB&#8209;2=
04;
N=3D4, HGB&#8209;205; N=3D15, HGB&#8209;207; N=3D3, HGB&#8209;212).<o:p></o=
:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk535595211'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk535595211'><i style=3D'mso-bidi-font-style:normal=
'><span
style=3D'font-size:11.0pt'>Mobilisation and apheresis<o:p></o:p></span></i>=
</span></p>

<span style=3D'mso-bookmark:_Hlk535595211'></span>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><a name=3D"_H=
lk433984"><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></a></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk433984'><span style=3D'font-size:11.0pt'>All pati=
ents
were administered G&#8209;CSF and plerixafor to mobilise stem cells prior to
the apheresis procedure. The planned dose of G&#8209;CSF was 10&nbsp;g/kg/=
day
in patients with a spleen, and 5&nbsp;g/kg/day in patients without a splee=
n,
given on Days&nbsp;1 through&nbsp;5 of mobilisation in the morning. The pla=
nned
dose of plerixafor was 0.24&nbsp;mg/kg/day, given on Days&nbsp;4 and&nbsp;5=
 of
mobilisation in the evening. If a third day of collection was needed,
plerixafor and G&#8209;CSF dosing was extended to Day&nbsp;6. The dose of G=
&#8209;CSF
was decreased by half if white blood cell (WBC) count was
&gt;100&nbsp;&nbsp;10<sup>9</sup>/L prior to the day of apheresis. For most
patients, the minimum number of CD34<sup>+</sup> cells to manufacture Zynte=
glo
was collected with 1&nbsp;cycle of mobilisation and apheresis. <o:p></o:p><=
/span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk433984'><span style=3D'font-size:11.0pt'><o:p>&nb=
sp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><span
style=3D'mso-bookmark:_Hlk433984'><i style=3D'mso-bidi-font-style:normal'><=
span
style=3D'font-size:11.0pt'>Pre-treatment conditioning<o:p></o:p></span></i>=
</span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><span
style=3D'mso-bookmark:_Hlk433984'><i style=3D'mso-bidi-font-style:normal'><=
span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></i></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><span
style=3D'mso-bookmark:_Hlk433984'><span style=3D'font-size:11.0pt'>All pati=
ents
received full myeloablative conditioning with busulfan prior to treatment w=
ith
Zynteglo. The planned dose of busulfan was 3.2&nbsp;mg/kg/day for patients
&#8805;18&nbsp;years as a 3&#8209;hour IV infusion daily for 4&nbsp;days wi=
th a
recommended target AUC<sub>0-24h </sub>of 3800&#8209;4500&nbsp;M*min. The
planned dose of busulfan was 0.8&nbsp;mg/kg for patients 12&#8209;17&nbsp;y=
ears
of age as a 2&#8209;hour IV infusion every 6&nbsp;hours for a total of
16&nbsp;doses with a recommended target of AUC<sub>0-6h </sub>of 950&#8209;=
1125&nbsp;M*min.
The busulfan SmPC was used for information on appropriate method for
determination of patient weight&#8209;based dosing. <a name=3D"_Hlk2978225"=
>Busulfan
dose adjustments were made as needed based on pharmacokinetic monitoring.<o=
:p></o:p></a></span></span></p>

<span style=3D'mso-bookmark:_Hlk2978225'></span>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk433984'><span style=3D'font-size:11.0pt'><o:p>&nb=
sp;</o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk433984'></span>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>The median (min, max) busulfan dose was 3.50&nbs=
p;(2.5,&nbsp;5.0)
mg/kg/day (N=3D32). AUC<sub>0-24h</sub> was measured during Day&nbsp;1 and
informed the dose for Day&nbsp;3; the median (min, max) estimated daily AUC=
 was
4394.5&nbsp;(3030,&nbsp;9087) &#956;M*min (N=3D32). All patients with non&#=
8209;&#946;<sup>0</sup>/&#946;<sup>0</sup>
genotypes received anti-seizure prophylaxis with agents other than phenytoin
prior to initiating busulfan. Phenytoin was not used for anti-seizure
prophylaxis because of its well understood induction of glutathione&#8209;S=
&#8209;transferase
and cytochrome P450 and resultant increased clearance of busulfan, and beca=
use
of the widespread availability of effective anti&#8209;seizure medications =
that
do not affect busulfan metabolism.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>In HGB&#8209;207 and HGB&#8209;212 prophylaxis f=
or
VOD/hepatic sinusoidal obstruction syndrome was required per institutional
practice with ursodeoxycholic acid or defibrotide. <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span style=3D'font-size:11.0pt'>Zynteglo administration<o:p></o:p>=
</span></i></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>All patients were administered Zynteglo with a m=
edian
(min, max) dose of 7.80&nbsp;&nbsp;10<sup>6 </sup>(5.0,&nbsp;19.4)&nbsp;CD=
34<sup>+</sup>&nbsp;cells/kg
as an intravenous infusion (N=3D32).<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><a name=3D"_H=
lk956286"></a><a
name=3D"_Hlk955665"><span style=3D'mso-bookmark:_Hlk956286'><i style=3D'mso=
-bidi-font-style:
normal'><span style=3D'font-size:11.0pt'>After Zynteglo administration<o:p>=
</o:p></span></i></span></a></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk955665'><span style=3D'mso-bookmark:_Hlk956286'><i
style=3D'mso-bidi-font-style:normal'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></i></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk955665'><span style=3D'mso-bookmark:_Hlk956286'><=
span
style=3D'font-size:11.0pt'>A total of 31.1% of patients (14/45; HGB&#8209;2=
04,
HGB&#8209;205, HGB&#8209;207, HGB&#8209;212) received G&#8209;CSF within
21&nbsp;days after Zynteglo infusion</span></span></span><span
style=3D'mso-bookmark:_Hlk956286'><span style=3D'font-size:11.0pt'>. Howeve=
r, G&#8209;CSF
use was not recommended for 21&nbsp;days after Zynteglo infusion in
Phase&nbsp;3 studies.</span></span><span style=3D'font-size:11.0pt'> <o:p><=
/o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Studies HGB&#8209;204 and HGB&#8209;205<o:p></o:=
p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>HGB&#8209;204 and HGB&#8209;205 were Phase&nbsp;=
1/2
open-label, single-arm 24&#8209;month studies that included 22&nbsp;patients
with TDT treated with Zynteglo (N=3D18, HGB&#8209;204; N=3D4, HGB&#8209;205=
), of
whom 14 had a non&#8209;&#946;<sup>0</sup>/&#946;<sup>0</sup> genotype (N=
=3D10,
HGB&#8209;204; N=3D4, HGB&#8209;205) and 8 had a &#946;<sup>0</sup>/&#946;<=
sup>0</sup>
genotype in HGB&#8209;204. All patients completed HGB&#8209;204 and HGB&#82=
09;205
and enrolled for long&#8209;term follow&#8209;up in the LTF&#8209;303 study.
The median (min, max) duration of follow-up of patients with a non&#8209;&#=
946;<sup>0</sup>/&#946;<sup>0</sup>
genotype was 44.63&nbsp;(35.8,&nbsp;61.3)<span class=3DMsoFootnoteReference=
> </span>months.
<a name=3D"_Hlk4078994">All patients remain alive at last follow-up.<span
style=3D'mso-spacerun:yes'> </span></a><o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>The primary endpoint was transfusion independenc=
e (TI)
by Month&nbsp;24, defined as a weighted average Hb&nbsp;&#8805;9&nbsp;g/dL
without any RBC transfusions for a continuous period of &#8805;12&nbsp;mont=
hs
at any time during the study after infusion of Zynteglo. Of the patients wi=
th a
non&#8209;&#946;<sup>0</sup>/&#946;<sup>0</sup> genotype, 11/14&nbsp;(78.6%=
,&nbsp;95%
CI 49.2%&#8209;95.3%) achieved TI by Month&nbsp;24 (Table 5). Among these
11&nbsp;patients, the median (min, max) weighted average Hb during TI was 1=
0.51&nbsp;(9.3,&nbsp;13.3)&nbsp;g/dL
(Table 5). <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>All patients who have achieved TI at any time ha=
ve
maintained TI at Month&nbsp;36 with a min, max duration of TI of 28.3+,&nbs=
p;57.6+&nbsp;months
(N=3D11). The median (min, max) time to last RBC transfusion was
0.46&nbsp;(0.2,&nbsp;5.8)<span class=3DMsoFootnoteReference> </span>months
following Zynteglo infusion. <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>In the 3 patients who did not achieve TI, reduct=
ions
of 100%, 86.9% and 26.8% in transfusion volume requirements and of 100%, 85=
.3%
and 20.7% in transfusion frequency were observed between Month&nbsp;6 throu=
gh
Month&nbsp;24 visit when compared to their pre-study levels of RBC
transfusions. Reductions in volume and frequency were maintained at last fo=
llow&#8209;up
in LTF&#8209;303.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt;background:yellow;mso-highlight:yellow'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>The median (min, max) total Hb at Month&nbsp;6 f=
or
patients who had not received a transfusion for the prior 60&nbsp;days was
10.60&nbsp;(7.6,&nbsp;13.4)&nbsp;g/dL (N=3D11). Total Hb remained stable at
Month&nbsp;24 with a median (min, max) of 10.60&nbsp;(8.8,&nbsp;13.7)&nbsp;=
g/dL
(N=3D12) and at Month&nbsp;36 with a median (min, max) of
10.60&nbsp;(7.8,&nbsp;13.5)&nbsp;g/dL (N=3D13).&nbsp;<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoCommentText style=3D'margin-bottom:0in;line-height:normal'><s=
pan
style=3D'font-size:11.0pt;font-family:"Times New Roman",serif'>After Zynteg=
lo
infusion, patient iron chelation was managed at physician discretion. Of the
14&nbsp;non&#8209;&#946;<sup>0/</sup>&#946;<sup>0</sup> patients treated in=
 HGB&#8209;204
and HGB&#8209;205 that completed Month&nbsp;6, 9&nbsp;patients (64.3%) repo=
rted
ongoing chelation use at last follow-up. The remaining 5&nbsp;patients (35.=
7%)
had stopped iron chelation, of whom 4&nbsp;patients (28.6%) have stopped
chelation for at least 6&nbsp;months with median (min, max) time from stopp=
ing
chelation to last follow-up of 26.40&nbsp;(11.5, 42.2) months for these
4&nbsp;patients. Additionally, of the 14&nbsp;treated patients, 3&nbsp;pati=
ents
in HGB&#8209;205 (21.4%) received phlebotomy to remove iron. For the
11&nbsp;patients that achieved TI, 4 patients (36.4%) stopped chelation for=
 at
least 6&nbsp;months and 3&nbsp;patients (27.3%) received phlebotomy.<o:p></=
o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><a name=3D"_H=
lk4398701"><span
style=3D'font-size:11.0pt'>At 48&nbsp;months after infusion of Zynteglo for
patients who achieved TI, the median reduction (min, max) in serum ferritin
levels from baseline was 70.00%&nbsp;(39.2,&nbsp;84.8) (N=3D5, HGB&#8209;20=
4;
N=3D2, HGB&#8209;205). The median reduction in liver iron content from base=
line
was 62.50%, ranging from an 83.3% reduction to a 269.2% increase (N=3D5, HG=
B&#8209;204;
N=3D2, HGB&#8209;205).</span></a><span style=3D'font-size:11.0pt'><o:p></o:=
p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Studies HGB&#8209;207 and HGB&#8209;212<o:p></o:=
p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><a name=3D"_H=
lk774161"><span
style=3D'font-size:11.0pt'>HGB&#8209;207 and HGB&#8209;212 are ongoing
Phase&nbsp;3 open&#8209;label, single-arm 24&#8209;month studies that are
planned to include approximately 39&nbsp;adults, adolescents, and children =
with
TDT (N=3D23, HGB&#8209;207; N=3D16,&nbsp;HGB&#8209;212), of whom 29 have a =
non&#8209;&#946;<sup>0</sup>/&#946;<sup>0</sup>
genotype (N=3D23, HGB&#8209;207; N=3D6, HGB&#8209;212) and 10&nbsp;have a &=
#946;<sup>0</sup>/&#946;<sup>0</sup>
genotype in HGB&#8209;212. </span></a><span style=3D'font-size:11.0pt'>These
studies are conducted with improved transduction compared to Phase&nbsp;1/2
studies, resulting in increased average number of functional copies of the
transgene (&#946;<sup>A&#8209;T87Q</sup>&#8209;globin) integrated in the
autologous CD34<sup>+</sup> cells. <a name=3D"_Hlk4244937">Eighteen adults =
and
adolescents with TDT with a non&#8209;&#946;<sup>0</sup>/&#946;<sup>0</sup>
genotype have been treated with Zynteglo in Phase 3 studies (N=3D15,&nbsp;H=
GB&#8209;207;&nbsp;N=3D3,&nbsp;HGB&#8209;212)
and their median (min, max) duration of follow-up was
15.92&nbsp;(5.6,&nbsp;26.3)&nbsp;months.</a> <a name=3D"_Hlk4079020">All pa=
tients
remain alive at last follow&#8209;up.<o:p></o:p></a></span></p>

<span style=3D'mso-bookmark:_Hlk4079020'></span>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>The primary endpoint was transfusion independenc=
e (TI)
by Month&nbsp;24, defined as a weighted average Hb &#8805;9&nbsp;g/dL witho=
ut
any RBC transfusions for a continuous period of &#8805;12&nbsp;months at any
time during the study after infusion of Zynteglo. Ten patients are evaluable
for assessment of TI. Of these, 9/10&nbsp;(90.0%, 95%&nbsp;CI&nbsp;55.5&#82=
09;99.7%)
achieved TI at last follow&#8209;up. Among these 9&nbsp;patients, the median
(min, max) weighted average Hb during TI was 12.22&nbsp;(11.4,&nbsp;12.8)&n=
bsp;g/dL
(Table 5). <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>All patients who have achieved TI have maintaine=
d TI
with a min, max duration of TI of 12.1+,&nbsp;21.3+&nbsp;months (N=3D9). The
median (min, max) time to last RBC transfusion was
1.08&nbsp;(0.5,&nbsp;2.2)&nbsp;months following Zynteglo infusion. <o:p></o=
:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><a
name=3D"_Hlk517114053"><span style=3D'font-size:11.0pt'>For the only patien=
t who
did not achieve TI, a reduction of 51.5% in transfusion volume requirements=
 and
a reduction of 43.4% in transfusion frequency were observed from Month 12 to
Month 24 when compared to their pre-study levels of RBC transfusions. <o:p>=
</o:p></span></a></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk517114053'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk517114053'><span style=3D'font-size:11.0pt'>The m=
edian
(min, max) total Hb at Month&nbsp;6 for patients who had not received a
transfusion for the prior 60 days was 11.85&nbsp;(8.4,&nbsp;13.3)&nbsp;g/dL
(N=3D18). Total Hb remained stable at Month&nbsp;24 with a median (min, max=
) of
12.85&nbsp;(12.5,&nbsp;13.2)&nbsp;g/dL (N=3D2).<o:p></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk517114053'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk517114053'></span>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><a
name=3D"_Hlk536092762"><span style=3D'font-size:11.0pt'>After Zynteglo infu=
sion,
patient iron chelation was managed at physician discretion. Of the 18&nbsp;=
non&#8209;&#946;<sup>0</sup>/&#946;<sup>0</sup>
patients treated in HGB&#8209;207 and HGB&#8209;212 that completed
Month&nbsp;6, 5&nbsp;patients (27.8%) reported ongoing chelation use at last
follow-up. The remaining 13&nbsp;patients (72.2%) had stopped iron chelatio=
n,
of whom 9&nbsp;patients (50.0%) have stopped chelation for at least
6&nbsp;months with median (min, max) time from stopping chelation to last
follow-up of 16.89&nbsp;(6.9,&nbsp;25.4)&nbsp;months for these 9&nbsp;patie=
nts.
Additionally, of the 18&nbsp;treated patients, 5&nbsp;patients in HGB&#8209=
;207
(27.8%) received phlebotomy to remove iron. For the 9&nbsp;patients that
achieved TI, 6&nbsp;patients (66.7%) stopped chelation for at least
6&nbsp;months and 2&nbsp;patients (22.2%) received phlebotomy.<o:p></o:p></=
span></a></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk536092762'><span style=3D'mso-spacerun:yes'></sp=
an></span><span
style=3D'mso-bookmark:_Hlk536092762'><span style=3D'font-size:11.0pt'><o:p>=
</o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk536092762'><span style=3D'font-size:11.0pt'>Explo=
ratory
analyses were performed to evaluate resolution of dyserythropoiesis, the
fundamental pathophysiological characteristic of TDT, in the bone marrow. B=
one
marrow biopsies taken before treatment were consistent with a diagnosis of =
TDT,
including a low myeloid/erythroid ratio (N=3D15, HGB&#8209;207; N=3D3, HGB&=
#8209;212),
reflective of erythroid hyperplasia. For 9&nbsp;patients who achieved TI and
had a Month&nbsp;12 bone marrow assessment, myeloid/erythroid ratios increa=
sed
from a median (min, max) of 0.2&nbsp;(0.1&nbsp;to 0.7) at baseline to a med=
ian
(min, max) of 0.83&nbsp;(0.6 to 1.9) at Month 12&nbsp;after Zynteglo infusi=
on,
suggesting that Zynteglo improves erythropoiesis in patients with TDT. <o:p=
></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk536092762'><a name=3D"_Ref442134"><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></a></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><span
style=3D'mso-bookmark:_Hlk536092762'><span style=3D'mso-bookmark:_Ref442134=
'><u><span
style=3D'font-size:11.0pt'>Overall results<o:p></o:p></span></u></span></sp=
an></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal;page-break-aft=
er:avoid'><span
style=3D'mso-bookmark:_Hlk536092762'><span style=3D'mso-bookmark:_Ref442134=
'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></span></span></p>

<p class=3DMsoCaption style=3D'margin-top:0in;margin-right:0in;margin-botto=
m:0in;
margin-left:1.0in;line-height:normal'><span style=3D'mso-bookmark:_Hlk53609=
2762'><span
style=3D'mso-bookmark:_Ref442134'><span style=3D'font-size:11.0pt'>Figure&n=
bsp;</span></span></span><span
style=3D'mso-bookmark:_Hlk536092762'><span style=3D'font-size:11.0pt'>1<span
style=3D'mso-tab-count:1'> </span>Median total haemoglobin over =
time
in non-&#946;<sup>0</sup>/&#946;<sup>0</sup> TDT patients treated with Zynt=
eglo
who have achieved transfusion independence (Studies HGB&#8209;204, HGB&#820=
9;205,
HGB&#8209;207, LTF&#8209;303)<o:p></o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk536092762'></span>

<p class=3DDefault style=3D'text-align:justify;text-justify:inter-ideograph=
'><span
lang=3DEN-GB style=3D'mso-ansi-language:EN-GB;mso-fareast-language:ZH-CN;
mso-no-proof:yes'><v:shape id=3D"Picture_x0020_3" o:spid=3D"_x0000_i1026" t=
ype=3D"#_x0000_t75"
 style=3D'width:6in;height:252pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src=3D"Zynteglo_clean_files/image002.png" o:title=3D""/>
</v:shape></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;text-aut=
ospace:
none'><i style=3D'mso-bidi-font-style:normal'><span style=3D'font-family:"T=
imes New Roman",serif'>Bars
represent interquartile ranges.<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;text-aut=
ospace:
none'><a name=3D"_Hlk31017224"><i style=3D'mso-bidi-font-style:normal'><span
style=3D'font-family:"Times New Roman",serif'>Total Hb represents those wit=
hout
any acute or chronic RBC transfusions within 60 days prior to the measureme=
nt
date.<o:p></o:p></span></i></a></p>

<span style=3D'mso-bookmark:_Hlk31017224'></span>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><a
name=3D"_Hlk4231781"><b><span style=3D'font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></b></a></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:1.0in;text-indent:-1.0in;line-height:normal;page-break-before:a=
lways'><span
style=3D'mso-bookmark:_Hlk4231781'><b><span style=3D'font-family:"Times New=
 Roman",serif'>Table
5<span style=3D'mso-tab-count:1'> </span>Efficacy outcomes for=
 non&#8209;&#946;<sup>0</sup>/&#946;<sup>0</sup>
TDT patients treated with Zynteglo (Studies HGB&#8209;204, HGB&#8209;205, H=
GB&#8209;207,
HGB&#8209;212, LTF&#8209;303)<o:p></o:p></span></b></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:1.0in;text-indent:-1.0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk4231781'><b><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></span></p>

<table class=3DMsoTableGrid border=3D1 cellspacing=3D0 cellpadding=3D0 widt=
h=3D591
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-yfti-tbllook:1184;mso-padding-alt:
 0in 5.4pt 0in 5.4pt'>
 <thead>
  <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;height:71.3pt'>
   <td width=3D86 valign=3Dtop style=3D'width:.9in;border:solid windowtext =
1.0pt;
   mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:
   71.3pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><b><span
   style=3D'font-family:"Times New Roman",serif'>HbA<sup>T87Q</sup> at
   6&nbsp;months<o:p></o:p></span></b></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif'>(g/dL)<o:p></o:p></span></=
span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>=
n<o:p></o:p></span></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>=
median
   (min, max)</span></span><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span><=
/p>
   </td>
   <span style=3D'mso-bookmark:_Hlk4231781'></span>
   <td width=3D86 valign=3Dtop style=3D'width:.9in;border:solid windowtext =
1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:71.3pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><b><span
   style=3D'font-family:"Times New Roman",serif'>HbA<sup>T87Q </sup>at 24 m=
onths<o:p></o:p></span></b></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif'>(g/dL)<o:p></o:p></span></=
span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>=
n<o:p></o:p></span></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>=
median<o:p></o:p></span></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk=
4231781'><span
   style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>=
(min,
   max)</span></span><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span><=
/p>
   </td>
   <span style=3D'mso-bookmark:_Hlk4231781'></span>
   <td width=3D86 valign=3Dtop style=3D'width:.9in;border:solid windowtext =
1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:71.3pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><b><span
   style=3D'font-family:"Times New Roman",serif'>Hb at 6&nbsp;months*<o:p><=
/o:p></span></b></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif'>(g/dL)<o:p></o:p></span></=
span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>=
n<o:p></o:p></span></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>=
median<o:p></o:p></span></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk=
4231781'><span
   style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>=
(min,
   max)</span></span><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span><=
/p>
   </td>
   <span style=3D'mso-bookmark:_Hlk4231781'></span>
   <td width=3D87 valign=3Dtop style=3D'width:65.5pt;border:solid windowtex=
t 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:71.3pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><b><span
   style=3D'font-family:"Times New Roman",serif'>Hb at 24&nbsp;months*<o:p>=
</o:p></span></b></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif'>(g/dL)<o:p></o:p></span></=
span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>=
n<o:p></o:p></span></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>=
median<o:p></o:p></span></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk=
4231781'><span
   style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>=
(min,
   max)</span></span><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span><=
/p>
   </td>
   <span style=3D'mso-bookmark:_Hlk4231781'></span>
   <td width=3D72 valign=3Dtop style=3D'width:.75in;border:solid windowtext=
 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:71.3pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><b><span la=
ng=3DFR
   style=3D'font-family:"Times New Roman",serif;mso-ansi-language:FR'>TI**<=
o:p></o:p></span></b></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span lang=
=3DFR
   style=3D'font-family:"Times New Roman",serif;mso-ansi-language:FR;mso-bi=
di-font-weight:
   bold'>n/N^ <o:p></o:p></span></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span lang=
=3DFR
   style=3D'font-family:"Times New Roman",serif;mso-ansi-language:FR;mso-bi=
di-font-weight:
   bold'>(%)<o:p></o:p></span></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk=
4231781'><span
   lang=3DFR style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:FR;
   mso-bidi-font-weight:bold'>[95% CI]</span></span><span style=3D'mso-book=
mark:
   _Hlk4231781'><span lang=3DFR style=3D'font-family:"Times New Roman",seri=
f;
   mso-ansi-language:FR'><o:p></o:p></span></span></p>
   </td>
   <span style=3D'mso-bookmark:_Hlk4231781'></span>
   <td width=3D86 valign=3Dtop style=3D'width:.9in;border:solid windowtext =
1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:71.3pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><b><span la=
ng=3DDA
   style=3D'font-family:"Times New Roman",serif;mso-ansi-language:DA'>WA Hb
   during TI </span></b></span><span style=3D'mso-bookmark:_Hlk4231781'><sp=
an
   lang=3DDA style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:DA'>(g/dL)<b><o:p></o:p></b></span></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>=
n<o:p></o:p></span></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>=
median<o:p></o:p></span></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk=
4231781'><span
   style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>=
(min,
   max)</span></span><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span><=
/p>
   </td>
   <span style=3D'mso-bookmark:_Hlk4231781'></span>
   <td width=3D86 valign=3Dtop style=3D'width:.9in;border:solid windowtext =
1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:71.3pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><b><span
   style=3D'font-family:"Times New Roman",serif'>Duration of TI<o:p></o:p><=
/span></b></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>=
(months)<o:p></o:p></span></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>=
n<o:p></o:p></span></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>=
median<o:p></o:p></span></span></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-alig=
n:center;
   line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
   style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>=
(min,
   max)<b><o:p></o:p></b></span></span></p>
   </td>
   <span style=3D'mso-bookmark:_Hlk4231781'></span>
  </tr>
 </thead>
 <tr style=3D'mso-yfti-irow:1;height:2.35pt'>
  <td width=3D591 colspan=3D7 valign=3Dtop style=3D'width:443.5pt;border:so=
lid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  background:#D9D9D9;mso-background-themecolor:background1;mso-background-t=
hemeshade:
  217;padding:0in 5.4pt 0in 5.4pt;height:2.35pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-b=
reak-after:
  avoid'><span style=3D'mso-bookmark:_Hlk4231781'><span style=3D'font-famil=
y:"Times New Roman",serif;
  color:black;mso-color-alt:windowtext'>HGB-205</span></span><span
  style=3D'mso-bookmark:_Hlk4231781'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:2;height:37.55pt'>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border:solid windowtext 1=
.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:37.55pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>4<o:p></o:p></span></span><=
/p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>7.543<o:p></o:p></span></sp=
an></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>(4.94, 9.59)<o:p></o:p></sp=
an></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border-top:none;border-le=
ft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.55pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>4<o:p></o:p></span></span><=
/p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>8.147<o:p></o:p></span></sp=
an></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>(6.72, 10.13)<o:p></o:p></s=
pan></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border-top:none;border-le=
ft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.55pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>4<o:p></o:p></span></span><=
/p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>10.73<o:p></o:p></span></sp=
an></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>(7.6, 13.4)<o:p></o:p></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D87 valign=3Dtop style=3D'width:65.5pt;border-top:none;border-=
left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.55pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>4<o:p></o:p></span></span><=
/p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>10.91<o:p></o:p></span></sp=
an></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>(8.8, 13.6)<o:p></o:p></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D72 valign=3Dtop style=3D'width:.75in;border-top:none;border-l=
eft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.55pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>3/4 <o:p></o:p></span></spa=
n></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>(75.0%)<br>
  [19.4, 99.4]<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border-top:none;border-le=
ft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.55pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>3<o:p></o:p></span></span><=
/p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>11.35<o:p></o:p></span></sp=
an></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>(10.5, 13.0)<o:p></o:p></sp=
an></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border-top:none;border-le=
ft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.55pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>3<o:p></o:p></span></span><=
/p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>NR <o:p></o:p></span></span=
></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>(38.2+, 57.6+)<o:p></o:p></=
span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:3;height:1.85pt'>
  <td width=3D591 colspan=3D7 valign=3Dtop style=3D'width:443.5pt;border:so=
lid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  background:#D9D9D9;mso-background-themecolor:background1;mso-background-t=
hemeshade:
  217;padding:0in 5.4pt 0in 5.4pt;height:1.85pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-b=
reak-after:
  avoid'><span style=3D'mso-bookmark:_Hlk4231781'><span style=3D'font-famil=
y:"Times New Roman",serif;
  color:black;mso-color-alt:windowtext'>HGB-204</span></span><span
  style=3D'mso-bookmark:_Hlk4231781'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:4;height:37.4pt'>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border:solid windowtext 1=
.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:37.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>10<o:p></o:p></span></span>=
</p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>4.153<o:p></o:p></span></sp=
an></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>(1.03, 8.52)<o:p></o:p></sp=
an></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border-top:none;border-le=
ft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>10<o:p></o:p></span></span>=
</p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>5.418<o:p></o:p></span></sp=
an></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>(1.10, 9.60)<o:p></o:p></sp=
an></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border-top:none;border-le=
ft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>7<o:p></o:p></span></span><=
/p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>9.20<o:p></o:p></span></spa=
n></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>(7.7, 13.3)<o:p></o:p></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D87 valign=3Dtop style=3D'width:65.5pt;border-top:none;border-=
left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>8<o:p></o:p></span></span><=
/p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>10.35<o:p></o:p></span></sp=
an></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>(9.1, 13.7)<o:p></o:p></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D72 valign=3Dtop style=3D'width:.75in;border-top:none;border-l=
eft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>8/10 (80.0%)<o:p></o:p></sp=
an></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>[44.4, 97.5]<o:p></o:p></sp=
an></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border-top:none;border-le=
ft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>8<o:p></o:p></span></span><=
/p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>10.27<o:p></o:p></span></sp=
an></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>(9.3, 13.3)<o:p></o:p></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border-top:none;border-le=
ft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>8<o:p></o:p></span></span><=
/p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>NR <o:p></o:p></span></span=
></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>(28.3+, 51.3+)<o:p></o:p></=
span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:5;height:5.3pt'>
  <td width=3D591 colspan=3D7 valign=3Dtop style=3D'width:443.5pt;border:so=
lid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  background:#D9D9D9;mso-background-themecolor:background1;mso-background-t=
hemeshade:
  217;padding:0in 5.4pt 0in 5.4pt;height:5.3pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-b=
reak-after:
  avoid'><span style=3D'mso-bookmark:_Hlk4231781'><span style=3D'font-famil=
y:"Times New Roman",serif;
  color:black;mso-color-alt:windowtext'>HGB-207</span></span><span
  style=3D'mso-bookmark:_Hlk4231781'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:6;height:37.4pt'>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border:solid windowtext 1=
.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:37.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>13<o:p></o:p></span></span>=
</p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>9.324<o:p></o:p></span></sp=
an></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>(3.35, 10.60)<o:p></o:p></s=
pan></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border-top:none;border-le=
ft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>3<o:p></o:p></span></span><=
/p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>8.766<o:p></o:p></span></sp=
an></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>(0.89, 11.40)<o:p></o:p></s=
pan></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border-top:none;border-le=
ft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>15<o:p></o:p></span></span>=
</p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>11.80<o:p></o:p></span></sp=
an></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>(8.4, 13.3)<o:p></o:p></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D87 valign=3Dtop style=3D'width:65.5pt;border-top:none;border-=
left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>2<o:p></o:p></span></span><=
/p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>12.85<o:p></o:p></span></sp=
an></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>(12.5, 13.2)<o:p></o:p></sp=
an></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D72 valign=3Dtop style=3D'width:.75in;border-top:none;border-l=
eft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>9/10<o:p></o:p></span></spa=
n></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>(90.0%)<br>
  [55.5, 99.7]<o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border-top:none;border-le=
ft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>9<o:p></o:p></span></span><=
/p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>12.22<o:p></o:p></span></sp=
an></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>(11.4, 12.8)<o:p></o:p></sp=
an></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border-top:none;border-le=
ft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>9<o:p></o:p></span></span><=
/p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>NR<o:p></o:p></span></span>=
</p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>(12.1+, 21.3+)<o:p></o:p></=
span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:7;height:.2in'>
  <td width=3D591 colspan=3D7 style=3D'width:443.5pt;border:solid windowtex=
t 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  background:#D9D9D9;mso-background-themecolor:background1;mso-background-t=
hemeshade:
  217;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-b=
reak-after:
  avoid'><span style=3D'mso-bookmark:_Hlk4231781'><span style=3D'font-famil=
y:"Times New Roman",serif;
  color:black;mso-color-alt:windowtext'>HGB-212</span></span><span
  style=3D'mso-bookmark:_Hlk4231781'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:8;mso-yfti-lastrow:yes;height:37.4pt'>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border:solid windowtext 1=
.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:37.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>3<o:p></o:p></span></span><=
/p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>10.094<o:p></o:p></span></s=
pan></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>(5.06, 10.33)<o:p></o:p></s=
pan></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border-top:none;border-le=
ft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>NA***<o:p></o:p></span></sp=
an></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border-top:none;border-le=
ft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>3<o:p></o:p></span></span><=
/p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>12.10<o:p></o:p></span></sp=
an></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>(8.5, 12.2)<o:p></o:p></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D87 valign=3Dtop style=3D'width:65.5pt;border-top:none;border-=
left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;text-autospace:none'><span style=3D'mso-bookmark:_Hlk4=
231781'><span
  style=3D'font-family:"Times New Roman",serif'>NA***<o:p></o:p></span></sp=
an></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D72 valign=3Dtop style=3D'width:.75in;border-top:none;border-l=
eft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>NA***<o:p></o:p></span></sp=
an></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border-top:none;border-le=
ft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>NA***<o:p></o:p></span></sp=
an></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
  <td width=3D86 valign=3Dtop style=3D'width:.9in;border-top:none;border-le=
ft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:3=
7.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal'><span style=3D'mso-bookmark:_Hlk4231781'><span
  style=3D'font-family:"Times New Roman",serif'>NA***<o:p></o:p></span></sp=
an></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk4231781'></span>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;text-aut=
ospace:
none'><span style=3D'mso-bookmark:_Hlk4231781'><span style=3D'font-family:"=
Times New Roman",serif;
color:white;mso-color-alt:windowtext;mso-bidi-font-weight:bold'>*Patients w=
ho
have not received transfusions in the prior 60 days. </span></span><span
style=3D'mso-bookmark:_Hlk4231781'><span style=3D'font-family:"Times New Ro=
man",serif;
mso-bidi-font-weight:bold'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;text-aut=
ospace:
none'><span style=3D'mso-bookmark:_Hlk4231781'><span style=3D'font-family:"=
Times New Roman",serif;
mso-bidi-font-weight:bold'>**Transfusion independence (TI): a weighted aver=
age
Hb &#8805;9&nbsp;g/dL without any RBC transfusions for a continuous period =
of
&#8805;12 months at any time during the study after medicinal product infus=
ion.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;text-aut=
ospace:
none'><span style=3D'mso-bookmark:_Hlk4231781'><span style=3D'font-family:"=
Times New Roman",serif;
mso-bidi-font-weight:bold'>***No patients are currently evaluable for these
endpoints.<span style=3D'mso-spacerun:yes'> </span><o:p></o:p></span></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;text-aut=
ospace:
none'><span style=3D'mso-bookmark:_Hlk4231781'><span style=3D'font-family:"=
Times New Roman",serif;
mso-bidi-font-weight:bold'>N^ represents the total number of patients evalu=
able
for TI, defined as patients who have completed their parent study (i.e., 24
months of follow&#8209;up), or achieved TI, or will not achieve TI in their
parent study. <o:p></o:p></span></span></p>

<p class=3DDefault><span style=3D'mso-bookmark:_Hlk4231781'><span style=3D'=
font-size:
11.0pt'>NR =3D Not reached. NA =3D Not applicable. Hb =3D Total Hb. WA Hb =
=3D Weighted
average Hb.<o:p></o:p></span></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk4231781'><span style=3D'font-size:11.0pt'><o:p>&n=
bsp;</o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk4231781'></span>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Paediatric population<o:p></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>The European Medicines Agency has deferred the
obligation to submit the results of studies with Zynteglo in one or more su=
bsets
of the paediatric population in &#946;&#8209;thalassaemia (see section 4.2 =
for
information on paediatric use).<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>This medicinal product has been authorised under=
 a
so-called conditional approval scheme. This means that further evidence on
this medicinal product is awaited. The European Medicines Agency will review
new information on this medicinal product at least every year and this SmPC
will be updated as necessary.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'>5.2<span
style=3D'mso-tab-count:1'> </span>Pharmacokinetic properties<o:p></o:p>=
</span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Zynteglo is an autologous gene therapy medicinal
product consisting of autologous cells that have been genetically modified =
<i
style=3D'mso-bidi-font-style:normal'>ex vivo</i>. The nature of Zynteglo is=
 such
that conventional studies on pharmacokinetics, absorption, distribution,
metabolism, and elimination are not applicable.<a name=3D"_Hlk500249629"><o=
:p></o:p></a></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'mso-bookmark:_Hlk500249629'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk500249629'></span>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;page-break-after:avoid;tab-stops:28.35pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>5.3<span style=3D'mso-tab-count:1'> </span>Pre=
clinical
safety data</span></b><span style=3D'font-family:"Times New Roman",serif'><=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Conventional mutagenicity, carcinogenicity and
reproductive and developmental toxicity studies have not been conducted.<o:=
p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>The pharmacology, toxicology and genotoxicity of=
 the
BB305 LVV used for transduction in the manufacture of Zynteglo were evaluat=
ed <i
style=3D'mso-bidi-font-style:normal'>in vitro</i> and <i style=3D'mso-bidi-=
font-style:
normal'>in vivo</i>. An <i style=3D'mso-bidi-font-style:normal'>in vitro</i>
immortalisation (IVIM) assay conducted with BB305 LVV&#8209;transduced mouse
bone marrow cells (BMCs) showed minimal mutagenic potential (Fitness Score
&#8776; 0.1&nbsp;&nbsp;10<sup>-4</sup>). Insertion site analysis (ISA) of
pre-transplantation transduced mouse BMCs and human CD34<sup>+</sup> HSCs
showed no enrichment for insertion in or near cancer-related genes. A
pharmacology, biodistribution, toxicity and genotoxicity study was conducte=
d in
a mouse model of &#946;&#8209;thalassaemia. In this study, there was no
evidence of toxicity, genotoxicity or oncogenesis (tumorigenicity) related =
to
BB305 LVV integration, and no toxicity related to production of &#946;<sup>=
A&#8209;T87Q</sup>&#8209;globin.
ISA of post-transplantation BMCs demonstrated no preferred integration in t=
he
proximity of or within genes associated clinically (for gamma retroviral
vectors) with either clonal dominance or leukaemia, and no evidence of clon=
al
dominance was observed. Additional studies with human CD34<sup>+</sup> HSCs
administered to immunodeficient, myeloablated mice demonstrated no toxicity,
tumorigenicity or genotoxicity.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>6.<span style=3D'mso-tab-count:1'> </span>PH=
ARMACEUTICAL
PARTICULARS<o:p></o:p></span></b></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'>6.1<span
style=3D'mso-tab-count:1'> </span>List of excipients<o:p></o:p></span><=
/b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Cryostor CS5<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Sodium chloride<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'>6.2<span
style=3D'mso-tab-count:1'> </span>Incompatibilities<o:p></o:p></span></=
b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>In the absence of compatibility studies, this
medicinal product must not be mixed with other medicinal products.<o:p></o:=
p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'>6.3<span
style=3D'mso-tab-count:1'> </span>Shelf life<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Frozen: 1 year at &#8804;-140C.<o:p></o:p></spa=
n></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Once thawed: maximum 4&nbsp;hours at room temper=
ature
(20C&#8209;25C).<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'>6.4<span
style=3D'mso-tab-count:1'> </span>Special precautions for storage<o:p><=
/o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Store in the vapour phase of liquid nitrogen at
&#8804;-140C until ready for thaw and administration. <o:p></o:p></span></=
p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Keep the infusion bag(s) in the metal cassette(s=
). <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Do not re-freeze after thawing.<o:p></o:p></span=
></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'>6.5<span
style=3D'mso-tab-count:1'> </span>Nature and contents of container <o:p=
></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>20&nbsp;mL fluorinated ethylene propylene infusi=
on
bag(s), each packed in a transparent pouch inside a metal cassette. <o:p></=
o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Zynteglo is shipped from the manufacturing facil=
ity to
the infusion centre storage facility in a cryoshipper, which may contain
multiple metal cassettes intended for a single patient. Each metal cassette
contains one infusion bag with Zynteglo. A patient may have multiple infusi=
on
bags. <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'>6.6<span
style=3D'mso-tab-count:1'> </span><a name=3D"_Hlk31012748">Special prec=
autions
for disposal and other handling</a><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-pagi=
nation:
none;tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Irradiation could lead to inactivation of the pr=
oduct.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span style=3D'font-size:11.0pt'>Precautions to be taken before han=
dling
or administering the medicinal product</span></i><span style=3D'font-size:1=
1.0pt'><o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin-top:0in;margin-right:0in;margin-botto=
m:0in;
margin-left:.5in;text-indent:-.25in;line-height:normal;mso-list:l32 level1 =
lfo24'><![if !supportLists]><span
style=3D'font-size:11.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>This medici=
nal
product contains genetically modified human blood cells. Healthcare
professionals handling Zynteglo should take appropriate precautions (wearing
gloves, protective clothing and eye protection) to avoid potential transmis=
sion
of infectious diseases.<span style=3D'mso-spacerun:yes'> </span><o:p></o:p=
></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span style=3D'font-size:11.0pt'>Preparation for the infusion<o:p><=
/o:p></span></i></p>

<p class=3DC-Bullet style=3D'margin-top:0in;margin-right:0in;margin-bottom:=
0in;
margin-left:.5in;line-height:normal;mso-list:l38 level1 lfo2;tab-stops:.5in=
'><![if !supportLists]><span
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
 </span></span></span><![endif]><span
style=3D'font-size:11.0pt'>Remove each metal cassette from liquid nitrogen
storage and remove each infusion bag from the metal cassette.<o:p></o:p></s=
pan></p>

<p class=3DC-Bullet style=3D'margin-top:0in;margin-right:0in;margin-bottom:=
0in;
margin-left:.5in;line-height:normal;mso-list:l38 level1 lfo2;tab-stops:.5in=
'><![if !supportLists]><span
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
 </span></span></span><![endif]><span
style=3D'font-size:11.0pt'>Confirm that Zynteglo is printed on the infusion
bag(s).<o:p></o:p></span></p>

<p class=3DC-Bullet style=3D'margin-top:0in;margin-right:0in;margin-bottom:=
0in;
margin-left:.5in;line-height:normal;mso-list:l38 level1 lfo2;tab-stops:.5in=
'><![if !supportLists]><span
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
 </span></span></span><![endif]><span
style=3D'font-size:11.0pt'>Confirm that patient identity matches the unique
patient identification information located on the Zynteglo infusion bag(s).=
 Do
not infuse Zynteglo if the information on the patient specific&#8209;label =
on
the infusion bag does not match the intended patient.<o:p></o:p></span></p>

<p class=3DC-Bullet style=3D'margin-top:0in;margin-right:0in;margin-bottom:=
0in;
margin-left:.5in;line-height:normal;mso-list:l38 level1 lfo2;tab-stops:.5in=
'><![if !supportLists]><span
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
 </span></span></span><![endif]><span
style=3D'font-size:11.0pt'>Account for all infusion bags and confirm each
infusion bag is within the expiry date using the accompanying Lot Informati=
on
Sheet. <o:p></o:p></span></p>

<p class=3DC-Bullet style=3D'margin-top:0in;margin-right:0in;margin-bottom:=
0in;
margin-left:.5in;line-height:normal;mso-list:l38 level1 lfo2;tab-stops:.5in=
'><![if !supportLists]><span
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
 </span></span></span><![endif]><span
style=3D'font-size:11.0pt'>Each infusion bag should be inspected for any br=
eaches
of integrity before thawing and infusion. If an infusion bag is compromised,
follow the local guidelines and contact bluebird bio immediately.<o:p></o:p=
></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span style=3D'font-size:11.0pt'>Thaw and administration<o:p></o:p>=
</span></i></p>

<p class=3DC-Bullet style=3D'margin-top:0in;margin-right:0in;margin-bottom:=
0in;
margin-left:.5in;text-indent:-13.5pt;line-height:normal;mso-list:l38 level1=
 lfo2;
tab-stops:.5in'><![if !supportLists]><span style=3D'mso-bidi-font-size:11.0=
pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>Thaw Zynteg=
lo at
37C in a water bath or dry bath. Thawing of each infusion bag takes
approximately 2 to 4&nbsp;minutes. Do not overthaw the medicinal product. Do
not leave the medicinal product unattended and do not submerge the infusion
ports if thawed in a water bath.<o:p></o:p></span></p>

<p class=3DC-Bullet style=3D'margin-top:0in;margin-right:0in;margin-bottom:=
0in;
margin-left:.5in;text-indent:-13.5pt;line-height:normal;mso-list:l38 level1=
 lfo2;
tab-stops:.5in'><![if !supportLists]><span style=3D'mso-bidi-font-size:11.0=
pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>After thaw,=
 mix
the medicinal product gently by massaging the infusion bag until all of the=
 contents
are uniform. Expose the sterile port on the infusion bag by tearing off a
protective wrap covering the port. <o:p></o:p></span></p>

<p class=3DC-Bullet style=3D'margin-top:0in;margin-right:0in;margin-bottom:=
0in;
margin-left:.5in;text-indent:-13.5pt;line-height:normal;mso-list:l38 level1=
 lfo2;
tab-stops:.5in'><![if !supportLists]><span style=3D'mso-bidi-font-size:11.0=
pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>Access the
medicinal product infusion bag and infuse per the administration sites
standard procedures for administration of cell therapy products. Do not use=
 an
in-line blood filter or an infusion pump.<o:p></o:p></span></p>

<p class=3DC-Bullet style=3D'margin-top:0in;margin-right:0in;margin-bottom:=
0in;
margin-left:.5in;text-indent:-13.5pt;line-height:normal;mso-list:l38 level1=
 lfo2;
tab-stops:.5in'><![if !supportLists]><span style=3D'mso-bidi-font-size:11.0=
pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>Do not samp=
le,
alter, or irradiate the medicinal product.<o:p></o:p></span></p>

<p class=3DC-Bullet style=3D'margin-top:0in;margin-right:0in;margin-bottom:=
0in;
margin-left:.5in;text-indent:-13.5pt;line-height:normal;mso-list:l38 level1=
 lfo2;
tab-stops:.5in'><![if !supportLists]><span style=3D'mso-bidi-font-size:11.0=
pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>Administer =
each
infusion bag of Zynteglo via intravenous infusion over a period of less than
30&nbsp;minutes. If more than one infusion bag is provided, administer each
infusion bag completely before proceeding to thaw and infuse the next bag.<=
o:p></o:p></span></p>

<p class=3DC-Bullet style=3D'margin-top:0in;margin-right:0in;margin-bottom:=
0in;
margin-left:.5in;text-indent:-13.5pt;line-height:normal;mso-list:l38 level1=
 lfo2;
tab-stops:.5in'><![if !supportLists]><span style=3D'mso-bidi-font-size:11.0=
pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>Infuse Zynt=
eglo
as soon as possible and no more than 4&nbsp;hours after thawing. Flush all
Zynteglo remaining in the infusion bag and any associated tubing with at le=
ast
50&nbsp;mL of 0.9% sodium chloride solution to ensure as many cells as poss=
ible
are infused into the patient.<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'>Precautions to be taken for the disposal of the
medicinal product<o:p></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><u><span
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>The medicinal product contains genetically&#8209=
;modified
cells. Local guidelines on handling human-derived material should be follow=
ed
for unused medicinal products or waste material. All material that has been=
 in
contact with Zynteglo (solid and liquid waste) should be handled and dispos=
ed
of as potentially infectious waste in accordance with local guidelines on
handling human-derived material. <o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>7.<span style=3D'mso-tab-count:1'> </span>MA=
RKETING
AUTHORISATION HOLDER<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o:p=
>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>bluebird bio (Netherlands) B.V.<o:p></o:p></span=
></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span lang=3D=
EN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Stadsplateau 7<o:p></o:p=
></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span lang=3D=
EN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>WTC Utrecht<o:p></o:p></=
span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span lang=3D=
EN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>3521AZ Utrecht<o:p></o:p=
></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span lang=3D=
EN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>The Netherlands<o:p></o:=
p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span lang=3D=
EN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span lang=3D=
EN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>8.<span style=3D'mso-tab-count:1'> </span>MA=
RKETING
AUTHORISATION NUMBER(S) <o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o:p=
>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'>EU/1=
/19/1367/001<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o:p=
>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o:p=
>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>9.<span style=3D'mso-tab-count:1'> </span>DA=
TE OF
FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o:p=
>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'>Date=
 of
first authorisation: 29 May 2019<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o:p=
>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o:p=
>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-hyphenate:n=
one;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>10.<span style=3D'mso-tab-count:1'> </span>DAT=
E OF
REVISION OF THE TEXT</span></b><span lang=3DEN-GB style=3D'font-family:"Tim=
es New Roman",serif;
mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'>{DD month YYYY}<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'>Detailed information on this
medicinal product is available on the website of the European Medicines Age=
ncy </span><a
href=3D"http://www.ema.europa.eu"><span lang=3DEN-GB style=3D'font-family:"=
Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'>http://w=
ww.ema.europa.eu</span></a><u><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";color:blue;mso-ansi-language:EN-GB'> </span></u><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'>&lt;, and on the website of {nam=
e of
MS Agency (link)}&gt;. <br clear=3Dall style=3D'mso-special-character:line-=
break;
page-break-before:always'>
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:27.0pt;text-indent:-27.0pt;line-height:normal;mso-list:skip;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:27.0pt;text-indent:-27.0pt;line-height:normal;mso-list:skip;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:27.0pt;text-indent:-27.0pt;line-height:normal;mso-list:skip;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:27.0pt;text-indent:-27.0pt;line-height:normal;mso-list:skip;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:-.=
1pt;
margin-bottom:0in;margin-left:27.0pt;text-align:center;text-indent:-27.0pt;
line-height:normal;mso-list:skip;tab-stops:28.35pt'><b style=3D'mso-bidi-fo=
nt-weight:
normal'><span lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:-.=
1pt;
margin-bottom:0in;margin-left:27.0pt;text-align:center;text-indent:-27.0pt;
line-height:normal;mso-list:skip;tab-stops:28.35pt'><b style=3D'mso-bidi-fo=
nt-weight:
normal'><span lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso=
-fareast-font-family:
"Times New Roman";mso-ansi-language:EN-GB'>ANNEX II<o:p></o:p></span></b></=
p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nb=
sp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:85.05pt;text-indent:-35.4pt;line-height:normal;mso-list:ski=
p;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>A.<span style=3D'mso-tab-count:1'> </span>MANUFACT=
URER(S)
OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE FOR B=
ATCH
RELEASE<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:85.05pt;text-indent:-35.4pt;line-height:normal;mso-list:ski=
p;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:85.05pt;text-indent:-35.4pt;line-height:normal;mso-list:ski=
p;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>B.<span style=3D'mso-tab-count:1'> </span>CONDITIO=
NS OR
RESTRICTIONS REGARDING SUPPLY AND USE<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:85.05pt;text-indent:-35.4pt;line-height:normal;mso-list:ski=
p;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:85.05pt;text-indent:-35.4pt;line-height:normal;mso-list:ski=
p;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>C.<span style=3D'mso-tab-count:1'> </span>OTHER
CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION<o:p></o:p></span=
></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:85.05pt;text-indent:-35.4pt;line-height:normal;mso-list:ski=
p;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:85.05pt;text-indent:-35.4pt;line-height:normal;mso-list:ski=
p;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>D.<span style=3D'mso-tab-count:1'> </span>CONDITIO=
NS OR
RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRO=
DUCT<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:85.05pt;text-indent:-35.4pt;line-height:normal;mso-list:ski=
p;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:85.05pt;text-indent:-35.4pt;line-height:normal;mso-list:ski=
p;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>E.<span style=3D'mso-tab-count:1'> </span>SPECIFIC
OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES FOR THE CONDITIONAL
MARKETING AUTHORISATION<o:p></o:p></span></b></p>

<span style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;mso-far=
east-font-family:
Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fare=
ast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'mso-special-charact=
er:line-break;
page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:27.0pt;text-indent:-27.0pt;line-height:normal;mso-list:skip;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>A.<span style=3D'mso-tab-count:1'> </span>MAN=
UFACTURER(S)
OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE FOR B=
ATCH
RELEASE<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><u><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'>Name and address of the
manufacturer(s) of the biological active substance(s)<o:p></o:p></span></u>=
</p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'>Minaris Regenerative Medicine Gm=
bH<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'>Haidgraben 5<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'>85521 Ottobrunn<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'>GERMANY</span><span
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman"'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><u><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'>Name and address of the manufact=
urer(s)
responsible for batch release</span></u><span lang=3DEN-GB style=3D'font-fa=
mily:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-ansi-=
language:
EN-GB'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'>Minaris Regenerative Medicine Gm=
bH<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'>Haidgraben 5<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'>85521 Ottobrunn<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'>GERMANY<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><a
name=3D"OLE_LINK2"><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>B.</span></b></a><b style=3D'mso-bidi-font-weight:=
normal'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'>=
 </span>CONDITIONS
OR RESTRICTIONS REGARDING SUPPLY AND USE <o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'>Medicinal product subject to spe=
cial
and restricted medical prescription (see Annex I: Summary of Product
Characteristics, section 4.2).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.25in;text-indent:-.25in;line-height:normal;mso-list:skip;
tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'font-family:"Times New Ro=
man",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'>C. <span
style=3D'mso-tab-count:1'> </span>OTHER CONDITIONS AND REQUIREMENTS OF THE
MARKETING AUTHORISATION<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><u><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
<span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.05pt;margin-bot=
tom:
0in;margin-left:.5in;text-indent:-.5in;line-height:normal;mso-list:l42 leve=
l1 lfo26;
tab-stops:28.35pt list .5in'><![if !supportLists]><span style=3D'font-famil=
y:
Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
style=3D'font-family:"Times New Roman",serif'>Periodic Safety Update Reports
(PSURs)<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>The
requirements for submission of PSURs for this medicinal product are set out=
 in
the list of Union reference dates (EURD list) </span><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>provided for under Article 107c(7) of Directive
2001/83/EC and <span style=3D'mso-bidi-font-style:italic'>any subsequent up=
dates
published on the European medicines web-portal.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'>The marketing authorisation hold=
er
(MAH) shall submit the first PSUR for this product within 6&nbsp;months
following authorisation. <span style=3D'mso-bidi-font-style:italic'><o:p></=
o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><u><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
<span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><u><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p><span style=3D'text-decorat=
ion:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.25in;text-indent:-.25in;line-height:normal;mso-list:skip;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB'>D.<span style=3D'mso-tab-count:1'> </span>CONDIT=
IONS
OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL
PRODUCT<span style=3D'mso-spacerun:yes'> </span><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><u><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
<span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.05pt;margin-bot=
tom:
0in;margin-left:.5in;text-indent:-.5in;line-height:normal;mso-list:l42 leve=
l1 lfo26;
tab-stops:28.35pt list .5in'><![if !supportLists]><span style=3D'font-famil=
y:
Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
style=3D'font-family:"Times New Roman",serif'>Risk management plan (RMP)<o:=
p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nb=
sp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-family:"Times New Roman=
",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'>The marketing authorisation holder (MAH) shall perform the required
pharmacovigilance activities and interventions detailed in the agreed RMP
presented in Module 1.8.2 of the marketing authorisation and any agreed
subsequent updates of the RMP.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-family:"Times New Roman=
",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-family:"Times New Roman=
",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'>An updated RMP should be submitted:<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpFirst style=3D'text-indent:-.25in;mso-list:l=
22 level1 lfo27'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol;mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-family:"Tim=
es New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'>At the request of the European Medicines Agency;<o:p></o:p></span><=
/p>

<p class=3DMsoListParagraphCxSpLast style=3D'text-indent:-.25in;mso-list:l2=
2 level1 lfo27'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol;mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-family:"Tim=
es New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'>Whenever the risk management system is modified, especially as the
result of new information being received that may lead to a significant cha=
nge
to the benefit/risk profile or as the result of an important (pharmacovigil=
ance
or risk minimisation) milestone being reached.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.05pt;margin-bot=
tom:
0in;margin-left:.5in;text-indent:-.5in;line-height:normal;mso-list:l42 leve=
l1 lfo26;
tab-stops:28.35pt list .5in'><![if !supportLists]><span lang=3DEN-GB
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol;mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
style=3D'font-family:"Times New Roman",serif'>Additional risk minimisation
measures </span></b><span lang=3DEN-GB style=3D'font-family:"Times New Roma=
n",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-bre=
ak-after:
avoid;mso-list:skip;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-fam=
ily:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-ansi-=
language:
EN-GB;mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-family:"Times New Roman=
",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'>Prior to launch of Zynteglo in each Member State the Marketing
Authorisation Holder (MAH) must agree about the content and format of the
educational and controlled distribution programme, including communication
media, distribution modalities, and any other aspects of the programme, with
the National Competent Authority. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><i><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>The
educational and controlled distribution programme is aimed at providing
information on the safe use of Zynteglo.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>The M=
AH
shall ensure that in each Member State where Zynteglo is marketed, all
healthcare professionals and patients/carers who are expected to prescribe,
dispense and/or use Zynteglo have access to/are provided with the following
educational package to be disseminated through professional bodies:<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.5in;text-indent:-.25in;line-height:normal;mso-list:l22 level1 =
lfo27;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-=
language:
EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Physi=
cian
educational material<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.5in;text-indent:-.25in;line-height:normal;mso-list:l22 level1 =
lfo27;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-=
language:
EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Patie=
nt
information pack<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>The physician education=
al
material </span></b><span lang=3DEN-GB style=3D'font-family:"Times New Roma=
n",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'>should contain:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>The
Summary of Product Characteristics <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Guide=
 for
healthcare professionals <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Guide=
 for
handling and method of administration.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.5in;text-indent:-.25in;line-height:normal;mso-list:l22 level1 =
lfo27;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-=
language:
EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'>The Guide for healthcare professionals</span></b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB;mso-bidi-font-style:italic'> shall contain the
following key elements:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt list 1.0in'><![if !supportLists]><span lang=3DEN-GB
style=3D'font-family:"Courier New";mso-fareast-font-family:"Courier New";
mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list=
:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Warni=
ngs
and precautions of the mobilisation agents and the myeloablative conditioni=
ng
agent must be considered.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt list 1.0in'><![if !supportLists]><span lang=3DEN-GB
style=3D'font-family:"Courier New";mso-fareast-font-family:"Courier New";
mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list=
:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Treat=
ment
with Zynteglo in the clinical trials was associated with delayed platelet
engraftment. No correlation was observed between incidence of bleeding adve=
rse
events (AEs) and time to platelet engraftment. Precautions regarding bleedi=
ng
consequences of thrombocytopenia need to be taken. Patients should be made
aware of the risk of bleeding events that are not easily identifiable, such=
 as
internal bleeding. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt list 1.0in'><![if !supportLists]><span lang=3DEN-GB
style=3D'font-family:"Courier New";mso-fareast-font-family:"Courier New";
mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list=
:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Treat=
ment
with Zynteglo is in theory associated with the risk of insertional mutagene=
sis,
potentially leading to development of malignancy. All patients must be advi=
sed
on signs of leukaemia and to seek immediate medical attention if these signs
are present.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt list 1.0in'><![if !supportLists]><span lang=3DEN-GB
style=3D'font-family:"Courier New";mso-fareast-font-family:"Courier New";
mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list=
:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>A
negative serology test for HIV is necessary to ensure acceptance of apheres=
is
material for Zynteglo manufacturing.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt list 1.0in'><![if !supportLists]><span lang=3DEN-GB
style=3D'font-family:"Courier New";mso-fareast-font-family:"Courier New";
mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list=
:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>The
potential risk of loss of response to gene therapy may lead to loss of
transfusion independence or increase transfusion needs for patients who did=
 not
reach transfusionindependence.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt list 1.0in'><![if !supportLists]><span lang=3DEN-GB
style=3D'font-family:"Courier New";mso-fareast-font-family:"Courier New";
mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list=
:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>All
patients should receive annual monitoring of complete blood counts and total
haemoglobin levels to monitor for leukaemia/lymphoma and maintenance of
efficacy, respectively.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt list 1.0in'><![if !supportLists]><span lang=3DEN-GB
style=3D'font-family:"Courier New";mso-fareast-font-family:"Courier New";
mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list=
:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>The
short-term potential risk of treatment with Zynteglo represents failure of
engraftment, which shall be managed by administration of rescue cells. <o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt list 1.0in'><![if !supportLists]><span lang=3DEN-GB
style=3D'font-family:"Courier New";mso-fareast-font-family:"Courier New";
mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list=
:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>The n=
eed
to explain and to ensure that patients understand:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:1.25in;text-indent:-.25in;line-height:normal;mso-list:l30 level=
2 lfo31;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-ansi-=
language:
EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
 </span></span></span><![endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>poten=
tial
risks of treatment with Zynteglo <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:1.25in;text-indent:-.25in;line-height:normal;mso-list:l30 level=
2 lfo31;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-ansi-=
language:
EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
 </span></span></span><![endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>signs=
 of
leukaemia/lymphoma and what action to take<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:1.25in;text-indent:-.25in;line-height:normal;mso-list:l30 level=
2 lfo31;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-ansi-=
language:
EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
 </span></span></span><![endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>conte=
nt
of patients guide<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:1.25in;text-indent:-.25in;line-height:normal;mso-list:l30 level=
2 lfo31;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-ansi-=
language:
EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
 </span></span></span><![endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>the n=
eed
to carry the patient alert card and show it to every healthcare professiona=
l<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:1.25in;text-indent:-.25in;line-height:normal;mso-list:l30 level=
2 lfo31;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-ansi-=
language:
EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
 </span></span></span><![endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>enrol=
ment
in the drug product Registry.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt list 1.0in'><![if !supportLists]><span lang=3DEN-GB
style=3D'font-family:"Courier New";mso-fareast-font-family:"Courier New";
mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list=
:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Scope=
 of
the Registry and how to enrol patients.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.5in;text-indent:-.25in;line-height:normal;mso-list:l22 level1 =
lfo27;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-=
language:
EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'>The Guide to handling and method of administration for healthcare
professionals</span></b><span lang=3DEN-GB style=3D'font-family:"Times New =
Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'> shall contain the following key elements:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt list .75in'><![if !supportLists]><span lang=3DEN-GB
style=3D'font-family:"Courier New";mso-fareast-font-family:"Courier New";
mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list=
:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Instr=
uctions
on receiving and storing of Zynteglo and how to check Zynteglo prior to
administration<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt list .75in'><![if !supportLists]><span lang=3DEN-GB
style=3D'font-family:"Courier New";mso-fareast-font-family:"Courier New";
mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list=
:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Instr=
uctions
about the thawing of Zynteglo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt list .75in'><![if !supportLists]><span lang=3DEN-GB
style=3D'font-family:"Courier New";mso-fareast-font-family:"Courier New";
mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list=
:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Instr=
uctions
on protective equipment and treatment of spills.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span=
></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-bre=
ak-after:
avoid;mso-list:skip;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>The
patient information pack</span></b><span lang=3DEN-GB style=3D'font-family:=
"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'> should contain:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Packa=
ge
leaflet<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>A
patient/carer guide<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>A pat=
ient
alert card.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.5in;text-indent:-.25in;line-height:normal;mso-list:l22 level1 =
lfo27;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-=
language:
EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'>The patient/carer</span></b><span lang=3DEN-GB style=3D'font-family=
:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'> <b style=3D'mso-bidi-font-weight:normal'>guide </b>shall contain t=
he
following key messages:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Treat=
ment
with Zynteglo is in theory associated with the risk of development of
malignancy. Signs of leukaemia and the need to obtain urgent medical care if
these signs are present. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Patie=
nt
alert card and the need to carry it on their person and tell any treating
healthcare professional that they were treated with Zynteglo.<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>The
potential risk of loss of response to gene therapy may lead to loss of
transfusion independence or increase transfusion needs for patients who did=
 not
reach transfusion-independence.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>The
importance of annual check-ups.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Treat=
ment
with Zynteglo is associated with the risk of delayed platelet engraftment t=
hat
could lead to an increased tendency for bleeding. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Signs=
 and
symptoms of bleeding and the need to contact the physician if any signs of
unusual or prolonged bleeding or any other relevant signs are present.<o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Enrol=
ment
in the drug product Registry.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.5in;text-indent:-.25in;line-height:normal;mso-list:l22 level1 =
lfo27;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-=
language:
EN-GB;mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'>The patient alert card</span></b><span lang=3DEN-GB style=3D'font-f=
amily:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-ansi-=
language:
EN-GB;mso-bidi-font-style:italic'> shall contain the following key messages=
:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Infor=
mation
of risk of delayed platelet engraftment, potentially leading to bleeds, and
theoretical risks.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>State=
ment
that the patient was treated with gene therapy and should not donate blood,
organs, tissues, or cells.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>State=
ment
that the patient was treated with Zynteglo, including LOT number and treatm=
ent
date(s).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Detai=
ls
on reporting of adverse effects.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Infor=
mation
on the possibility of false positivity of certain commercial HIV tests beca=
use
of Zynteglo.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.75in;text-indent:-.25in;line-height:normal;mso-list:l11 level1=
 lfo28;
tab-stops:28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'font-fa=
mily:
"Courier New";mso-fareast-font-family:"Courier New";mso-ansi-language:EN-GB;
mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'>o<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Conta=
ct
details where a health care professional can receive further information.<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-family:"Times New Roman=
",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-family:"Times New Roman=
",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'>The MAH shall ensure that in each Member State where Zynteglo is
marketed, a system aimed to control distribution to Zynteglo beyond the lev=
el
of control ensured by routine risk minimisation measures. The following
requirements need to be fulfilled before the product is prescribed,
manufactured, dispensed and used:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-family:"Times New Roman=
",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'><o:p>&nbsp;</o:p></span></p>

<ul style=3D'margin-top:0in' type=3Ddisc>
 <li class=3DMsoNormal style=3D'margin-right:-.1pt;margin-bottom:0in;line-h=
eight:
     normal;mso-list:l42 level1 lfo30;tab-stops:.5in'><span lang=3DEN-GB
     style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"=
Times New Roman";
     mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Zynteglo will only=
 be
     available through bluebird bio qualified treatment centres to ensure
     traceability of the patient`s cells and manufactured drug product betw=
een
     the treating hospital and manufacturing site. The selection of the
     treatment centres will be conducted in collaboration with national hea=
lth
     authorities as appropriate.<b style=3D'mso-bidi-font-weight:normal'><o=
:p></o:p></b></span></li>
</ul>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.05pt;margin-bot=
tom:
0in;margin-left:.5in;text-indent:-.5in;line-height:normal;mso-list:l42 leve=
l1 lfo26;
tab-stops:28.35pt list .5in'><![if !supportLists]><span style=3D'font-famil=
y:
Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
style=3D'font-family:"Times New Roman",serif'>Obligation to conduct
post-authorisation measures <o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>The M=
AH
shall complete, within the stated timeframe, the below measures:<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D"98%"
 style=3D'width:98.0%;border-collapse:collapse;border:none;mso-border-alt:s=
olid windowtext .5pt;
 mso-yfti-tbllook:480;mso-padding-alt:0in 5.4pt 0in 5.4pt;mso-border-inside=
h:
 .5pt solid windowtext;mso-border-insidev:.5pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D"81%" valign=3Dtop style=3D'width:81.28%;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fa=
mily:"Times New Roman",serif;
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bid=
i-font-style:
  italic'>Description<o:p></o:p></span></b></p>
  </td>
  <td width=3D"18%" valign=3Dtop style=3D'width:18.72%;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fa=
mily:"Times New Roman",serif;
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bid=
i-font-style:
  italic'>Due date<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D"81%" valign=3Dtop style=3D'width:81.28%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Tim=
es New Roman";
  mso-bidi-font-style:italic'>In order to further confirm the appropriatene=
ss
  of the acceptance criteria, the MAH should re-evaluate the acceptance
  criteria for attributes related to potency tests using batch release data=
 and
  clinical results after 6 months follow-up of 20 patients treated with
  commercial batches.<span style=3D'mso-spacerun:yes'> </span></span><span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:=
p></o:p></span></p>
  </td>
  <td width=3D"18%" valign=3Dtop style=3D'width:18.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Int=
erim
  report: at each annual renewal <o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:=
p>&nbsp;</o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Whe=
n 20
  patients have been treated with 6 months follow-up<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;mso-yfti-lastrow:yes;page-break-inside:avoid'>
  <td width=3D"81%" valign=3Dtop style=3D'width:81.28%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Non
  interventional post-authorisation safety study (PASS): In order to further
  characterise and contextualise the long-term safety and efficacy of Zynte=
glo
  in patients 12 years and older with transfusion-dependent &#946;&#8209;th=
alassaemia
  (TDT) who do not have a &#946;<sup>0</sup>/&#946;<sup>0</sup> genotype, t=
he
  MAH should conduct and submit the results of a study based on data from a
  product registry (REG-501) and use data on HLA&#8209;matched allogenic HS=
CT
  treated patients from an established European registry as a comparator gr=
oup.<o:p></o:p></span></p>
  </td>
  <td width=3D"18%" valign=3Dtop style=3D'width:18.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Pro=
tocol
  submission: December&nbsp;2020<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:=
p>&nbsp;</o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Int=
erim
  results: <o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>- at
  each annual renewal <o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>- D=
ec.
  2024<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>- D=
ec.
  2034<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:=
p>&nbsp;</o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Fin=
al
  results: Q4 2039<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:21.3pt;text-indent:-21.3pt;line-height:normal;mso-list:skip;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman";
mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>E.<span style=3D'mso-ta=
b-count:
1'> </span>SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES F=
OR
THE CONDITIONAL MARKETING AUTHORISATION<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-=
font-style:
italic'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>This
being a conditional marketing authorisation and pursuant to Article 14(7) of
Regulation (EC) No 726/2004, the MAH shall complete, within the stated
timeframe, the following measures:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D"98%"
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-yfti-tbllook:480;mso-padding-alt:
 0in 5.4pt 0in 5.4pt;mso-border-insideh:.75pt solid windowtext;mso-border-i=
nsidev:
 .75pt solid windowtext'>
 <thead>
  <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
   <td width=3D"81%" valign=3Dtop style=3D'width:81.1%;border:solid windowt=
ext 1.0pt;
   mso-border-alt:solid windowtext .5pt;mso-border-right-alt:solid windowte=
xt .75pt;
   padding:0in 5.4pt 0in 5.4pt'>
   <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-b=
ottom:
   0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'>=
<b
   style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-f=
amily:
   "Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
   mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Description<o:p></o:=
p></span></b></p>
   </td>
   <td width=3D"18%" valign=3Dtop style=3D'width:18.9%;border:solid windowt=
ext 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .75pt;mso-border-a=
lt:
   solid windowtext .5pt;mso-border-left-alt:solid windowtext .75pt;padding:
   0in 5.4pt 0in 5.4pt'>
   <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-b=
ottom:
   0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'>=
<b
   style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-f=
amily:
   "Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
   mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Due date<o:p></o:p><=
/span></b></p>
   </td>
  </tr>
 </thead>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D"81%" valign=3Dtop style=3D'width:81.1%;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .75pt;mso-border-alt:
  solid windowtext .75pt;mso-border-left-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>In
  order to confirm the efficacy and safety of Zynteglo in patients 12 years=
 and
  older with transfusion-dependent &#946;-thalassaemia (TDT) who do not hav=
e a
  &#946;<sup>0</sup>/&#946;<sup>0 </sup>genotype, the MAH should submit int=
erim
  and final data on Study HGB&#8209;207<o:p></o:p></span></p>
  </td>
  <td width=3D"18%" valign=3Dtop style=3D'width:18.9%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .75pt;mso-border-left-alt:solid windo=
wtext .75pt;
  mso-border-alt:solid windowtext .75pt;mso-border-right-alt:solid windowte=
xt .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Int=
erim
  results: at each annual renewal <o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:=
p>&nbsp;</o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Fin=
al
  results: December 2021<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2'>
  <td width=3D"81%" valign=3Dtop style=3D'width:81.1%;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .75pt;mso-border-alt:
  solid windowtext .75pt;mso-border-left-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>In
  order to confirm the efficacy and safety of Zynteglo in patients 12 years=
 and
  older with transfusion-dependent &#946;-thalassaemia (TDT) who do not hav=
e a
  &#946;<sup>0</sup>/&#946;<sup>0</sup> genotype, the MAH should submit int=
erim
  and final data from patients with a severe non-&#946;<sup>0</sup>/&#946;<=
sup>0</sup>
  genotype such as IVS-I-110 included in Study HGB&#8209;212.<o:p></o:p></s=
pan></p>
  </td>
  <td width=3D"18%" valign=3Dtop style=3D'width:18.9%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .75pt;mso-border-left-alt:solid windo=
wtext .75pt;
  mso-border-alt:solid windowtext .75pt;mso-border-right-alt:solid windowte=
xt .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Int=
erim
  results: at each annual renewal <o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:=
p>&nbsp;</o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Fin=
al
  results: December 2021<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;mso-yfti-lastrow:yes'>
  <td width=3D"81%" valign=3Dtop style=3D'width:81.1%;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .75pt;mso-border-top-=
alt:
  .75pt;mso-border-left-alt:.5pt;mso-border-bottom-alt:.5pt;mso-border-righ=
t-alt:
  .75pt;mso-border-color-alt:windowtext;mso-border-style-alt:solid;padding:
  0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>In
  order to confirm the efficacy and safety of Zynteglo in patients 12 years=
 and
  older with transfusion-dependent &#946;-thalassaemia (TDT) who do not hav=
e a
  &#946;<sup>0</sup>/&#946;<sup>0</sup> genotype, the MAH should submit int=
erim
  data and the 5 years follow-up results of Study LTF-303.<o:p></o:p></span=
></p>
  </td>
  <td width=3D"18%" valign=3Dtop style=3D'width:18.9%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .75pt;mso-border-left-alt:solid windo=
wtext .75pt;
  mso-border-top-alt:.75pt;mso-border-left-alt:.75pt;mso-border-bottom-alt:
  .5pt;mso-border-right-alt:.5pt;mso-border-color-alt:windowtext;mso-border=
-style-alt:
  solid;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Int=
erim
  results: at each annual renewal <o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:=
p>&nbsp;</o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><=
span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-fon=
t-family:
  "Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'>Fin=
al
  results: December 2024<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<b style=3D'mso-bidi-font-weight:normal'><span style=3D'font-size:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-far=
east-theme-font:
minor-latin;mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-lan=
guage:
AR-SA'><br clear=3Dall style=3D'mso-special-character:line-break;page-break=
-before:
always'>
</span></b>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align:c=
enter;
line-height:normal;mso-outline-level:1;tab-stops:28.35pt'><b><span lang=3DE=
N-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>ANNEX=
 III</span></b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align:c=
enter;
line-height:normal'><span style=3D'font-family:"Times New Roman",serif'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align:c=
enter;
line-height:normal;mso-outline-level:1;tab-stops:28.35pt'><b><span lang=3DE=
N-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>LABEL=
LING
AND PACKAGE LEAFLET</span></b><span style=3D'font-family:"Times New Roman",=
serif'><o:p></o:p></span></p>

<b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-far=
east-theme-font:
minor-latin;mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-lan=
guage:
AR-SA'><br clear=3Dall style=3D'mso-special-character:line-break;page-break=
-before:
always'>
</span></b>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align:c=
enter;
line-height:normal;mso-outline-level:1;tab-stops:28.35pt'><b><span lang=3DE=
N-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>A.
LABELLING</span></b><span lang=3DEN-GB style=3D'font-family:"Times New Roma=
n",serif;
mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;color:bl=
ack;
mso-color-alt:windowtext;mso-ansi-language:EN-GB;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA'><br clear=3Dall style=3D'mso-special-character:lin=
e-break;
page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt;
background:white;mso-background-themecolor:background1'><span style=3D'font=
-family:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB style=3D'font-family:"Times =
New Roman",serif;
mso-ansi-language:EN-GB'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING  MET=
AL CASSETTE</span></b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:0in 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-outline-lev=
el:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:0in 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>1.</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>NAME OF THE MEDICINAL PRODUCT</span></s=
pan></b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Zynteglo
1.2&#8209;20&nbsp;&nbsp;10<sup>6</sup>&nbsp;cells/mL dispersion for infusi=
on <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>(betibeglogene
autotemcel)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-bidi-font-fam=
ily:
Arial;mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-GB'><o:p>&nbsp;</=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-bidi-font-fam=
ily:
Arial;mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-GB'><o:p>&nbsp;</=
o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-outline-lev=
el:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><a name=3D"_Hlk793172"=
><b><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>2.</span></b></a><span
style=3D'mso-bookmark:_Hlk793172'><b style=3D'mso-bidi-font-weight:normal'>=
<span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><span
style=3D'mso-tab-count:1'> </span><span style=3D'mso-bidi-font-weight=
:bold'>STATEMENT
OF ACTIVE SUBSTANCE(S)</span></span></b></span><span style=3D'mso-bookmark:=
_Hlk793172'><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'mso-bookmark:_Hlk793172'><span lang=3DEN-GB style=3D'font-family:"=
Times New Roman",serif;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'mso-bookmark:_Hlk793172'><span style=3D'font-family:"Times New Rom=
an",serif'>A
genetically modified autologous CD34<sup>+</sup> cell enriched population t=
hat
contains haematopoietic stem cells transduced with lentiviral vector encodi=
ng
the &#946;<sup>A-T87Q</sup>-globin gene with a strength of 1.2&#8209;20&nbs=
p;&nbsp;10<sup>6</sup>
cell/mL. <o:p></o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk793172'></span>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-outline-lev=
el:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>3.</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>LIST OF EXCIPIENTS</span></span></b><sp=
an
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;vertical=
-align:
baseline'><span style=3D'font-family:"Times New Roman",serif'>Also contains
Cryostor CS5 and sodium chloride.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;vertical=
-align:
baseline'><span style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-outline-lev=
el:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>4.</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>PHARMACEUTICAL FORM AND CONTENTS</span>=
</span></b><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;background:lightg=
rey;
mso-highlight:lightgrey;mso-ansi-language:EN-GB'>Dispersion for infusion</s=
pan><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>20&nbsp;mL<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>See Lot Information Sheet for
number of infusion bags and CD34<sup>+</sup> cells per kg for this patient.=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-outline-lev=
el:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>5.</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>METHOD AND ROUTE(S) OF ADMINISTRATION</=
span></span></b><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Read
the package leaflet before use.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>For intravenous use.</span><s=
pan
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-outline-lev=
el:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>6.</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>SPECIAL WARNING THAT THE MEDICINAL PROD=
UCT
MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></span></b><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-family:"Times New Rom=
an",serif;
mso-ansi-language:EN-GB'>Keep out of the sight and reach of children.<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-outline-lev=
el:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>7.</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>OTHER SPECIAL WARNING(S), IF NECESSARY<=
/span></span></b><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>For
autologous use only.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt 37.45pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt 37.45pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-outline-lev=
el:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>8.</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>EXPIRY DATE</span></span></b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>EXP:</span><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;page-break-afte=
r:
avoid;mso-outline-level:1;tab-stops:28.35pt;border:none;mso-border-alt:soli=
d windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>9.</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>SPECIAL STORAGE CONDITIONS</span></span=
></b><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-bre=
ak-after:
avoid;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-family:"Times New=
 Roman",serif;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Store
in the vapour phase of liquid nitrogen at &#8804;-140C until ready for thaw
and administration. Keep infusion bag(s) in the metal cassette(s). Once tha=
wed
do not re-freeze.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-outline-lev=
el:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>10.</=
span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>SPECIAL PRECAUTIONS FOR DISPOSAL OF UNU=
SED MEDICINAL
PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF
APPROPRIATE</span></span></b><span style=3D'font-family:"Times New Roman",s=
erif'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>This
medicine contains genetically&#8209;modified cells. Unused medicine must be
disposed of in compliance with the local guidelines on handling human-deriv=
ed
material. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>11.</=
span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>NAME AND ADDRESS OF THE MARKETING
AUTHORISATION HOLDER</span></span></b><span style=3D'font-family:"Times New=
 Roman",serif'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>bluebird bio (Netherlands) B.=
V.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>Stadsplateau 7<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>WTC Utrecht<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>3521AZ Utrecht<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>The Netherlands<span
style=3D'background:yellow;mso-highlight:yellow'><o:p></o:p></span></span><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DPT style=3D'font-family:"Times New Roman",serif;mso-ansi-language:PT=
'>Tel:
+31 (0) 303 100 450<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DPT style=3D'font-family:"Times New Roman",serif;mso-ansi-language:PT=
'>e-mail:
medinfo@bluebirdbio.com<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DPT style=3D'font-family:"Times New Roman",serif;mso-ansi-language:PT=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DPT style=3D'font-family:"Times New Roman",serif;mso-ansi-language:PT=
'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>12.</=
span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>MARKETING AUTHORISATION NUMBER(S) </spa=
n></span></b><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'>EU=
/1/19/1367/001</span><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>13.</=
span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>BATCH NUMBER, DONATION AND PRODUCT CODE=
S</span></span></b><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Patient
ID:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>COI
ID:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Last
Name:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>First
Name: <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Date
of Birth:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>DIN:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Lot:
</span><span style=3D'font-family:"Times New Roman",serif'><o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Bag
ID:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>14.</=
span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>GENERAL CLASSIFICATION FOR SUPPLY</span=
></span></b><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:2.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>15.</=
span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>INSTRUCTIONS ON USE</span></span></b><s=
pan
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 0in 4.0pt'><b><span lang=3DEN-GB style=3D'font-family:"Times Ne=
w Roman",serif;
mso-ansi-language:EN-GB'>16.</span></b><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><span
style=3D'mso-tab-count:1'> </span><span style=3D'mso-bidi-font-weight:b=
old'>INFORMATION
IN BRAILLE</span></span></b><span lang=3DEN-GB style=3D'font-family:"Times =
New Roman",serif;
mso-ansi-language:EN-GB'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;color:black;mso-c=
olor-alt:
windowtext;background:#CCCCCC;mso-ansi-language:EN-GB'>Justification for not
including Braille accepted.</span><span lang=3DEN-GB style=3D'font-family:"=
Times New Roman",serif;
background:#CCCCCC;mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;background:#CCCCC=
C;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;border:n=
one;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 0in 4.0pt'><b><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>17.</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><sp=
an
style=3D'mso-bidi-font-weight:bold'>UNIQUE IDENTIFIER  2D BARCODE</span></=
span></b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;color:black;mso-c=
olor-alt:
windowtext;background:#CCCCCC;mso-ansi-language:EN-GB'>Not applicable.</spa=
n><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;border:n=
one;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 0in 4.0pt'><b><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>18.</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><sp=
an
style=3D'mso-bidi-font-weight:bold'>UNIQUE IDENTIFIER - HUMAN READABLE DATA=
</span></span></b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;color:black;mso-c=
olor-alt:
windowtext;background:lightgrey;mso-highlight:lightgrey;mso-shading:#CCCCCC;
mso-ansi-language:EN-GB'>Not applicable.</span><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;display:none;mso-hide:all;
mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<b><span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roma=
n",serif;
mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi=
-language:
EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=3Dall
style=3D'page-break-before:always'>
</span></b>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB style=3D'font-family:"Times =
New Roman",serif;
mso-ansi-language:EN-GB'>MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE P=
ACKAGING
UNITS</span></b><span style=3D'font-family:"Times New Roman",serif'><o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB style=3D'font-family:"Times =
New Roman",serif;
mso-ansi-language:EN-GB'>INFUSION BAG </span></b><span style=3D'font-family=
:"Times New Roman",serif'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>1.</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>NAME OF THE MEDICINAL PRODUCT AND ROUTE=
(S) OF
ADMINISTRATION</span></span></b><span style=3D'font-family:"Times New Roman=
",serif'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;tab-stops:28.35=
pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-bidi-font-fam=
ily:
Arial;mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-GB'>Zynteglo 1.2&=
#8209;20&nbsp;&nbsp;10<sup>6</sup>&nbsp;cells/mL
dispersion for infusion <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'>(betibeglogene autotemcel)</span=
><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>For
intravenous use.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>2.</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>METHOD OF ADMINISTRATION</span></span><=
/b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Read
the package leaflet before use.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>3.</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>EXPIRY DATE</span></span></b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>EXP:</span><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>4.</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>BATCH NUMBER, DONATION AND PRODUCT CODE=
S</span></span></b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Patient
ID:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>COI
ID:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Last
Name <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>First
Name:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Date
of Birth:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>DIN:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Lot:
</span><span style=3D'font-family:"Times New Roman",serif'><o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Bag
ID:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'><o:p>=
&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>5.</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>CONTENTS BY WEIGHT, BY VOLUME OR BY UNI=
T</span></span></b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>See Lot Information Sheet for
number of infusion bags and CD34<sup>+</sup> cells per kg for this patient.=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>20&nb=
sp;mL<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'><o:p>=
&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>6.</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>OTHER</span></span></b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:5.=
65pt;
margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-family:"Times New Roman=
",serif;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>For
autologous use only.<o:p></o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi=
-language:
EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=3Dall
style=3D'page-break-before:always'>
</span>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB style=3D'font-family:"Times =
New Roman",serif;
mso-ansi-language:EN-GB'>PARTICULARS TO APPEAR ON THE LOT INFORMATION SHEET
INCLUDED WITH EACH SHIPMENT FOR ONE PATIENT</span></b><span style=3D'font-f=
amily:
"Times New Roman",serif'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:0in 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-outline-lev=
el:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:0in 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>1.</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>NAME OF THE MEDICINAL PRODUCT</span></s=
pan></b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Zynteglo
1.2&#8209;20&nbsp;&nbsp;10<sup>6</sup> cells/mL dispersion for infusion <o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>(betibeglogene
autotemcel)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-outline-lev=
el:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>2.</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>STATEMENT OF ACTIVE SUBSTANCE(S)</span>=
</span></b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>Zynteglo is a genetically mod=
ified
autologous CD34<sup>+</sup> cell enriched population that contains
haematopoietic stem cells transduced with lentiviral vector encoding the &#=
946;<sup>A&#8209;T87Q</sup>&#8209;globin
gene.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span style=3D'font-family:"Times New Roman",serif'>3.</span></b><s=
pan
style=3D'font-family:"Times New Roman",serif'><span style=3D'mso-tab-count:=
1'> </span><b
style=3D'mso-bidi-font-weight:normal'>DONATION AND PRODUCT CODES</b><o:p></=
o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>PATIENT
INFORMATION<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Name
(Last, First):<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Date
of Birth (DD/MM/YYYY):<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>Weigh=
t at
First Collection (kg): <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>Patie=
nt ID:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>4.<sp=
an
style=3D'mso-tab-count:1'> </span>BATCH NUMBER, CONTENTS BY WEIGHT, BY
VOLUME OR BY UNIT, AND EXPIRY DATE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>INFOR=
MATION
ON SUPPLIED LOT(S)</span><span style=3D'font-family:"Times New Roman",serif=
'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>The following lot(s) was
manufactured and included in the shipment:<o:p></o:p></span></p>

<table class=3DMsoTableGrid border=3D1 cellspacing=3D0 cellpadding=3D0 widt=
h=3D615
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-yfti-tbllook:1184;mso-padding-alt:
 0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D90 valign=3Dtop style=3D'width:67.25pt;border:solid windowtex=
t 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
3.5pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><b><span style=3D'font-family:"Times New Roman",serif'=
>Lot
  Number / COI ID </span></b></p>
  </td>
  <td width=3D93 valign=3Dtop style=3D'width:69.55pt;border:solid windowtex=
t 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
3.5pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><b><span style=3D'font-family:"Times New Roman",serif'=
>DIN</span></b></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
3.5pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'>(L=
ist
  all collections)<o:p></o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border:solid windowtex=
t 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align=
:center;
  line-height:normal;tab-stops:0in'><b><span style=3D'font-family:"Times Ne=
w Roman",serif'>Number
  of Infusion Bags</span></b><span style=3D'font-family:"Times New Roman",s=
erif'><o:p></o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border:solid windowtex=
t 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
  style=3D'font-family:"Times New Roman",serif;mso-bidi-font-family:Arial;
  mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-GB'>Bag ID<o:p></o:p>=
</span></b></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
2.0pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:0in'><span lang=3DEN-GB style=3D'font-family:"Times New Roman",=
serif;
  mso-bidi-font-family:Arial;mso-bidi-theme-font:minor-bidi;mso-ansi-langua=
ge:
  EN-GB'>(List each infusion bag)<o:p></o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border:solid windowtex=
t 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
4.0pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:.5pt'><b><span style=3D'font-family:"Times New Roman",serif'>St=
rength</span></b><span
  style=3D'font-family:"Times New Roman",serif'> (&nbsp;10<sup>6</sup> cel=
ls/mL)<o:p></o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border:solid windowtex=
t 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
6.0pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:0in'><b><span style=3D'font-family:"Times New Roman",serif'>CD3=
4<sup>+</sup>
  Cells</span></b><span style=3D'font-family:"Times New Roman",serif'><br
  clear=3Dall>
  (&nbsp;10<sup>6</sup> CD34<sup>+</sup> cells)<o:p></o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border:solid windowtex=
t 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><b><span lang=3DEN-GB style=3D'font-family:"Times New =
Roman",serif;
  mso-ansi-language:EN-GB'>Expiry Date<o:p></o:p></span></b></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'>(D=
D/MM/YYYY)</span><b><span
  lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-langua=
ge:EN-GB'><o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D90 valign=3Dtop style=3D'width:67.25pt;border:solid windowtex=
t 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D93 valign=3Dtop style=3D'width:69.55pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2'>
  <td width=3D90 valign=3Dtop style=3D'width:67.25pt;border:solid windowtex=
t 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D93 valign=3Dtop style=3D'width:69.55pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3'>
  <td width=3D90 valign=3Dtop style=3D'width:67.25pt;border:solid windowtex=
t 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D93 valign=3Dtop style=3D'width:69.55pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;mso-yfti-lastrow:yes'>
  <td width=3D90 valign=3Dtop style=3D'width:67.25pt;border:solid windowtex=
t 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D93 valign=3Dtop style=3D'width:69.55pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D86 valign=3Dtop style=3D'width:64.85pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
5.65pt;
  margin-bottom:0in;margin-left:0in;text-align:center;line-height:normal;
  tab-stops:28.35pt'><span style=3D'font-family:"Times New Roman",serif'><o=
:p>&nbsp;</o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'><o:p>=
&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>5.</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-fami=
ly:"Times New Roman",serif;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>DOSE OF THE MEDICINAL PRODUCT</span></s=
pan></b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><b><span lang=3DE=
N-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'>Total
Number of Infusion Bags: __</span></b><span style=3D'font-family:"Times New=
 Roman",serif'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><b><span
style=3D'font-family:"Times New Roman",serif'>Dose: {N.N}<span style=3D'col=
or:#2E74B5'>
</span><span style=3D'color:#2E74B5'> </span></span></b><span style=3D'fon=
t-family:
"Times New Roman",serif'>10<sup>6</sup>&nbsp;CD34<sup>+</sup> cells/kg <o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>The minimum recommended dose of Zynteglo is
5.0&nbsp;&nbsp;10<sup>6</sup>&nbsp;CD34<sup>+</sup> cells/kg. In clinical
studies doses up to 20&nbsp;&nbsp;10<sup>6</sup>&nbsp;CD34+ cells/kg have =
been
administered.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'><o:p>=
&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;page-break-afte=
r:
avoid;mso-outline-level:1;tab-stops:28.35pt;border:none;mso-border-alt:soli=
d windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span style=3D'font=
-family:
"Times New Roman",serif'>6.</span></b><span style=3D'font-family:"Times New=
 Roman",serif'><span
style=3D'mso-tab-count:1'> </span><b>OTHER SPECIAL WARNING(S), IF NEC=
ESSARY</b></span><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-bre=
ak-after:
avoid;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-family:"Times New=
 Roman",serif;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><a
name=3D"_Hlk520301262"><span style=3D'font-family:"Times New Roman",serif'>=
SAVE
THIS DOCUMENT AND PREPARE TO HAVE IT AVAILABLE AT THE TIME OF ZYNTEGLO
INFUSION.<o:p></o:p></span></a></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'mso-bookmark:_Hlk520301262'><span lang=3DEN-GB style=3D'font-famil=
y:"Times New Roman",serif;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk520301262'></span>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Read
the package leaflet before use.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>For
autologous use only.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt 37.45pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt 37.45pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;page-break-afte=
r:
avoid;mso-outline-level:1;tab-stops:28.35pt;border:none;mso-border-alt:soli=
d windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span style=3D'font=
-family:
"Times New Roman",serif'>7.</span></b><span style=3D'font-family:"Times New=
 Roman",serif'><span
style=3D'mso-tab-count:1'> </span><b>SPECIAL STORAGE CONDITIONS</b></=
span><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>INSTRUCTIONS
FOR STORAGE AND USE</span><span style=3D'font-family:"Times New Roman",seri=
f'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>Store
in the vapour phase of liquid nitrogen at &#8804;-140C until ready for thaw
and administration. Keep infusion bag(s) in the metal cassette(s). Once tha=
wed
do not re-freeze.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;tab-stops:28.35=
pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-outline-lev=
el:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span style=3D'font=
-family:
"Times New Roman",serif'>8.</span></b><span style=3D'font-family:"Times New=
 Roman",serif'><span
style=3D'mso-tab-count:1'> </span><b>SPECIAL PRECAUTIONS FOR DISPOSAL=
 OF
UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL
PRODUCTS, IF APPROPRIATE</b><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>This medicine contains
genetically-modified cells. Unused medicine must be disposed of in complian=
ce
with the local guidelines on handling human-derived material.<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span style=3D'font=
-family:
"Times New Roman",serif'>9.</span></b><span style=3D'font-family:"Times New=
 Roman",serif'><span
style=3D'mso-tab-count:1'> </span><b>NAME AND ADDRESS OF THE MARKETING
AUTHORISATION HOLDER</b><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>MARKETING AUTHORISATION HOLDE=
R AND
NUMBER<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>bluebird bio (Netherlands) B.=
V.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>Stadsplateau 7<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>WTC Utrecht<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>3521AZ Utrecht<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>The Netherlands<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'>e-mail:
</span><span style=3D'font-family:"Times New Roman",serif'>medinfo@bluebird=
bio.com</span><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span style=3D'font=
-family:
"Times New Roman",serif'>10.</span></b><span style=3D'font-family:"Times Ne=
w Roman",serif'><span
style=3D'mso-tab-count:1'> </span><b>MARKETING AUTHORISATION NUMBER(S) =
</b></span><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-family:"Times New Rom=
an",serif;
mso-ansi-language:EN-GB'>EU/1/19/1367/001<o:p></o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ansi=
-language:
EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=3Dall
style=3D'mso-special-character:line-break;page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:5.65pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;tab-stops:28.35pt'><span lang=3DEN-GB
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:EN-GB'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align:c=
enter;
line-height:normal;mso-outline-level:1;tab-stops:28.35pt'><b style=3D'mso-b=
idi-font-weight:
normal'><span style=3D'font-family:"Times New Roman",serif'>B. PACKAGE LEAF=
LET<o:p></o:p></span></b></p>

<span style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;mso-far=
east-font-family:
Calibri;mso-fareast-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fare=
ast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'mso-special-charact=
er:line-break;
page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1'><span style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></s=
pan></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align:c=
enter;
line-height:normal;mso-outline-level:1'><b><span style=3D'font-family:"Time=
s New Roman",serif'>Package
leaflet: Information for the patient or carer</span></b><span style=3D'font=
-family:
"Times New Roman",serif'><o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align:c=
enter;
line-height:normal;mso-outline-level:1;tab-stops:28.35pt 49.65pt'><b><span
style=3D'font-family:"Times New Roman",serif'>Zynteglo 1.2&#8209;20&nbsp;&=
nbsp;10<sup>6
</sup>cells/mL dispersion for infusion</span></b><span style=3D'font-family=
:"Times New Roman",serif'><o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:0in;text-align:c=
enter;
line-height:normal'><span style=3D'font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman"'>betibeglogene autotemcel </span>=
<span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-ansi-language=
:EN-GB;
mso-fareast-language:ZH-CN;mso-no-proof:yes'><v:shape id=3D"Picture_x0020_1=
882439266"
 o:spid=3D"_x0000_i1025" type=3D"#_x0000_t75" alt=3D"BT_1000x858px" style=
=3D'width:15.9pt;
 height:13.2pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src=3D"Zynteglo_clean_files/image003.png" o:title=3D"BT_1000x=
858px"/>
</v:shape></span><span style=3D'font-family:"Times New Roman",serif'>This
medicine is subject to additional monitoring. This will allow quick
identification of new safety information. You can help by reporting any side
effects you may get. See the end of section 4 for how to report side effect=
s.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hyph=
enate:
none'><b><span style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o=
:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hyph=
enate:
none'><b><span style=3D'font-family:"Times New Roman",serif'>Read all of th=
is
leaflet carefully before you are given this medicine because it contains
important information for you.<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hyph=
enate:
none'><b><span style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o=
:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-layo=
ut-grid-align:
none;text-autospace:none'><span style=3D'font-family:"Times New Roman",seri=
f'>You
will be given a <b>Patient Alert Card</b> which contains important safety
information that you need to know about your treatment with Zynteglo. You
should carry the Patient Alert Card with you at all times and show it to yo=
ur
doctor or nurse when you see them or if you are admitted to the hospital.<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.25in;text-indent:-.25in;line-height:normal;mso-list:l10 level1=
 lfo10;
tab-stops:28.35pt'><![if !supportLists]><span style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman"'><span style=3D'mso-list:Ignore'>=
-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>Keep
this leaflet. You may need to read it again. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.25in;text-indent:-.25in;line-height:normal;mso-list:l10 level1=
 lfo10;
tab-stops:28.35pt'><![if !supportLists]><span style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman"'><span style=3D'mso-list:Ignore'>=
-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>If
you have any further questions, ask your doctor or nurse.<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.25in;text-indent:-.25in;line-height:normal;mso-list:l10 level1=
 lfo10;
tab-stops:28.35pt'><![if !supportLists]><span style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman"'><span style=3D'mso-list:Ignore'>=
-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>If
you get any side effects, talk to your doctor or nurse.<span style=3D'color=
:red'>
</span>This includes any possible side effects not listed in this leaflet. =
See
section 4.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.25in;text-indent:-.25in;line-height:normal;mso-list:l10 level1=
 lfo10;
tab-stops:28.35pt'><![if !supportLists]><span style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman"'><span style=3D'mso-list:Ignore'>=
-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>Read
the Patient Alert Card carefully and follow the instructions on it. <o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.25in;line-height:normal;tab-stops:28.35pt'><span style=3D'font=
-family:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><b><span style=3D'font-fa=
mily:
"Times New Roman",serif'>What is in this leaflet</span></b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:21.3pt'><span
style=3D'font-family:"Times New Roman",serif'>1.<span style=3D'mso-tab-coun=
t:1'> </span>What
Zynteglo is and what it is used for <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:21.3pt'><span
style=3D'font-family:"Times New Roman",serif'>2.<span style=3D'mso-tab-coun=
t:1'> </span>What
you need to know before you are given Zynteglo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:21.3pt'><span
style=3D'font-family:"Times New Roman",serif'>3.<span style=3D'mso-tab-coun=
t:1'> </span>How
Zynteglo is given<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:21.3pt'><span
style=3D'font-family:"Times New Roman",serif'>4.<span style=3D'mso-tab-coun=
t:1'> </span>Possible
side effects <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;tab-stops:21.3pt'><span
style=3D'font-family:"Times New Roman",serif'>5.<span style=3D'mso-tab-coun=
t:1'> </span>How
to store Zynteglo <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;tab-stops:21.3pt'><span
style=3D'font-family:"Times New Roman",serif'>6.<span style=3D'mso-tab-coun=
t:1'> </span>Contents
of the pack and other information<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;tab-stops:21.3pt'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;tab-stops:21.3pt'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;tab-stops:28.35pt'><b><span
style=3D'font-family:"Times New Roman",serif'>1.</span></b><b style=3D'mso-=
bidi-font-weight:
normal'><span style=3D'font-family:"Times New Roman",serif'><span
style=3D'mso-tab-count:1'> </span><span style=3D'mso-bidi-font-weight=
:bold'>What
Zynteglo is and what it is used for</span></span></b><span style=3D'font-fa=
mily:
"Times New Roman",serif'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal'><span style=3D'font-family:"Times New R=
oman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal'><span style=3D'font-family:"Times New R=
oman",serif;
mso-bidi-font-weight:bold'>Zynteglo</span><span style=3D'font-family:"Times=
 New Roman",serif'>
is used to treat a serious genetic disease called transfusion&#8209;depende=
nt
beta&#8209;thalassaemia (TDT), which includes the disease commonly known as
beta&#8209;thalassaemia major, in people 12 years and older. People with th=
is
condition cannot make enough haemoglobin, a protein in the blood that carri=
es
oxygen. More specifically, people with TDT do not make enough of a part of =
the
haemoglobin called beta-globin, due to a gene defect. Because of this defec=
t,
people with TDT are anaemic and need frequent blood transfusions to survive=
.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal'><span style=3D'font-family:"Times New R=
oman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal'><span style=3D'font-family:"Times New R=
oman",serif'>Zynteglo
is a type of medicine called gene therapy. It is made specifically for each
patient, using the patients own (also called autologous) blood stem cells.
Zynteglo works by adding functional copies of the beta-globin gene into the=
se cells,
so that the patient can make enough beta-globin to increase total haemoglob=
in,
improve anaemia, and carry more oxygen around their body. This reduces or
eliminates the need for blood transfusions.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal'><span style=3D'font-family:"Times New R=
oman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal'><span style=3D'font-family:"Times New R=
oman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;tab-stops:28.35pt'><b><span
style=3D'font-family:"Times New Roman",serif'>2.</span></b><span
style=3D'font-family:"Times New Roman",serif'><span style=3D'mso-tab-count:=
1'> </span><b>What
you need to know before you are given Zynteglo</b><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;mso-list:skip'><b><span style=3D'font-family:"Times New Roman",serif'>You=
 must
not be given Zynteglo if you</span></b><span style=3D'font-family:"Times Ne=
w Roman",serif'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.25in;text-indent:-.25in;line-height:normal;mso-outline-level:1;
mso-list:l10 level1 lfo10;tab-stops:28.35pt'><![if !supportLists]><span
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman"'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>are
allergic to any of the ingredients of this medicine (listed in section 6)<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.25in;text-indent:-.25in;line-height:normal;mso-outline-level:1;
mso-list:l10 level1 lfo10;tab-stops:28.35pt'><![if !supportLists]><span
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman"'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>are
pregnant or breast-feeding<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.25in;text-indent:-.25in;line-height:normal;mso-outline-level:1;
mso-list:l10 level1 lfo10;tab-stops:28.35pt'><a name=3D"_Hlk817587"><![if !=
supportLists]><span
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman"'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>have
previously received gene therapy of your blood stem cells<o:p></o:p></span>=
</a></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:0in;
margin-left:.25in;text-indent:-.25in;line-height:normal;mso-outline-level:1;
mso-list:l10 level1 lfo10;tab-stops:28.35pt'><span style=3D'mso-bookmark:_H=
lk817587'><![if !supportLists]><span
style=3D'font-family:"Times New Roman",serif;mso-fareast-font-family:"Times=
 New Roman"'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>are
allergic to any of the ingredients in the medicines you will be given for
mobilisation and chemotherapy (see section 3).<o:p></o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk817587'></span>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-outl=
ine-level:
1;mso-list:skip'><b><span style=3D'font-family:"Times New Roman",serif'>War=
nings
and precautions </span></b><span style=3D'font-family:"Times New Roman",ser=
if'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Talk to your doctor before yo=
u are
given Zynteglo.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'>Before treatment with Zynteglo, you will be given
medicines know as mobilisation medicine and chemotherapy medicine (see sect=
ions
3 and 4 for more information on these medicines, including possible side
effects).<o:p></o:p></span></p>

<p class=3DC-BodyText style=3D'margin:0in;line-height:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Before treatment with Zyntegl=
o,
your doctor will perform tests to make sure your heart and liver are
functioning properly so you can be treated safely with Zynteglo. <o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'>Zyn=
teglo</span><span
style=3D'font-family:"Times New Roman",serif'> is made specifically for you,
using your own blood stem cells. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>After you have been treated w=
ith
Zynteglo, you will not be able to donate blood, organs, or tissues in the
future. This is because Zynteglo is a gene therapy medicine. <o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Adding a new gene into the DN=
A of
your blood stem cells could theoretically cause leukaemia or lymphoma, alth=
ough
no patients have developed leukaemia or lymphoma in clinical trials with
Zynteglo. After treatment with Zynteglo, you will be asked to enrol in a
registry for at least 15 years in order to better understand the long-term
effects of Zynteglo. During the long-term follow-up, your doctor will monit=
or
you for any signs of leukaemia or lymphoma. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Zynteglo is prepared using pa=
rts of
the human immunodeficiency virus (HIV), which have been altered so that they
cannot cause HIV infection. The modified virus is used to insert a function=
al
beta-globin gene into your blood stem cells. Although this medicine will not
give you HIV infection, having Zynteglo in your blood may cause a false
positive HIV test result with some commercial tests that recognise a piece =
of
HIV used to make Zynteglo. If you test positive for HIV following treatment,
please contact your doctor or nurse. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Before receiving Zynteglo you=
 will
be given chemotherapy in order to remove your existing bone marrow. If Zynt=
eglo
cannot be administered after chemotherapy or if the modified stem cells do =
not
take hold (engraft) in your body, the doctor may give you an infusion of yo=
ur
own original blood stem cells that were collected and stored before the
treatment started (see also section 3, How Zynteglo is given)<i
style=3D'mso-bidi-font-style:normal'>. <o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>After you receive Zynteglo, y=
ou may
have a low number of platelets in your blood. This means that your blood may
not be able to clot as well as normal and you may be prone to bleeding. You
must get medical attention if you: <o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-bottom:0in;text-indent:-.25in;
line-height:normal;mso-list:l13 level1 lfo12;tab-stops:0in'><![if !supportL=
ists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>bump
your head or have a head injury<o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-bottom:0in;text-indent:-.25in;
line-height:normal;mso-list:l13 level1 lfo12;tab-stops:0in'><![if !supportL=
ists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>have
symptoms that could be from internal bleeding, such as unusual stomach or b=
ack
pain, or severe headache<o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-bottom:0in;text-indent:-.25in;
line-height:normal;mso-list:l13 level1 lfo12;tab-stops:0in'><![if !supportL=
ists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>have
abnormal bruising or bleeding (such as bruising without injury, blood in yo=
ur
urine, stool, vomit, or cough up blood).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Your doctor will tell you whe=
n your
platelet count has recovered to normal levels.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><b><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><b><span
style=3D'font-family:"Times New Roman",serif'>Other medicines and Zynteglo =
<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Tell your doctor if you are t=
aking,
have recently taken or might take any other medicines.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>You should not take hydroxyur=
ea (a
medicine for blood disorders) or any medicines for HIV infection from at le=
ast
one month before you undergo mobilisation until at least 7 days after Zynte=
glo
infusion (see also section 3, How Zynteglo is given).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>You should stop taking medici=
nes to
remove iron from your body (so-called chelating agents: deferoxamine,
deferiprone and/or deferasirox) 7 days before you start the chemotherapy be=
fore
the infusion of Zynteglo (see section 3, How Zynteglo is given). Your doctor
will advise you if and when you should start taking these medicines after
Zynteglo infusion. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Talk to your doctor if you ne=
ed to
have any vaccinations. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><b><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-bre=
ak-after:
avoid;mso-list:skip'><b><span style=3D'font-family:"Times New Roman",serif'=
>Pregnancy,
breast-feeding and fertility<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>If you are pregnant or
breast-feeding, think you may be pregnant or are planning to have a baby, t=
ell
your doctor before you are given this medicine.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>If you are a woman, you will =
be
given a pregnancy test before starting mobilisation, before you are given
chemotherapy, and before Zynteglo treatment in order to confirm that you are
not pregnant.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Women who could become pregna=
nt and
men capable of fathering a child must start using a reliable method of
contraception from before their blood stem cells are collected and continue
until at least 6 months after receiving Zynteglo.<span
style=3D'mso-spacerun:yes'> </span>Reliable methods of contraception inclu=
de
intra-uterine device or a combination of oral contraceptive (also know as t=
he
pill) and condoms.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>The added gene from Zynteglo =
will
not be passed on to your children. Your children are still at risk of
inheriting your original beta&#8209;globin gene.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>You should not be given Zynte=
glo if
you are breast-feeding. It is not known whether the ingredients of Zynteglo=
 can
pass into breast milk.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>It may no longer be possible =
for
you to become pregnant or father a child after receiving chemotherapy medic=
ine.
If you are concerned about having children, you should discuss this with yo=
ur
doctor before treatment. Options may include providing reproductive material
for storage in a tissue bank to use at a later time. For men, this may be s=
perm
or testicular tissue. For women, this may be eggs (oocytes) or ovarian tiss=
ue.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-outline-level:1;mso-list:skip'><b><s=
pan
style=3D'font-family:"Times New Roman",serif'>Driving and using machines<o:=
p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><a name=3D"_Hlk32575891">=
<span
style=3D'font-family:"Times New Roman",serif'>Zynteglo has no influence on =
the
ability to drive or use machines. However, the mobilisation and chemotherap=
y medicines
may cause dizziness and fatigue. Avoid driving or using machines if you feel
dizzy, tired or unwell.<o:p></o:p></span></a></p>

<span style=3D'mso-bookmark:_Hlk32575891'></span>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><b><span style=3D'font-fa=
mily:
"Times New Roman",serif'>Sodium content<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'>This medicine contains 391&#8209;1564&nbsp;mg sodi=
um
(main component of cooking/table salt) in each dose. This is equivalent to =
<span
style=3D'color:black'>20&#8209;78% </span>of the recommended maximum daily
dietary intake of sodium for an adult.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;page-break-after:avoid;tab-stops:28.35pt=
'><b><span
style=3D'font-family:"Times New Roman",serif'>3.</span></b><b style=3D'mso-=
bidi-font-weight:
normal'><span style=3D'font-family:"Times New Roman",serif'><span
style=3D'mso-tab-count:1'> </span><span style=3D'mso-bidi-font-weight=
:bold'>How
Zynteglo is given</span></span></b><span style=3D'font-family:"Times New Ro=
man",serif'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'>Zynteglo is given by a drip (infusion) into a vein=
. It
can only be given in a specialised hospital by doctors who are experienced =
in
treating patients with TDT, administering bone marrow transplants, and using
gene therapy medicines.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'>Zynteglo can only be made if enough of the right k=
ind
of blood stem cells can be collected from your blood (CD34<sup>+</sup> blood
stem cells). Approximately 2 months before treatment with Zynteglo, you wil=
l be
given a mobilisation medicine that will move your blood stem cells from your
bone marrow into your blood stream. The blood stem cells can then be collec=
ted
by a machine that separates blood components (apheresis machine). It may ta=
ke
more than 1 day to collect enough blood stem cells to make Zynteglo and to
store as replacement cells if Zynteglo cannot be given or does not work.<o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal'><span style=3D'font-family:"Times New R=
oman",serif'><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;border:none;mso-border-alt:solid windowt=
ext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0in 5.4pt 0in 5.4pt;mso-border-insid=
eh:
 .5pt solid windowtext;mso-border-insidev:.5pt solid windowtext'>
 <thead>
  <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
   <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid window=
text 1.0pt;
   mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
   <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-b=
ottom:
   0in;margin-left:0in;line-height:normal;mso-list:skip'><b><span
   style=3D'font-family:"Times New Roman",serif'>Time</span></b><span
   style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>
   </td>
   <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid window=
text 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
   <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-b=
ottom:
   0in;margin-left:0in;line-height:normal;mso-list:skip'><b><span
   style=3D'font-family:"Times New Roman",serif'>What happens</span></b><sp=
an
   style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>
   </td>
   <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid window=
text 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
   <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-b=
ottom:
   0in;margin-left:0in;line-height:normal;mso-list:skip'><b><span
   style=3D'font-family:"Times New Roman",serif'>Why</span></b><span
   style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>
   </td>
  </tr>
 </thead>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font=
-family:
  "Times New Roman",serif'>Approximately 2&nbsp;months before Zynteglo infu=
sion<o:p></o:p></span></p>
  </td>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font=
-family:
  "Times New Roman",serif'>Mobilisation medicine is given<o:p></o:p></span>=
</p>
  </td>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font=
-family:
  "Times New Roman",serif'>To move the blood stem cells from your bone marr=
ow
  into your blood stream.<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font=
-family:
  "Times New Roman",serif'>Approximately 2&nbsp;months before Zynteglo infu=
sion<o:p></o:p></span></p>
  </td>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font=
-family:
  "Times New Roman",serif'>Blood stem cells are collected <o:p></o:p></span=
></p>
  </td>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font=
-family:
  "Times New Roman",serif'>To make Zynteglo and to serve as replacement cel=
ls
  if needed.<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font=
-family:
  "Times New Roman",serif'>At least 6&nbsp;days before Zynteglo infusion<o:=
p></o:p></span></p>
  </td>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font=
-family:
  "Times New Roman",serif'>A chemotherapy medicine is given for 4&nbsp;days=
 in
  a hospital<o:p></o:p></span></p>
  </td>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font=
-family:
  "Times New Roman",serif'>To prepare your bone marrow for treatment with
  Zynteglo.<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;page-break-inside:avoid'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font=
-family:
  "Times New Roman",serif'>Start of Zynteglo treatment<o:p></o:p></span></p>
  </td>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font=
-family:
  "Times New Roman",serif'>Zynteglo is given by a drip (infusion) into a ve=
in.
  This will take place in a hospital and will take less than 30 minutes for
  each infusion bag. The number of bags will vary by patient.<o:p></o:p></s=
pan></p>
  </td>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bo=
ttom:
  0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font=
-family:
  "Times New Roman",serif'>To add blood stem cells containing functional co=
pies
  of the beta-globin into your bone marrow.<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;mso-yfti-lastrow:yes'>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-b=
reak-after:
  avoid;mso-list:skip'><span style=3D'font-family:"Times New Roman",serif'>=
After
  Zynteglo infusion<o:p></o:p></span></p>
  </td>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-b=
reak-after:
  avoid;mso-list:skip'><span style=3D'font-family:"Times New Roman",serif'>=
You
  will remain in the hospital for approximately 3&#8209;6 weeks<o:p></o:p><=
/span></p>
  </td>
  <td width=3D202 valign=3Dtop style=3D'width:151.25pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;page-b=
reak-after:
  avoid;mso-list:skip'><span style=3D'font-family:"Times New Roman",serif'>=
To
  recover and be monitored until your doctor is satisfied that it is safe f=
or
  you to leave the hospital.<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-list:skip'>=
<a
name=3D"_Hlk512253721"><b><span style=3D'font-family:"Times New Roman",seri=
f'><o:p>&nbsp;</o:p></span></b></a></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-list:skip'>=
<span
style=3D'mso-bookmark:_Hlk512253721'><b><span style=3D'font-family:"Times N=
ew Roman",serif'><o:p>&nbsp;</o:p></span></b></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-list:skip'>=
<span
style=3D'mso-bookmark:_Hlk512253721'><b><span style=3D'font-family:"Times N=
ew Roman",serif'>4.</span></b></span><span
style=3D'mso-bookmark:_Hlk512253721'><b style=3D'mso-bidi-font-weight:norma=
l'><span
style=3D'font-family:"Times New Roman",serif'><span style=3D'mso-tab-count:=
1'> </span><span
style=3D'mso-bidi-font-weight:bold'>Possible side effects<o:p></o:p></span>=
</span></b></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-list:skip'>=
<span
style=3D'mso-bookmark:_Hlk512253721'><span style=3D'font-family:"Times New =
Roman",serif'><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'mso-bo=
okmark:
_Hlk512253721'><span style=3D'font-family:"Times New Roman",serif'>Like all
medicines, this medicine can cause side effects, although not everybody gets
them. <o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal'><span style=3D'mso-bookmark:_Hlk512=
253721'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal'><span style=3D'mso-bookmark:_Hlk512=
253721'><span
style=3D'font-family:"Times New Roman",serif'>Some side effects observed in
clinical studies with Zynteglo are related to mobilisation and blood stem c=
ell
collection or to the chemotherapy medicine used to prepare your bone marrow=
 for
treatment with Zynteglo. <o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal'><span style=3D'mso-bookmark:_Hlk512=
253721'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'mso-bo=
okmark:
_Hlk512253721'><span style=3D'font-family:"Times New Roman",serif'>You shou=
ld
discuss possible side effects due to the mobilisation medicines and
chemotherapy medicine with your doctor. You should also read the package
leaflets for these medicines.<o:p></o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk512253721'></span>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;tab-stops:0in'><b><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip'><b style=3D'mso-bidi-=
font-weight:
normal'><u><span style=3D'font-family:"Times New Roman",serif'>Mobilisation=
 and
blood stem cell collection<o:p></o:p></span></u></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-f=
amily:
"Times New Roman",serif'>Most of these side effects occur during or within a
few days after mobilisation and blood stem cell collection but can occur la=
ter.
Tell your doctor immediately if side effects become severe or serious. <o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip'><b style=3D'mso-bidi-=
font-weight:
normal'><span style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:=
p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip'><b style=3D'mso-bidi-=
font-weight:
normal'><span style=3D'font-family:"Times New Roman",serif'>Very common side
effects </span></b><span style=3D'font-family:"Times New Roman",serif'>(may
affect more than 1 in 10 people)<b style=3D'mso-bidi-font-weight:normal'><o=
:p></o:p></b></span></p>

<ul style=3D'margin-top:0in' type=3Ddisc>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l44 level1 lfo20'><a name=3D"_Hlk542621"><span
     style=3D'font-family:"Times New Roman",serif'>a low level of blood
     platelets, which may reduce the ability of blood to clot<b
     style=3D'mso-bidi-font-weight:normal'><o:p></o:p></b></span></a></li>
</ul>

<p class=3DMsoListParagraph style=3D'margin-top:0in;margin-right:-1.45pt;
margin-bottom:0in;margin-left:.5in;text-indent:-.25in;line-height:normal;
mso-list:l44 level1 lfo20'><span style=3D'mso-bookmark:_Hlk542621'><![if !s=
upportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>bone
pain<o:p></o:p></span></span></p>

<ul style=3D'margin-top:0in' type=3Ddisc>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l44 level1 lfo20'><span style=3D'mso-bookmark:_Hlk5426=
21'><span
     style=3D'font-family:"Times New Roman",serif'>numbness and pain in han=
ds and
     feet<o:p></o:p></span></span></li>
</ul>

<p class=3DMsoListParagraph style=3D'margin-top:0in;margin-right:-1.45pt;
margin-bottom:0in;margin-left:.5in;text-indent:-.25in;line-height:normal;
mso-list:l44 level1 lfo20'><span style=3D'mso-bookmark:_Hlk542621'><![if !s=
upportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>feeling
sick (nausea)<o:p></o:p></span></span></p>

<ul style=3D'margin-top:0in' type=3Ddisc>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l44 level1 lfo20'><span style=3D'mso-bookmark:_Hlk5426=
21'><span
     style=3D'font-family:"Times New Roman",serif'>headache<o:p></o:p></spa=
n></span></li>
</ul>

<p class=3DMsoListParagraph style=3D'margin-top:0in;margin-right:-1.45pt;
margin-bottom:0in;margin-left:.5in;text-indent:-.25in;line-height:normal;
mso-list:l44 level1 lfo20'><span style=3D'mso-bookmark:_Hlk542621'><![if !s=
upportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>low
blood calcium level<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal'><span style=3D'mso-bookmark:_Hlk542=
621'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal'><span style=3D'mso-bookmark:_Hlk542=
621'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times New=
 Roman",serif'>Common
side effects </span></b></span><span style=3D'mso-bookmark:_Hlk542621'><span
style=3D'font-family:"Times New Roman",serif'>(may affect up to 1 in 10 peo=
ple)<o:p></o:p></span></span></p>

<p class=3DMsoListParagraphCxSpFirst style=3D'margin-bottom:0in;mso-add-spa=
ce:auto;
text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><a name=3D"_Hlk540035"><![if !supportList=
s]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>bleeding
<o:p></o:p></span></a></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>low
oxygen level in blood <o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>low
blood pressure<o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>abdominal
pain<o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>back
pain<o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>bone
or muscle pain<o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>chest
pain or discomfort<o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>other
pain<o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>agitation
<o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>abnormal
blood test results (decrease in magnesium and potassium, too much citrate, =
or
increase in white blood cells)<o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>abnormal
heart rhythm <o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>bruising,
bleeding or pain from catheter or injection site<o:p></o:p></span></span></=
span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>injection
site reaction <o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>bruising<span
style=3D'mso-spacerun:yes'> </span><o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>dizziness,
tiredness<o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>head
discomfort<o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>excessive
sweating<o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>flu
like illness<o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>lip
swelling<o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>tingling
or numbness of the hands, feet, or mouth<o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>fever<o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>rash<o:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>enlarged
spleen which may result in pain in your upper left belly or left shoulder<o=
:p></o:p></span></span></span></p>

<p class=3DMsoListParagraphCxSpLast style=3D'margin-bottom:0in;mso-add-spac=
e:auto;
text-indent:-.25in;line-height:normal;mso-list:l29 level1 lfo22'><span
style=3D'mso-bookmark:_Hlk542621'><span style=3D'mso-bookmark:_Hlk540035'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>vomiting
</span></span></span><span style=3D'mso-bookmark:_Hlk542621'><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk542621'></span>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip'><b style=3D'mso-bidi-=
font-weight:
normal'><u><span style=3D'font-family:"Times New Roman",serif'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip'><b style=3D'mso-bidi-=
font-weight:
normal'><u><span style=3D'font-family:"Times New Roman",serif'>Chemotherapy
medicine<o:p></o:p></span></u></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip'><b style=3D'mso-bidi-=
font-weight:
normal'><span style=3D'font-family:"Times New Roman",serif'>Tell your doctor
immediately </span></b><span style=3D'font-family:"Times New Roman",serif'>=
if you
get any of the following side effects after receiving chemotherapy medicine.
They usually happen within the first few days and several weeks after recei=
ving
chemotherapy medicine, but can also develop much later.<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-f=
amily:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip'><b style=3D'mso-bidi-=
font-weight:
normal'><span style=3D'font-family:"Times New Roman",serif'>Very common </s=
pan></b><span
style=3D'font-family:"Times New Roman",serif'>(may affect more than 1 in 10
people)<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpFirst style=3D'margin-top:0in;margin-right:-=
1.45pt;
margin-bottom:0in;margin-left:.5in;mso-add-space:auto;text-indent:-.25in;
line-height:normal;mso-list:l15 level1 lfo21'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>Pain
in the right upper abdomen under the ribs, yellowing of eyes or skin, rapid
weight gain, swelling of arms, legs and abdomen, and trouble breathing. The=
se
may be signs of a serious liver condition called veno-occlusive disease.<o:=
p></o:p></span></p>

<p class=3DMsoListParagraphCxSpLast style=3D'margin-top:0in;margin-right:-1=
.45pt;
margin-bottom:0in;margin-left:.5in;mso-add-space:auto;text-indent:-.25in;
line-height:normal;mso-list:l15 level1 lfo21'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>Prolonged
bleeding or bleeding without injury such as nosebleeds, bleeding from gums,=
 or
vaginal bleeding.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal'><span style=3D'font-family:"Times N=
ew Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal'><b style=3D'mso-bidi-font-weight:no=
rmal'><span
style=3D'font-family:"Times New Roman",serif'>Other possible side effects<o=
:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal'><b style=3D'mso-bidi-font-weight:no=
rmal'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal'><span style=3D'font-family:"Times N=
ew Roman",serif'>Tell
your doctor immediately if side effects become severe or serious.<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip'><b style=3D'mso-bidi-=
font-weight:
normal'><span style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:=
p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip'><b style=3D'mso-bidi-=
font-weight:
normal'><span style=3D'font-family:"Times New Roman",serif'>Very common side
effects </span></b><span style=3D'font-family:"Times New Roman",serif'>(may
affect more than 1 in 10 people)<o:p></o:p></span></p>

<ul style=3D'margin-top:0in' type=3Ddisc>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l41 level1 lfo19'><a name=3D"_Hlk543255"><span
     style=3D'font-family:"Times New Roman",serif'>low level of red and whi=
te
     blood cells, sometimes with a fever<o:p></o:p></span></a></li>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l41 level1 lfo19'><span style=3D'mso-bookmark:_Hlk5432=
55'><span
     style=3D'font-family:"Times New Roman",serif'>increase of certain enzy=
mes in
     the blood which may indicate a problem with your liver<o:p></o:p></spa=
n></span></li>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l41 level1 lfo19'><span style=3D'mso-bookmark:_Hlk5432=
55'><span
     style=3D'font-family:"Times New Roman",serif'>a low level of blood
     platelets, which may reduce the ability of blood to clot<o:p></o:p></s=
pan></span></li>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l41 level1 lfo19'><span style=3D'mso-bookmark:_Hlk5432=
55'><span
     style=3D'font-family:"Times New Roman",serif'>unusual hair loss or thi=
nning<o:p></o:p></span></span></li>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l41 level1 lfo19'><span style=3D'mso-bookmark:_Hlk5432=
55'><span
     style=3D'font-family:"Times New Roman",serif'>stomach pain, constipati=
on,
     diarrhoea<b style=3D'mso-bidi-font-weight:normal'><o:p></o:p></b></spa=
n></span></li>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l41 level1 lfo19'><span style=3D'mso-bookmark:_Hlk5432=
55'><span
     style=3D'font-family:"Times New Roman",serif'>feeling sick (nausea), b=
eing
     sick (vomiting)<b style=3D'mso-bidi-font-weight:normal'><o:p></o:p></b=
></span></span></li>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l41 level1 lfo19'><span style=3D'mso-bookmark:_Hlk5432=
55'><span
     style=3D'font-family:"Times New Roman",serif'>fever<b style=3D'mso-bid=
i-font-weight:
     normal'><o:p></o:p></b></span></span></li>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l41 level1 lfo19'><span style=3D'mso-bookmark:_Hlk5432=
55'><span
     style=3D'font-family:"Times New Roman",serif'>soreness of the mouth<b
     style=3D'mso-bidi-font-weight:normal'><o:p></o:p></b></span></span></l=
i>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l41 level1 lfo19'><span style=3D'mso-bookmark:_Hlk5432=
55'><span
     style=3D'font-family:"Times New Roman",serif'>inflammation of the thro=
at<b
     style=3D'mso-bidi-font-weight:normal'><o:p></o:p></b></span></span></l=
i>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l41 level1 lfo19'><span style=3D'mso-bookmark:_Hlk5432=
55'><span
     style=3D'font-family:"Times New Roman",serif'>dark patches on skin<o:p=
></o:p></span></span></li>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l41 level1 lfo19'><span style=3D'mso-bookmark:_Hlk5432=
55'><span
     style=3D'font-family:"Times New Roman",serif'>soreness of the rectum a=
rea<b
     style=3D'mso-bidi-font-weight:normal'><o:p></o:p></b></span></span></l=
i>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l41 level1 lfo19'><span style=3D'mso-bookmark:_Hlk5432=
55'><span
     style=3D'font-family:"Times New Roman",serif'>trouble sleeping<o:p></o=
:p></span></span></li>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l41 level1 lfo19'><span style=3D'mso-bookmark:_Hlk5432=
55'><span
     style=3D'font-family:"Times New Roman",serif'>decreased appetite<o:p><=
/o:p></span></span></li>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l41 level1 lfo19'><span style=3D'mso-bookmark:_Hlk5432=
55'><span
     style=3D'font-family:"Times New Roman",serif'>headache<o:p></o:p></spa=
n></span></li>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l41 level1 lfo19'><span style=3D'mso-bookmark:_Hlk5432=
55'><span
     style=3D'font-family:"Times New Roman",serif'>tiredness<o:p></o:p></sp=
an></span></li>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l41 level1 lfo19'><span style=3D'mso-bookmark:_Hlk5432=
55'><span
     style=3D'font-family:"Times New Roman",serif'>itchy skin<o:p></o:p></s=
pan></span></li>
</ul>

<span style=3D'mso-bookmark:_Hlk543255'></span>

<p class=3DMsoListParagraph style=3D'margin-bottom:0in;mso-add-space:auto;
text-indent:-.25in;line-height:normal;mso-list:l41 level1 lfo19'><![if !sup=
portLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>soreness
and swelling of the digestive tract lining which runs from the mouth to the
anus<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:.5in;line-height:normal'><b style=3D'mso-bidi-font-weight:n=
ormal'><o:p>&nbsp;</o:p></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal'><b style=3D'mso-bidi-font-weight:no=
rmal'><span
style=3D'font-family:"Times New Roman",serif'>Common side effects </span></=
b><span
style=3D'font-family:"Times New Roman",serif'>(may affect up to 1 in 10 peo=
ple)<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpFirst style=3D'margin-bottom:0in;mso-add-spa=
ce:auto;
text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if !sup=
portLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>life-threatening
inflammatory response to an infection along with low white blood cell count=
<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>heart
failure<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>infections
which may make you feel warm, chilly, or sweaty<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>mass
in the lungs<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>enlarged
abdomen<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>enlarged
liver<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>difficulty
breathing <o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>abdominal
pain<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>bleeding
or bruising <o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>blood
in urine<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>yellowing
of eyes or skin<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>small
tear in tissue that lines the anus<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>dizziness,
or sensation of feeling off balance or like the room is spinning<o:p></o:p>=
</span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>memory
problems <o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>anxiety
<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>positive
test for Aspergillus (lung disease caused by fungus)<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>changes
and abnormalities in heart rhythm<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>pain,
including in back, bone, skin, limbs, anus, or muscles<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>vaginal
yeast infection<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>heartburn<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>inflammation
of the gallbladder<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>gallstones<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>cough<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>abnormal
sense of taste or loss of taste<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>difficulty
swallowing<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>swelling
of the face<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>feeling
cold<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>excess
water in the body<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>inflammation
or infection of hair follicles<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>decrease
in speed of air leaving your lungs<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>stomach
discomfort with nausea and vomiting<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>inflammation
in the digestive tract<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>gum
disease<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>piles
(haemorrhoids)<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>hiccups<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>low
blood pressure<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>low
body temperature<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>low
oxygen level in blood<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>pain
in mouth, throat or larynx (voice box)<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>lack
of energy<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>irregular
menstruation<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>loss
of function or decreased function of your ovaries or testes<o:p></o:p></spa=
n></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>premature
menopause <o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>spots
on skin from bleeding under the skin<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>skin
that is discoloured, blotchy, or darker or lighter than normal <o:p></o:p><=
/span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>fluid
in or around the lung<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>hot
flush<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>increased
frequency of urination<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>dry,
itchy skin <o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>dry
lips<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>rash
sometimes with lesions or pus <o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>inflamed
skin lesions<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>skin
abrasion/scrape<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>sweat
gland disorder<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>transfusion
reaction<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>weight
decreased<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>abnormal
liver tests<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>increased
concentration of haemoglobin in cells<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
lang=3DDE style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bi=
di-font-family:
Symbol;mso-ansi-language:DE'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;
</span></span></span><![endif]><span lang=3DDE style=3D'font-family:"Times =
New Roman",serif;
mso-ansi-language:DE'>changes in magnesium, calcium, potassium, phosphate,
albumin, protein, sodium in blood<o:p></o:p></span></p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-bottom:0in;mso-add-sp=
ace:
auto;text-indent:-.25in;line-height:normal;mso-list:l21 level1 lfo23'><![if=
 !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>increase
in blood test for inflammation</span><span lang=3DEN-GB style=3D'font-famil=
y:"Times New Roman",serif;
mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-bottom:0in;text-indent:-.25in;
line-height:normal;mso-list:l21 level1 lfo23'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>excess
acid in the body not removed by the kidneys<o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-bottom:0in;text-indent:-.25in;
line-height:normal;mso-list:l21 level1 lfo23'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>increase
or decrease in white blood cells<o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-bottom:0in;text-indent:-.25in;
line-height:normal;mso-list:l21 level1 lfo23'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>low
number of immature (not fully developed) red blood cells <o:p></o:p></span>=
</p>

<p class=3DMsoListParagraph style=3D'margin-bottom:0in;text-indent:-.25in;
line-height:normal;mso-list:l21 level1 lfo23'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>increase
in female hormones<o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-bottom:0in;text-indent:-.25in;
line-height:normal;mso-list:l21 level1 lfo23'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>decreased
testosterone<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal'><b><u><span style=3D'font-family:"T=
imes New Roman",serif'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;page-break-after:avoid'><b><u><span
style=3D'font-family:"Times New Roman",serif'>Zynteglo<o:p></o:p></span></u=
></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal'><span style=3D'font-family:"Times N=
ew Roman",serif;
mso-bidi-font-weight:bold'>Most side effects occur during or within a few d=
ays
after treatment with Zynteglo but can occur later. </span><span
style=3D'font-family:"Times New Roman",serif'>Tell your doctor immediately =
if
side effects become severe or serious.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip'><b><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip'><b><span
style=3D'font-family:"Times New Roman",serif'>Very common side effects </sp=
an></b><span
style=3D'font-family:"Times New Roman",serif'>(may affect more than 1 in 10
people)<o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-top:0in;margin-right:-1.45pt;
margin-bottom:0in;margin-left:.5in;text-indent:-.25in;line-height:normal;
mso-list:l26 level1 lfo33;tab-stops:0in'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol;mso-bidi-font-weight:bold'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>stomach
pain<b><o:p></o:p></b></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal'><b><span style=3D'font-family:"Time=
s New Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal'><b><span style=3D'font-family:"Time=
s New Roman",serif'>Common
side effects </span></b><span style=3D'font-family:"Times New Roman",serif'=
>(may
affect up to 1 in 10 people)<b><o:p></o:p></b></span></p>

<ul style=3D'margin-top:0in' type=3Ddisc>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l27 level1 lfo13'><span style=3D'font-family:"Times Ne=
w Roman",serif'>low
     level of blood platelets, which may reduce the ability of blood to clo=
t<o:p></o:p></span></li>
 <li class=3DMsoNormal style=3D'margin-right:-1.45pt;margin-bottom:0in;line=
-height:
     normal;mso-list:l27 level1 lfo13'><span style=3D'font-family:"Times Ne=
w Roman",serif'>low
     level of white blood cells<b style=3D'mso-bidi-font-weight:normal'><o:=
p></o:p></b></span></li>
</ul>

<p class=3DMsoListParagraph style=3D'margin-top:0in;margin-right:-1.45pt;
margin-bottom:0in;margin-left:.5in;text-indent:-.25in;line-height:normal;
mso-list:l27 level1 lfo13;tab-stops:0in'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>shortness
of breath<o:p></o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-top:0in;margin-right:-1.45pt;
margin-bottom:0in;margin-left:.5in;text-indent:-.25in;line-height:normal;
mso-list:l27 level1 lfo13;tab-stops:0in'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol;mso-bidi-font-weight:bold'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>chest
pain not due to a heart problem<b><o:p></o:p></b></span></p>

<p class=3DMsoListParagraph style=3D'margin-top:0in;margin-right:-1.45pt;
margin-bottom:0in;margin-left:.5in;text-indent:-.25in;line-height:normal;
mso-list:l27 level1 lfo13;tab-stops:0in'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>flushing
(redness and warmth of skin)<b style=3D'mso-bidi-font-weight:normal'><o:p><=
/o:p></b></span></p>

<p class=3DMsoListParagraph style=3D'margin-top:0in;margin-right:-1.45pt;
margin-bottom:0in;margin-left:.5in;text-indent:-.25in;line-height:normal;
mso-list:l27 level1 lfo13;tab-stops:0in'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>pain
in legs<b style=3D'mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>

<p class=3DMsoListParagraph style=3D'margin-top:0in;margin-right:-1.45pt;
margin-bottom:0in;margin-left:.5in;line-height:normal;tab-stops:0in'><b
style=3D'mso-bidi-font-weight:normal'><o:p>&nbsp;</o:p></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;page-break-after:avoid;mso-list:skip=
'><b><span
style=3D'font-family:"Times New Roman",serif'>Reporting of side effects</sp=
an></b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-f=
amily:
"Times New Roman",serif'>If you get any side effects, talk to your doctor or
nurse. This includes any possible side effects not listed in this leaflet. =
You
can also report side effects directly via <span style=3D'background:lightgr=
ey;
mso-highlight:lightgrey'>the national reporting system listed in </span></s=
pan><a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc"><span
style=3D'font-family:"Times New Roman",serif;background:lightgrey;mso-highl=
ight:
lightgrey;mso-fareast-language:EN-GB'>Appendix V</span></a><span
style=3D'font-family:"Times New Roman",serif;background:lightgrey;mso-highl=
ight:
lightgrey;mso-fareast-language:EN-GB'>.</span><span style=3D'font-family:"T=
imes New Roman",serif;
mso-fareast-language:EN-GB'> By reporting side effects you can help provide
more information on the safety of this medicine.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-f=
amily:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-f=
amily:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;mso-list:skip'>=
<b><span
style=3D'font-family:"Times New Roman",serif'>5.</span></b><span
style=3D'font-family:"Times New Roman",serif'><span style=3D'mso-tab-count:=
1'> </span><b>How
to store Zynteglo</b><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'>This information is intended for doctors only.<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'>As this medicine will be given by a qualified doct=
or,
they are responsible for the correct storage of the medicine before and dur=
ing
its use, as well as for its correct disposal. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'>Keep this medicine out of the sight and reach of
children. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'>Do not use this medicine after the expiry date whi=
ch
is stated on the outer container label(s) and infusion bag label(s).<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'>Store at &#8804;-140C for up to a year. Do not th=
aw
the product until it is ready to be used. Once thawed store at room tempera=
ture
(20C&#8209;25C) and use within 4 hours.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'>This medicine contains genetically-modified cells.
Unused medicine must be disposed of in compliance with the local guidelines=
 on
handling human-derived material. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><b><span
style=3D'font-family:"Times New Roman",serif'>6.</span></b><span
style=3D'font-family:"Times New Roman",serif'><span style=3D'mso-tab-count:=
1'> </span><b>Contents
of the pack and other information</b><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><b><span style=3D'font-fa=
mily:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><b><span style=3D'font-fa=
mily:
"Times New Roman",serif'>What Zynteglo contains </span></b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.25in;text-indent:-.25in;line-height:normal;mso-list:l37 level1=
 lfo11;
tab-stops:28.35pt'><![if !supportLists]><span style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman"'><span style=3D'mso-list:Ignore'>=
-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>The
active substance of Zynteglo consists of your own blood stem cells that con=
tain
functional copies of the beta-globin gene that can be measured in your bloo=
d.
The concentration is 1.2&#8209;20&nbsp;&nbsp;10<sup>6</sup>&nbsp;CD34<sup>=
+</sup>
cells (blood stem cells) per millilitre.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.25in;text-indent:-.25in;line-height:normal;mso-list:l37 level1=
 lfo11;
tab-stops:28.35pt'><![if !supportLists]><span style=3D'font-family:"Times N=
ew Roman",serif;
mso-fareast-font-family:"Times New Roman"'><span style=3D'mso-list:Ignore'>=
-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;
</span></span></span><![endif]><span style=3D'font-family:"Times New Roman"=
,serif'>The
other ingredients are a solution used to preserve frozen cells and sodium
chloride. See section 2, Sodium content.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><b><span style=3D'font-fa=
mily:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><b><span style=3D'font-fa=
mily:
"Times New Roman",serif'>What Zynteglo looks like and contents of the pack<=
/span></b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><a
name=3D"_Hlk511315491"><span style=3D'font-family:"Times New Roman",serif'>=
Zynteglo
is a clear to slightly cloudy, colourless to yellow or pink dispersion of c=
ells</span></a><span
style=3D'font-family:"Times New Roman",serif'> that is supplied in one or m=
ore
clear infusion bags, each packed in a transparent pouch inside a closed met=
al
container. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>Your name and date of birth, =
as
well as coded information identifying you as the patient, are printed onto =
each
infusion bag and each metal container.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><b><span style=3D'font-fa=
mily:
"Times New Roman",serif'>Marketing Authorisation Holder and Manufacturer</s=
pan></b><span
style=3D'font-family:"Times New Roman",serif'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>bluebird bio (Netherlands)
B.V.&nbsp;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DNL style=3D'font-family:"Times New Roman",serif;mso-ansi-language:NL=
'>Stadsplateau
7&nbsp;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DNL style=3D'font-family:"Times New Roman",serif;mso-ansi-language:NL=
'>WTC
Utrecht&nbsp;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DNL style=3D'font-family:"Times New Roman",serif;mso-ansi-language:NL=
'>3521AZ
Utrecht&nbsp;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
lang=3DNL style=3D'font-family:"Times New Roman",serif;mso-ansi-language:NL=
'>The
Netherlands&nbsp;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><a
href=3D"mailto:medinfo@bluebirdbio.com"><span lang=3DPT style=3D'font-famil=
y:"Times New Roman",serif;
mso-ansi-language:PT'>medinfo@bluebirdbio.com</span></a><span lang=3DPT
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:PT'><o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span l=
ang=3DPT
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:PT'><o:p>&nb=
sp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><b><span lang=3DPT
style=3D'font-family:"Times New Roman",serif;mso-ansi-language:PT'>Manufact=
urer</span></b><span
lang=3DPT style=3D'font-family:"Times New Roman",serif;mso-ansi-language:PT=
'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
lang=3DPT style=3D'font-family:"Times New Roman",serif;mso-ansi-language:PT=
'>Minaris
Regenerative Medicine GmbH <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Haidgraben 5<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>85521 Ottobrunn<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Germany<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'>For any information about this medicine, please
contact the local representative of the Marketing Authorisation Holder:<span
style=3D'color:red'> </span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-stop=
s:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D0 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D624
 style=3D'margin-left:-1.7pt;border-collapse:collapse;mso-table-layout-alt:=
fixed;
 mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-st=
ops:
  28.35pt'><a name=3D"_Hlk1050692"><b><span lang=3DDE style=3D'font-family:=
"Times New Roman",serif;
  mso-ansi-language:DE'>Deutschland</span></b></a><span style=3D'mso-bookma=
rk:
  _Hlk1050692'><span lang=3DDE style=3D'font-family:"Times New Roman",serif;
  mso-ansi-language:DE'><o:p></o:p></span></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-st=
ops:
  28.35pt'><span style=3D'mso-bookmark:_Hlk1050692'><span lang=3DDE
  style=3D'font-family:"Times New Roman",serif;mso-ansi-language:DE'>bluebi=
rd bio
  (Germany) GmbH<o:p></o:p></span></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-st=
ops:
  28.35pt'><span style=3D'mso-bookmark:_Hlk1050692'><span lang=3DDE
  style=3D'font-family:"Times New Roman",serif;mso-ansi-language:DE'>Tel: +=
49 (0)
  893 803 7456 (0800 181 0702)<o:p></o:p></span></span></p>
  <span style=3D'mso-bookmark:_Hlk1050692'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-st=
ops:
  28.35pt'><span style=3D'mso-bookmark:_Hlk1050692'><span lang=3DDE
  style=3D'font-family:"Times New Roman",serif;mso-ansi-language:DE'><o:p>&=
nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk1050692'></span>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk1050692'><b style=3D'mso-bidi-font-weight:norma=
l'><span
  lang=3DES style=3D'font-family:"Times New Roman",serif;mso-ansi-language:=
ES'>Italia</span></b></span><span
  style=3D'mso-bookmark:_Hlk1050692'><span lang=3DES style=3D'font-family:"=
Times New Roman",serif;
  mso-ansi-language:ES'><o:p></o:p></span></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk1050692'><span lang=3DES style=3D'font-family:"=
Times New Roman",serif;
  mso-ansi-language:ES'>bluebird bio (Italy) S.r.l.<o:p></o:p></span></span=
></p>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hy=
phenate:
  none;tab-stops:28.35pt'><span style=3D'mso-bookmark:_Hlk1050692'><span la=
ng=3DDE
  style=3D'font-family:"Times New Roman",serif;mso-ansi-language:DE'>Tel: <=
/span></span><span
  style=3D'mso-bookmark:_Hlk1050692'><span style=3D'font-family:"Times New =
Roman",serif'>+39
  029 475 9755 (800 728 026)<o:p></o:p></span></span></p>
  <span style=3D'mso-bookmark:_Hlk1050692'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hy=
phenate:
  none;tab-stops:28.35pt'><span style=3D'mso-bookmark:_Hlk1050692'><span la=
ng=3DNL
  style=3D'font-family:"Times New Roman",serif;mso-ansi-language:NL'><o:p>&=
nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk1050692'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hy=
phenate:
  none;tab-stops:-.5in 28.35pt 3.15in'><span style=3D'mso-bookmark:_Hlk1050=
692'><b><span
  style=3D'font-family:"Times New Roman",serif'>France</span></b></span><sp=
an
  style=3D'mso-bookmark:_Hlk1050692'><span style=3D'font-family:"Times New =
Roman",serif'><o:p></o:p></span></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hy=
phenate:
  none;tab-stops:-.5in 28.35pt'><span style=3D'mso-bookmark:_Hlk1050692'><s=
pan
  style=3D'font-family:"Times New Roman",serif'>bluebird bio <span
  style=3D'mso-bidi-font-weight:bold'>(</span>France<span style=3D'mso-bidi=
-font-weight:
  bold'>)</span> SAS<o:p></o:p></span></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-st=
ops:
  28.35pt;mso-layout-grid-align:none;text-autospace:none'><span
  style=3D'mso-bookmark:_Hlk1050692'><span style=3D'font-family:"Times New =
Roman",serif'>Tl:
  +33 (0)1 85 14 97 89 (0800 914 510)<o:p></o:p></span></span></p>
  <span style=3D'mso-bookmark:_Hlk1050692'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-st=
ops:
  28.35pt;mso-layout-grid-align:none;text-autospace:none'><span
  style=3D'mso-bookmark:_Hlk1050692'><span lang=3DEN-GB style=3D'font-famil=
y:"Times New Roman",serif;
  mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk1050692'></span>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hy=
phenate:
  none;tab-stops:-.5in 28.35pt'><span style=3D'mso-bookmark:_Hlk1050692'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DNL style=3D'font-famil=
y:"Times New Roman",serif;
  mso-ansi-language:NL'>Nederland</span></b></span><span style=3D'mso-bookm=
ark:
  _Hlk1050692'><span lang=3DNL style=3D'font-family:"Times New Roman",serif;
  mso-ansi-language:NL'><o:p></o:p></span></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hy=
phenate:
  none;tab-stops:-.5in 28.35pt'><span style=3D'mso-bookmark:_Hlk1050692'><s=
pan
  lang=3DNL style=3D'font-family:"Times New Roman",serif;mso-ansi-language:=
NL'>bluebird
  bio (Netherlands) B.V.<o:p></o:p></span></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hy=
phenate:
  none;tab-stops:-.5in 28.35pt'><span style=3D'mso-bookmark:_Hlk1050692'><s=
pan
  style=3D'font-family:"Times New Roman",serif'>Tel: +</span></span><span
  style=3D'mso-bookmark:_Hlk1050692'><span lang=3DDE style=3D'font-family:"=
Times New Roman",serif;
  mso-ansi-language:DE'>31 (0) 303 100 450</span></span><span style=3D'mso-=
bookmark:
  _Hlk1050692'><span style=3D'font-family:"Times New Roman",serif'><o:p></o=
:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk1050692'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:2;mso-yfti-lastrow:yes'>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk1050692'><b><span style=3D'font-family:"Times N=
ew Roman",serif'>Belgi/Belgique/Belgien,
  &#1041;&#1098;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;, &#268;esk
  republika, Danmark, Eesti, &#917;&#955;&#955;&#940;&#948;&#945;, Espaa, =
</span></b></span><span
  style=3D'mso-bookmark:_Hlk1050692'><b style=3D'mso-bidi-font-weight:norma=
l'><span
  style=3D'font-family:"Times New Roman",serif'>Hrvatska, Ireland, sland,
  &#922;&#973;&#960;&#961;&#959;&#962;, Latvija, <span style=3D'mso-bidi-fo=
nt-weight:
  bold'>Lietuva, Luxembourg/Luxemburg, Magyarorszg, Malta, Norge, sterrei=
ch,
  Polska, Portugal, </span>Romnia, Slovenija, Slovensk republika,
  Suomi/Finland, Sverige<o:p></o:p></span></b></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hy=
phenate:
  none;tab-stops:-.5in 28.35pt'><span style=3D'mso-bookmark:_Hlk1050692'><s=
pan
  style=3D'font-family:"Times New Roman",serif'>bluebird bio (Netherlands) =
B.V.<o:p></o:p></span></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hy=
phenate:
  none;tab-stops:-.5in 3.15in'><span style=3D'mso-bookmark:_Hlk1050692'><sp=
an
  style=3D'font-family:"Times New Roman",serif'>Tl/Tel/Te&#1083;/Tlf/&#932=
;&#951;&#955;/Smi/Puh:
  <o:p></o:p></span></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hy=
phenate:
  none;tab-stops:-.5in 3.15in'><span style=3D'mso-bookmark:_Hlk1050692'><sp=
an
  style=3D'font-family:"Times New Roman",serif'>+31 (0) </span></span><span
  style=3D'mso-bookmark:_Hlk1050692'><span lang=3DDE style=3D'font-family:"=
Times New Roman",serif;
  mso-ansi-language:DE'>303 100 450<o:p></o:p></span></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hy=
phenate:
  none;tab-stops:-.5in 28.35pt'><span style=3D'mso-bookmark:_Hlk1050692'></=
span><a
  href=3D"mailto:medinfo@bluebirdbio.com"><span style=3D'mso-bookmark:_Hlk1=
050692'><span
  lang=3DDE style=3D'font-family:"Times New Roman",serif;mso-ansi-language:=
DE'>medinfo@bluebirdbio.com</span></span></a><span
  style=3D'mso-bookmark:_Hlk1050692'><span lang=3DDE style=3D'font-family:"=
Times New Roman",serif;
  mso-ansi-language:DE'><span style=3D'mso-spacerun:yes'> </span><o:p></o:=
p></span></span></p>
  <span style=3D'mso-bookmark:_Hlk1050692'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hy=
phenate:
  none;tab-stops:-.5in 28.35pt'><span style=3D'mso-bookmark:_Hlk1050692'><s=
pan
  lang=3DDE style=3D'font-family:"Times New Roman",serif;mso-ansi-language:=
DE'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk1050692'></span>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hy=
phenate:
  none;tab-stops:-.5in 3.15in'><span style=3D'mso-bookmark:_Hlk1050692'><b
  style=3D'mso-bidi-font-weight:normal'><span style=3D'font-family:"Times N=
ew Roman",serif'>United
  Kingdom<o:p></o:p></span></b></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
  style=3D'mso-bookmark:_Hlk1050692'><span style=3D'font-family:"Times New =
Roman",serif'>bluebird
  bio (UK) Limited<o:p></o:p></span></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hy=
phenate:
  none;tab-stops:-.5in'><span style=3D'mso-bookmark:_Hlk1050692'><span
  style=3D'font-family:"Times New Roman",serif'>Tel: +44 (0) 207 660 0754<o=
:p></o:p></span></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hy=
phenate:
  none;tab-stops:-.5in'><span style=3D'mso-bookmark:_Hlk1050692'><span
  style=3D'font-family:"Times New Roman",serif'><span
  style=3D'mso-spacerun:yes'></span>(0800-069-8046)<o:p></o:p></span></spa=
n></p>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-hy=
phenate:
  none;tab-stops:-.5in'><span style=3D'mso-bookmark:_Hlk1050692'><span
  style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></s=
pan></p>
  <span style=3D'mso-bookmark:_Hlk1050692'></span>
  <p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;tab-st=
ops:
  28.35pt'><span style=3D'mso-bookmark:_Hlk1050692'><span style=3D'font-fam=
ily:
  "Times New Roman",serif'><o:p>&nbsp;</o:p></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk1050692'></span>
 </tr>
</table>

<span style=3D'mso-bookmark:_Hlk1050692'></span>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-outline-level:1;mso-list:skip'><b><s=
pan
style=3D'font-family:"Times New Roman",serif'>This leaflet was last revised=
 in
&lt;</span></b><span style=3D'font-family:"Times New Roman",serif'>{<b>MM/Y=
YYY</b>}&gt;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>This medicine has been given
conditional approval. This means that there is more evidence to come about
this medicine. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>The European Medicines Agency=
 will
review new information on this medicine at least every year and this leaflet
will be updated as necessary.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'>Detailed information on this
medicine is available on the European Medicines Agency web site: </span><sp=
an
style=3D'mso-field-code:" HYPERLINK "'><u><span lang=3DEN-GB style=3D'font-=
family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";color:blu=
e;
mso-ansi-language:EN-GB'>http://www.ema.europa.eu</span></u></span><span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;mso-fareast-font-=
family:
"Times New Roman";mso-ansi-language:EN-GB'>&lt;, and on the website of {nam=
e of
MS Agency (link)}&gt;.</span><span style=3D'font-family:"Times New Roman",s=
erif'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'>This leaflet is available in =
all
EU/EEA languages on the European Medicines Agency website.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:0in;line-height:normal;mso-list:skip'><span style=3D'font-famil=
y:
"Times New Roman",serif'>--------------------------------------------------=
---------------------------------------------------------------<o:p></o:p><=
/span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:0in;line-height:normal;mso-list:skip;tab-stops:28.35pt 132.=
85pt'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:-2.0pt;line-height:normal;page-break-after:avoid;mso-list:s=
kip;
tab-stops:28.35pt 132.85pt'><b><span style=3D'font-family:"Times New Roman"=
,serif'>The
following information is intended for healthcare professionals only: <o:p><=
/o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:-2.0pt;line-height:normal;page-break-after:avoid;mso-list:s=
kip;
tab-stops:28.35pt 132.85pt'><span style=3D'font-family:"Times New Roman",se=
rif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Zynteglo is shipped from the
manufacturing facility to the infusion centre storage facility in a
cryoshipper, which may contain multiple metal cassettes intended for a sing=
le
patient. Each metal cassette contains one infusion bag with Zynteglo. A pat=
ient
may have multiple infusion bags. The infusion bag(s) must be kept inside the
metal cassette(s) until ready to thaw and use.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Confirm that Zynteglo is prin=
ted on
the infusion bag(s). Confirm that patient identity matches the unique patie=
nt
information located on the infusion bag(s) and metal cassette(s) prior to
infusion.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Account for all infusion bags=
 and
confirm each infusion bag of Zynteglo is within the expiry date using the
accompanying Lot Information Sheet. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Inspect each infusion bag for=
 any
breaches of integrity before thawing and infusion. If an infusion bag is
compromised, follow the local guidelines on handling human-derived material=
 and
contact bluebird bio immediately.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Zynteglo is intended solely f=
or
autologous use. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>After carefully removing the =
outer
metal container, thaw each infusion bag at 37C in a water bath or dry bath=
 for
approximately 2&#8209;4&nbsp;minutes. Do not overthaw the medicinal product=
. Do
not leave the medicinal product unattended and do not submerge the infusion
ports if thawed in a water bath. After thaw, mix the medicinal product gent=
ly
by massaging the infusion bag until all of the contents are uniform. Expose=
 the
sterile port on the infusion bag by tearing off the protective wrap covering
the port. Access the infusion bag and infuse per the administration sites
standard procedures for administration of cell therapy products. Do not use=
 an
in-line blood filter or an infusion pump. Do not sample, alter, or irradiate
the medicinal product. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Administer each infusion bag =
via
intravenous infusion over a period of less than 30&nbsp;minutes. If more th=
an
one infusion bag is provided, administer each infusion bag completely before
proceeding to thaw and infuse the next bag. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Zynteglo must not be re&#8209=
;frozen.
Infuse as soon as possible and no more than 4&nbsp;hours after thawing. <o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Flush all Zynteglo remaining =
in the
infusion bag and any associated tubing with at least 50&nbsp;mL of 0.9% sod=
ium
chloride solution to ensure as many cells as possible are infused into the
patient.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>This medicinal product contai=
ns
genetically-modified cells. Local guidelines on handling and waste of human=
-derived
material applicable for such products should be followed.<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Healthcare professionals hand=
ling
Zynteglo should take standard precautions (wearing gloves, protective cloth=
ing
and eye protection) to avoid potential transmission of infectious diseases.=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'>Work surfaces and material wh=
ich
have potentially been in contact with Zynteglo must be decontaminated with a
viricidal disinfectant according to the manufacturer's instructions. <o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal;mso-list=
:skip'><span
style=3D'font-family:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

</div>

</body>

</html>

------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean_files/item0001.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"utf-8"?><LongProperties xmlns=3D"http://s=
chemas.microsoft.com/office/2006/metadata/longProperties"/>
------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean_files/props002.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{0190AF2E-4F56-4548-81B3-A60EEB45ACA0}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.microsoft.com/office/20=
06/metadata/longProperties"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean_files/item0003.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?><b:Sources Sele=
ctedStyle=3D"\APASixthEditionOfficeOnline.xsl" StyleName=3D"APA" Version=3D=
"6" xmlns=3D"http://schemas.openxmlformats.org/officeDocument/2006/bibliogr=
aphy" xmlns:b=3D"http://schemas.openxmlformats.org/officeDocument/2006/bibl=
iography"></b:Sources>
------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean_files/props004.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{CA23CC72-9C05-42DD-9110-0C93062F75F6}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.openxmlformats.org/offi=
ceDocument/2006/bibliography"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean_files/item0005.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"utf-8"?><p:properties xmlns:p=3D"http://s=
chemas.microsoft.com/office/2006/metadata/properties" xmlns:xsi=3D"http://w=
ww.w3.org/2001/XMLSchema-instance" xmlns:pc=3D"http://schemas.microsoft.com=
/office/infopath/2007/PartnerControls"><documentManagement><SharedWithUsers=
 xmlns=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9"><UserInfo><DisplayName>Anne=
-Virginie Eggimann</DisplayName><AccountId>106</AccountId><AccountType/></U=
serInfo><UserInfo><DisplayName>Jessie Hanrahan</DisplayName><AccountId>795<=
/AccountId><AccountType/></UserInfo><UserInfo><DisplayName>Fran Smith</Disp=
layName><AccountId>199</AccountId><AccountType/></UserInfo><UserInfo><Displ=
ayName>Barb Morollo</DisplayName><AccountId>273</AccountId><AccountType/></=
UserInfo><UserInfo><DisplayName>Mohammed Asmal</DisplayName><AccountId>258<=
/AccountId><AccountType/></UserInfo><UserInfo><DisplayName>Weiliang Shi</Di=
splayName><AccountId>890</AccountId><AccountType/></UserInfo></SharedWithUs=
ers></documentManagement></p:properties>
------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean_files/props006.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{12AECD07-F387-4733-8088-E73871C78D86}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.microsoft.com/office/20=
06/metadata/properties"/><ds:schemaRef ds:uri=3D"http://schemas.microsoft.c=
om/office/infopath/2007/PartnerControls"/><ds:schemaRef ds:uri=3D"0ac2e3cc-=
46bd-4320-b2ac-d7f7d167e1a9"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean_files/item0007.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"utf-8"?><FormTemplates xmlns=3D"http://sc=
hemas.microsoft.com/sharepoint/v3/contenttype/forms"><Display>DocumentLibra=
ryForm</Display><Edit>DocumentLibraryForm</Edit><New>DocumentLibraryForm</N=
ew></FormTemplates>
------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean_files/props008.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{D8EC0FF5-1591-4CFB-96E8-40BCBDEA307F}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.microsoft.com/sharepoin=
t/v3/contenttype/forms"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean_files/item0009.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"utf-8"?><ct:contentTypeSchema ct:_=3D"" m=
a:_=3D"" ma:contentTypeName=3D"Document" ma:contentTypeID=3D"0x010100726F91=
DD1AE57B44B1BCEB7F1056F5D0" ma:contentTypeVersion=3D"6" ma:contentTypeDescr=
iption=3D"Create a new document." ma:contentTypeScope=3D"" ma:versionID=3D"=
80d1dd17cb0c17b7740334051d5d16b2" xmlns:ct=3D"http://schemas.microsoft.com/=
office/2006/metadata/contentType" xmlns:ma=3D"http://schemas.microsoft.com/=
office/2006/metadata/properties/metaAttributes">
<xsd:schema targetNamespace=3D"http://schemas.microsoft.com/office/2006/met=
adata/properties" ma:root=3D"true" ma:fieldsID=3D"c170dc105f61f60cf84b7b3e6=
d807e4f" ns2:_=3D"" ns3:_=3D"" xmlns:xsd=3D"http://www.w3.org/2001/XMLSchem=
a" xmlns:xs=3D"http://www.w3.org/2001/XMLSchema" xmlns:p=3D"http://schemas.=
microsoft.com/office/2006/metadata/properties" xmlns:ns2=3D"a6a35199-84b7-4=
ca5-aa1c-39e9ca4c46ff" xmlns:ns3=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9">
<xsd:import namespace=3D"a6a35199-84b7-4ca5-aa1c-39e9ca4c46ff"/>
<xsd:import namespace=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9"/>
<xsd:element name=3D"properties">
<xsd:complexType>
<xsd:sequence>
<xsd:element name=3D"documentManagement">
<xsd:complexType>
<xsd:all>
<xsd:element ref=3D"ns2:MediaServiceMetadata" minOccurs=3D"0"/>
<xsd:element ref=3D"ns2:MediaServiceFastMetadata" minOccurs=3D"0"/>
<xsd:element ref=3D"ns2:MediaServiceAutoKeyPoints" minOccurs=3D"0"/>
<xsd:element ref=3D"ns2:MediaServiceKeyPoints" minOccurs=3D"0"/>
<xsd:element ref=3D"ns3:SharedWithUsers" minOccurs=3D"0"/>
<xsd:element ref=3D"ns3:SharedWithDetails" minOccurs=3D"0"/>
</xsd:all>
</xsd:complexType>
</xsd:element>
</xsd:sequence>
</xsd:complexType>
</xsd:element>
</xsd:schema>
<xsd:schema targetNamespace=3D"a6a35199-84b7-4ca5-aa1c-39e9ca4c46ff" elemen=
tFormDefault=3D"qualified" xmlns:xsd=3D"http://www.w3.org/2001/XMLSchema" x=
mlns:xs=3D"http://www.w3.org/2001/XMLSchema" xmlns:dms=3D"http://schemas.mi=
crosoft.com/office/2006/documentManagement/types" xmlns:pc=3D"http://schema=
s.microsoft.com/office/infopath/2007/PartnerControls">
<xsd:import namespace=3D"http://schemas.microsoft.com/office/2006/documentM=
anagement/types"/>
<xsd:import namespace=3D"http://schemas.microsoft.com/office/infopath/2007/=
PartnerControls"/>
<xsd:element name=3D"MediaServiceMetadata" ma:index=3D"8" nillable=3D"true"=
 ma:displayName=3D"MediaServiceMetadata" ma:hidden=3D"true" ma:internalName=
=3D"MediaServiceMetadata" ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note"/>
</xsd:simpleType>
</xsd:element>
<xsd:element name=3D"MediaServiceFastMetadata" ma:index=3D"9" nillable=3D"t=
rue" ma:displayName=3D"MediaServiceFastMetadata" ma:hidden=3D"true" ma:inte=
rnalName=3D"MediaServiceFastMetadata" ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note"/>
</xsd:simpleType>
</xsd:element>
<xsd:element name=3D"MediaServiceAutoKeyPoints" ma:index=3D"10" nillable=3D=
"true" ma:displayName=3D"MediaServiceAutoKeyPoints" ma:hidden=3D"true" ma:i=
nternalName=3D"MediaServiceAutoKeyPoints" ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note"/>
</xsd:simpleType>
</xsd:element>
<xsd:element name=3D"MediaServiceKeyPoints" ma:index=3D"11" nillable=3D"tru=
e" ma:displayName=3D"KeyPoints" ma:internalName=3D"MediaServiceKeyPoints" m=
a:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note">
<xsd:maxLength value=3D"255"/>
</xsd:restriction>
</xsd:simpleType>
</xsd:element>
</xsd:schema>
<xsd:schema targetNamespace=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9" elemen=
tFormDefault=3D"qualified" xmlns:xsd=3D"http://www.w3.org/2001/XMLSchema" x=
mlns:xs=3D"http://www.w3.org/2001/XMLSchema" xmlns:dms=3D"http://schemas.mi=
crosoft.com/office/2006/documentManagement/types" xmlns:pc=3D"http://schema=
s.microsoft.com/office/infopath/2007/PartnerControls">
<xsd:import namespace=3D"http://schemas.microsoft.com/office/2006/documentM=
anagement/types"/>
<xsd:import namespace=3D"http://schemas.microsoft.com/office/infopath/2007/=
PartnerControls"/>
<xsd:element name=3D"SharedWithUsers" ma:index=3D"12" nillable=3D"true" ma:=
displayName=3D"Shared With" ma:internalName=3D"SharedWithUsers" ma:readOnly=
=3D"true">
<xsd:complexType>
<xsd:complexContent>
<xsd:extension base=3D"dms:UserMulti">
<xsd:sequence>
<xsd:element name=3D"UserInfo" minOccurs=3D"0" maxOccurs=3D"unbounded">
<xsd:complexType>
<xsd:sequence>
<xsd:element name=3D"DisplayName" type=3D"xsd:string" minOccurs=3D"0"/>
<xsd:element name=3D"AccountId" type=3D"dms:UserId" minOccurs=3D"0" nillabl=
e=3D"true"/>
<xsd:element name=3D"AccountType" type=3D"xsd:string" minOccurs=3D"0"/>
</xsd:sequence>
</xsd:complexType>
</xsd:element>
</xsd:sequence>
</xsd:extension>
</xsd:complexContent>
</xsd:complexType>
</xsd:element>
<xsd:element name=3D"SharedWithDetails" ma:index=3D"13" nillable=3D"true" m=
a:displayName=3D"Shared With Details" ma:internalName=3D"SharedWithDetails"=
 ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note">
<xsd:maxLength value=3D"255"/>
</xsd:restriction>
</xsd:simpleType>
</xsd:element>
</xsd:schema>
<xsd:schema targetNamespace=3D"http://schemas.openxmlformats.org/package/20=
06/metadata/core-properties" elementFormDefault=3D"qualified" attributeForm=
Default=3D"unqualified" blockDefault=3D"#all" xmlns=3D"http://schemas.openx=
mlformats.org/package/2006/metadata/core-properties" xmlns:xsd=3D"http://ww=
w.w3.org/2001/XMLSchema" xmlns:xsi=3D"http://www.w3.org/2001/XMLSchema-inst=
ance" xmlns:dc=3D"http://purl.org/dc/elements/1.1/" xmlns:dcterms=3D"http:/=
/purl.org/dc/terms/" xmlns:odoc=3D"http://schemas.microsoft.com/internal/ob=
d">
<xsd:import namespace=3D"http://purl.org/dc/elements/1.1/" schemaLocation=
=3D"http://dublincore.org/schemas/xmls/qdc/2003/04/02/dc.xsd"/>
<xsd:import namespace=3D"http://purl.org/dc/terms/" schemaLocation=3D"http:=
//dublincore.org/schemas/xmls/qdc/2003/04/02/dcterms.xsd"/>
<xsd:element name=3D"coreProperties" type=3D"CT_coreProperties"/>
<xsd:complexType name=3D"CT_coreProperties">
<xsd:all>
<xsd:element ref=3D"dc:creator" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element ref=3D"dcterms:created" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element ref=3D"dc:identifier" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"contentType" minOccurs=3D"0" maxOccurs=3D"1" type=3D"x=
sd:string" ma:index=3D"0" ma:displayName=3D"Content Type"/>
<xsd:element ref=3D"dc:title" minOccurs=3D"0" maxOccurs=3D"1" ma:index=3D"4=
" ma:displayName=3D"Title"/>
<xsd:element ref=3D"dc:subject" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element ref=3D"dc:description" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"keywords" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:=
string"/>
<xsd:element ref=3D"dc:language" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"category" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:=
string"/>
<xsd:element name=3D"version" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:s=
tring"/>
<xsd:element name=3D"revision" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:=
string">
<xsd:annotation>
<xsd:documentation>
                        This value indicates the number of saves or revisio=
ns. The application is responsible for updating this value after each revis=
ion.
                    </xsd:documentation>
</xsd:annotation>
</xsd:element>
<xsd:element name=3D"lastModifiedBy" minOccurs=3D"0" maxOccurs=3D"1" type=
=3D"xsd:string"/>
<xsd:element ref=3D"dcterms:modified" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"contentStatus" minOccurs=3D"0" maxOccurs=3D"1" type=3D=
"xsd:string"/>
</xsd:all>
</xsd:complexType>
</xsd:schema>
<xs:schema targetNamespace=3D"http://schemas.microsoft.com/office/infopath/=
2007/PartnerControls" elementFormDefault=3D"qualified" attributeFormDefault=
=3D"unqualified" xmlns:pc=3D"http://schemas.microsoft.com/office/infopath/2=
007/PartnerControls" xmlns:xs=3D"http://www.w3.org/2001/XMLSchema">
<xs:element name=3D"Person">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:DisplayName" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:AccountId" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:AccountType" minOccurs=3D"0"></xs:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"DisplayName" type=3D"xs:string"></xs:element>
<xs:element name=3D"AccountId" type=3D"xs:string"></xs:element>
<xs:element name=3D"AccountType" type=3D"xs:string"></xs:element>
<xs:element name=3D"BDCAssociatedEntity">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:BDCEntity" minOccurs=3D"0" maxOccurs=3D"unbounded"></=
xs:element>
</xs:sequence>
<xs:attribute ref=3D"pc:EntityNamespace"></xs:attribute>
<xs:attribute ref=3D"pc:EntityName"></xs:attribute>
<xs:attribute ref=3D"pc:SystemInstanceName"></xs:attribute>
<xs:attribute ref=3D"pc:AssociationName"></xs:attribute>
</xs:complexType>
</xs:element>
<xs:attribute name=3D"EntityNamespace" type=3D"xs:string"></xs:attribute>
<xs:attribute name=3D"EntityName" type=3D"xs:string"></xs:attribute>
<xs:attribute name=3D"SystemInstanceName" type=3D"xs:string"></xs:attribute>
<xs:attribute name=3D"AssociationName" type=3D"xs:string"></xs:attribute>
<xs:element name=3D"BDCEntity">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:EntityDisplayName" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityInstanceReference" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId1" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId2" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId3" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId4" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId5" minOccurs=3D"0"></xs:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"EntityDisplayName" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityInstanceReference" type=3D"xs:string"></xs:elemen=
t>
<xs:element name=3D"EntityId1" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId2" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId3" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId4" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId5" type=3D"xs:string"></xs:element>
<xs:element name=3D"Terms">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:TermInfo" minOccurs=3D"0" maxOccurs=3D"unbounded"></x=
s:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"TermInfo">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:TermName" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:TermId" minOccurs=3D"0"></xs:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"TermName" type=3D"xs:string"></xs:element>
<xs:element name=3D"TermId" type=3D"xs:string"></xs:element>
</xs:schema>
</ct:contentTypeSchema>
------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean_files/props010.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{30BCAF30-DF6D-4B03-8C77-03FBBC6BB762}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.microsoft.com/office/20=
06/metadata/contentType"/><ds:schemaRef ds:uri=3D"http://schemas.microsoft.=
com/office/2006/metadata/properties/metaAttributes"/><ds:schemaRef ds:uri=
=3D"http://www.w3.org/2001/XMLSchema"/><ds:schemaRef ds:uri=3D"http://schem=
as.microsoft.com/office/2006/metadata/properties"/><ds:schemaRef ds:uri=3D"=
a6a35199-84b7-4ca5-aa1c-39e9ca4c46ff"/><ds:schemaRef ds:uri=3D"0ac2e3cc-46b=
d-4320-b2ac-d7f7d167e1a9"/><ds:schemaRef ds:uri=3D"http://schemas.microsoft=
.com/office/2006/documentManagement/types"/><ds:schemaRef ds:uri=3D"http://=
schemas.microsoft.com/office/infopath/2007/PartnerControls"/><ds:schemaRef =
ds:uri=3D"http://schemas.openxmlformats.org/package/2006/metadata/core-prop=
erties"/><ds:schemaRef ds:uri=3D"http://purl.org/dc/elements/1.1/"/><ds:sch=
emaRef ds:uri=3D"http://purl.org/dc/terms/"/><ds:schemaRef ds:uri=3D"http:/=
/schemas.microsoft.com/internal/obd"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean_files/themedata.thmx
Content-Transfer-Encoding: base64
Content-Type: application/vnd.ms-officetheme
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------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean_files/colorschememapping.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"yes"?>
<a:clrMap xmlns:a=3D"http://schemas.openxmlformats.org/drawingml/2006/main"=
 bg1=3D"lt1" tx1=3D"dk1" bg2=3D"lt2" tx2=3D"dk2" accent1=3D"accent1" accent=
2=3D"accent2" accent3=3D"accent3" accent4=3D"accent4" accent5=3D"accent5" a=
ccent6=3D"accent6" hlink=3D"hlink" folHlink=3D"folHlink"/>
------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean_files/image001.png
Content-Transfer-Encoding: base64
Content-Type: image/png

iVBORw0KGgoAAAANSUhEUgAAAC4AAAAsCAYAAAAacYo8AAAAAXNSR0IArs4c6QAAAARnQU1BAACx
jwv8YQUAAAAJcEhZcwAAIdUAACHVAQSctJ0AAADsSURBVGhD1c5LCsIwFEbhogsQXJcTd+rAbQnO
FfTGgVQ8xqa5rxz4Rk2Tf5Ieg3pFHzJ7Rx8z+4gOZPQVHcoIo4OZ/IwOZ1KNfsjgb3dBP0a6iUXR
z5EWdxZ0QYSTaIouidDcXtBFnnZiVXSZp67oQg/d0aUeVKKLLalFl1tSjR6woB49YsEkekiTWfSY
JtPoQQ3m0aMaXKKHe7hFj/dwjQas4R6NWCMkGtIiLBrTIjQatER4V0HDai4iRTSuJk1HQQPJQaSK
RpJ0bQUNnduIlNHYudTR4CJ9NLoYoiFHl4YdXhpydGnY4YZN0xMhUPA7yBt18QAAAABJRU5ErkJg
gk==

------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean_files/image002.png
Content-Transfer-Encoding: base64
Content-Type: image/png
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------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean_files/image003.png
Content-Transfer-Encoding: base64
Content-Type: image/png

iVBORw0KGgoAAAANSUhEUgAAADEAAAApCAYAAACcGcHqAAAAAXNSR0IArs4c6QAAAARnQU1BAACx
jwv8YQUAAAAJcEhZcwAAIdUAACHVAQSctJ0AAADeSURBVGhD3c/NDYJAEEBh6vdmIx4sxMQmtAwd
TCDRPIRd5peXfCeW2dlBeh3AJ/pQxdxZ0IHsTuIrOpQdRgezWowOZ/U3+iGb1a6CfsziIjZFP2fR
FA2I1hwNidYVDYrS3V3QQG83sSsa6k0lGuxFLRruRTW6wJp6T0EXWXkIk+gyK6bRhdrMo0u1uUQX
a3GLLtfiGi2wV0i0SK+waJleodFCrcKjpVqliBbbKlW04Jp00ZJrUkaLLkkbLbskdbTwrxLR4pMy
0fKTUpV/wNghHjFW/gFT5R8wZvyIYXgDdbrrLIF5CWoAAAAASUVORK5CYIJ=

------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean_files/header.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1252"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
2">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 15">
<meta name=3DOriginator content=3D"Microsoft Word 15">
<link id=3DMain-File rel=3DMain-File href=3D"../Zynteglo_clean.htm">
<![if IE]>
<base href=3D"file:///C:/8467A08E/Zynteglo_clean_files/header.htm"
id=3D"webarch_temp_base_tag">
<![endif]><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"2049"/>
</xml><![endif]-->
</head>

<body lang=3DEN-US link=3Dblue vlink=3D"#954F72">

<div style=3D'mso-element:footnote-separator' id=3Dfs>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'mso-special-character:footnote-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></p>

</div>

<div style=3D'mso-element:footnote-continuation-separator' id=3Dfcs>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'mso-special-character:footnote-continuation-separator'><![if !supp=
ortFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></p>

</div>

<div style=3D'mso-element:footnote-continuation-notice' id=3Dfcn>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><o:p>&n=
bsp;</o:p></p>

</div>

<div style=3D'mso-element:endnote-separator' id=3Des>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'mso-special-character:footnote-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></p>

</div>

<div style=3D'mso-element:endnote-continuation-separator' id=3Decs>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><span
style=3D'mso-special-character:footnote-continuation-separator'><![if !supp=
ortFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></p>

</div>

<div style=3D'mso-element:endnote-continuation-notice' id=3Decn>

<p class=3DMsoNormal style=3D'margin-bottom:0in;line-height:normal'><o:p>&n=
bsp;</o:p></p>

</div>

<div style=3D'mso-element:footer' id=3Df1>

<p class=3DMsoFooter align=3Dcenter style=3D'margin-right:4.8pt;text-align:=
center;
tab-stops:center 3.25in right 446.55pt 6.5in'><!--[if supportFields]><span
style=3D'mso-element:field-begin'></span><span
style=3D'mso-spacerun:yes'></span>EQ <![endif]--><!--[if supportFields]><s=
pan
style=3D'mso-element:field-end'></span><![endif]--><!--[if supportFields]><=
span
class=3DMsoPageNumber><span style=3D'font-size:8.0pt;line-height:107%;font-=
family:
"Arial",sans-serif'><span style=3D'mso-element:field-begin'></span>PAGE<span
style=3D'mso-spacerun:yes'> </span><span style=3D'mso-element:field-separa=
tor'></span></span></span><![endif]--><span
class=3DMsoPageNumber><span style=3D'font-size:8.0pt;line-height:107%;font-=
family:
"Arial",sans-serif'><span style=3D'mso-no-proof:yes'>33</span></span></span=
><!--[if supportFields]><span
class=3DMsoPageNumber><span style=3D'font-size:8.0pt;line-height:107%;font-=
family:
"Arial",sans-serif'><span style=3D'mso-element:field-end'></span></span></s=
pan><![endif]--><span
style=3D'font-size:8.0pt;line-height:107%;font-family:"Arial",sans-serif'><=
o:p></o:p></span></p>

</div>

<div style=3D'mso-element:footer' id=3Dff1>

<p class=3DMsoFooter align=3Dcenter style=3D'margin-right:4.8pt;text-align:=
center;
tab-stops:center 3.25in right 446.55pt 6.5in'><!--[if supportFields]><span
style=3D'mso-element:field-begin'></span><span
style=3D'mso-spacerun:yes'></span>EQ <![endif]--><!--[if supportFields]><s=
pan
style=3D'mso-element:field-end'></span><![endif]--><!--[if supportFields]><=
span
class=3DMsoPageNumber><span style=3D'font-family:"Calibri",sans-serif;mso-a=
scii-theme-font:
minor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:Arial;
mso-bidi-theme-font:minor-bidi'><span style=3D'mso-element:field-begin'></s=
pan>PAGE<span
style=3D'mso-spacerun:yes'> </span><span style=3D'mso-element:field-separa=
tor'></span></span></span><![endif]--><span
class=3DMsoPageNumber><span style=3D'font-family:"Calibri",sans-serif;mso-a=
scii-theme-font:
minor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:Arial;
mso-bidi-theme-font:minor-bidi'><span style=3D'mso-no-proof:yes'>1</span></=
span></span><!--[if supportFields]><span
class=3DMsoPageNumber><span style=3D'font-family:"Calibri",sans-serif;mso-a=
scii-theme-font:
minor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:Arial;
mso-bidi-theme-font:minor-bidi'><span style=3D'mso-element:field-end'></spa=
n></span></span><![endif]--></p>

</div>

</body>

</html>

------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean_files/editdata.mso
Content-Transfer-Encoding: base64
Content-Type: application/x-mso

QWN0aXZlTWltZQAAAfAEAAAA/////wAADfD6AAAARQEAAOoAAAAAAAAACQQAAP8DAgAAAAAAAAAm
BP8AAAACAAAAAAAAACgE/wAAAAIAAQARAgABACwAUQBCAFAATABVAFMAUABMAFUARwBJAE4AMgAw
ADAANwAuAFEAQgBQAEwAVQBTAE0AQQBJAE4ALgBRAFgAXwBHAE8AVABPAE4ARQBYAFQARgBJAEUA
TABEAAAAAAAwAFEAQgBQAEwAVQBTAFAATABVAEcASQBOADIAMAAwADcALgBRAEIAUABMAFUAUwBN
AEEASQBOAC4AUQBYAF8ARwBPAFQATwBQAFIARQBWAEkATwBVAFMARgBJAEUATABEAAAAQAAAC/AE
AAAAEjRWeD==

------=_NextPart_01D74BE8.F0EBCC80
Content-Location: file:///C:/8467A08E/Zynteglo_clean_files/filelist.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml; charset="utf-8"

<xml xmlns:o=3D"urn:schemas-microsoft-com:office:office">
 <o:MainFile HRef=3D"../Zynteglo_clean.htm"/>
 <o:File HRef=3D"item0001.xml"/>
 <o:File HRef=3D"props002.xml"/>
 <o:File HRef=3D"item0003.xml"/>
 <o:File HRef=3D"props004.xml"/>
 <o:File HRef=3D"item0005.xml"/>
 <o:File HRef=3D"props006.xml"/>
 <o:File HRef=3D"item0007.xml"/>
 <o:File HRef=3D"props008.xml"/>
 <o:File HRef=3D"item0009.xml"/>
 <o:File HRef=3D"props010.xml"/>
 <o:File HRef=3D"themedata.thmx"/>
 <o:File HRef=3D"colorschememapping.xml"/>
 <o:File HRef=3D"image001.png"/>
 <o:File HRef=3D"image002.png"/>
 <o:File HRef=3D"image003.png"/>
 <o:File HRef=3D"header.htm"/>
 <o:File HRef=3D"editdata.mso"/>
 <o:File HRef=3D"filelist.xml"/>
</xml>
------=_NextPart_01D74BE8.F0EBCC80--
